The role of the transcription factor Foxn1 in Thymus organogenesis and maintenance by Bosch, Angela Jeanne Tamara
 
 
 
 
The Role of the Transcription Factor Foxn1 in Thymus 
Organogenesis and Maintenance 
 
 
Inauguraldissertation 
 
 
 
zur  
Erlangung der Würde eines Doktors der Philosophie  
vorgelegt der  
Philosophisch-Naturwissenschaftliche Fakultät  
der Universität Basel 
 
 
von 
 
 
Angela Jeanne Tamara Bosch 
aus Mammern TG 
 
 
 
 
Basel, 2014 
 2 
 
 
 
 
Genehmigt von der Philosophisch-Naturwissenschaftlichen Fakultät 
 
auf Antrag von 
 
 
 
 
Prof. Dr. Georg A. Holländer 
Dissertationsleiter und Fakultätsverantwortlicher 
 
 
Prof. Dr. Antonius G. Rolink 
Korreferent 
 
 
Prof. Dr. Giulio C. Spagnoli 
Korreferent 
 
 
 
 
 
 
 
Basel, den 20. 5. 2014 
 
 
 
 
 
 
 
 
 
 
         Prof. Dr. Jörg Schibler 
    Dekan der Philosophisch-Naturwissenschaftlichen Faktultät 
  
 3 
Summary 
The thymus is the primary lymphoid organ responsible for T-cell development and selection, 
which requires a specialised stromal microenvironment. The thymic stroma consists mainly of 
thymic epithelial cells (TEC), which can be divided into cortical (c) and medullary (m) TECs, 
mediating each different functions during T-cell development. The organisation of the thymus 
compartments is crucial for T-cell development. Therefore it is important to understand the 
mechanisms behind thymus development as defects in thymus function can lead to 
immunodeficiency or autoimmunity.  
In the context of thymus organogenesis, Foxn1 serves as a master transcription factor 
essential for TEC development. The loss of Foxn1 constitutes then a molecular cause for 
athymia as the molecules absence blocks TEC growth and differentiation. Consequently the 
epithelial cells adapt another cell fate and the thymus rudiment fails to attract lymphoid 
precursors. 
Mice with either a reduced or time restricted Foxn1 expression at the onset of thymus 
organogenesis displayed a severely disturbed thymus development. Though able to develop 
into cTEC and mTEC, they remain in an immature state as demonstrated by the absence of 
mature TEC. Similar as in congenital athymic nude mice, devoid of Foxn1 expression, also 
common bipotent progenitor TEC were detected. T-cell development was impaired resulting 
consequently in severe peripheral lymphopenia, which only slightly mitigated with 
progressive age. Importantly the peripheral T-cells in both mouse models differ from that of 
nude mice, in that cells with effector and regulatory functions were detected. Furthermore 
inadequate Foxn1 expression lead to colitis and early death. Bowel inflammation was 
associated with an increase in Th1 polarised CD4+ T-cells among intraepithelial and lamina 
propria lymphocytes.  
In aggregate this study showed that TEC differentiation and maintenance depends on both a 
continuous and adequate Foxn1 expression, as short-term or low level Foxn1 expression were 
insufficient to sustain regular thymus development and function. Inadequate expression of 
Foxn1 expression resulted consequently in the loss/absence of a regular thymus 
microenvironment and selection of an autoreactive T-cell repertoire causing auto-immune 
colitis.  
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 6 
1. Introduction 
 
The thymus is a bilobed organ located anterior to the heart. Although the thymus was already 
known for centuries1, its function remained elusive until 1961 when J.F.A.P Miller discovered 
its contribution to the immune system2. Mice that were thymectomised 1-16 hours after birth 
had underdeveloped lymphoid tissues, the lymph nodes and spleen showed a deficiency of 
germinal centres and only few plasma cells were detected. Furthermore these mice were more 
susceptible to infections, however the mortality was reduced when the mice were kept under 
pathogen-free conditions. By transferring genetically marked cells into thymectomised mice it 
was finally shown that the antibody-producing cells (B-cells) were derived from the bone 
marrow whereas thymus derived cells were essential to allow B-cells to respond to 
antigens3,4. The thymus is the primary lymphoid organ responsible for T-cell development, 
which is critically dependant on thymic stromal cells. The thymic stroma mainly consists of 
thymic epithelial cells (TEC) which form a three dimensional meshwork where TEC and 
developing T-cells interact5,6. The size of the thymus decreases after puberty, a process called 
thymic involution7. Although the thymic stroma is indispensable for T-cell development, it 
accounts for less than 1% of the thymic cellularity in the postnatal thymus. The majority of 
the remaining cells are of hematopoietic origin and consist mainly of thymocytes and to a 
lesser extent of phagocytic macrophages and antigen-presenting dendritic cells (DC)7. 
 Thymus organogenesis  1.1.
Thymus development is closely linked to that of the parathyroid. Both organs emerge from a 
bilaterally positioned organ primordium that arises from the third pharyngeal pouch 
endoderm8. Thymus organogenesis initiates at embryonic day (E) 9.5 with the formation of 
the pharyngeal pouches and the consequent development of a thymus primordium. At E10.5 a 
visible thymus-parathyroid anlage is created by the interaction of epithelial cells of the third 
pharyngeal pouch endoderm and mesenchymal cells9.  
An early descriptive study based on morphological analyses suggested that endodermal and 
ectodermal germ layers of the third pharyngeal pouch interact at E9.5 with each other to form 
this primordium10. This claim lead to the dual-origin model, proposing that the thymic stroma 
is derived from both endodermal and ectodermal layers, and that the endodermal layer would 
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give rise to medullary TEC whereas contributions of the ectodermal layer differentiates into 
cortical thymic epithelial cells. In parallel N. M. Le Douarin and F. V. Jotereau11 
demonstrated with chick-quail chimeras that the thymus evolves only from the endoderm. 
This conclusion was drawn from experiments in which pharyngeal endoderm was isolated 
from quail embryos and transplanted into the body cavity of 3 days old chick-embryos. Using 
two different species enabled them to distinguish the origin of the cells. The grafted tissue 
developed into a thymus, the developing T-cells however where of chick origin. The stroma 
cells inside the graft were shown to be of quail origin, indicating that both cortex and medulla 
developed from the grafted endoderm. Nevertheless, there was a long standing debate on the 
contribution of endoderm and ectoderm to the formation of the thymus medulla and cortex12. 
Textbooks favoured to dual-origin model, since the experiments were conducted in mice, 
whereas the single origin model was derived from an avian model. This debate persisted until 
Gordon et al. confirmed in 2004 the single origin theory in a mammalian model13. They 
demonstrated the direct contact of the third pharyngeal pouch endoderm and the third 
pharyngeal cleft ectoderm. However labelling cells form the third pharyngeal ectoderm 
showed no contribution of ectoderm to the thymus primordium. Transplantation exclusively 
of E8.5-E9 pharyngeal endoderm under the kidney capsule of athymic mice (also known as 
nude mice) showed that a functional thymus was generated, including cortical and medullary 
areas mediating normal T-cell development. To rule out a contribution of the ectoderm, the 
endoderm was isolated at a developmental stage (E8.5-E9) before the interaction with the 
ectoderm takes place. Two recent studies using human embryonic stem cells (hESCs) 
underline the single endodermal origin of the thymus. hESCs were differentiated first into 
endoderm, then into anterior foregut endoderm, followed by differentiation into ventral 
pharyngeal endoderm and finally into thymic epithelial progenitor cells (TEPC). The TEPC 
were transplanted into a nude mice where they were shown to mature into thymic epithelium 
able to support T-cell development14,15.  
Thymus organogenesis can be divided into distinct steps (Figure 1.1). It starts at E9.5 with the 
positioning of the pouches a process dependent on several transcription factors. The 
transcription factors paired box gene 1 (Pax1), paired box gene 9 (Pax9), T-box1 (Tbx1) and 
eye absent homolog (Eya1) as well as fibroblast growth factor 8 (FGF8) are involved in the 
early pouch formation. In mice deficient for Pax9 or Fgf8 the thymus is severely reduced in 
size and develops ectopically16,17. The deficiency of Pax1 leads to a hypoplastic thymus with 
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a reduced frequency of CD4 and CD8 double positive thymocytes18. Eya1 was shown to be 
upstream of Pax1, Tbx1 and Fgf8, as the development of the thymus/parathyroid organ 
primordia failed in Eya1 deficient mice19,20. The homeobox protein a3 (Hoxa3) defines the 
axial identity of the pouch and is involved together with sine oculis homolog 1/4 (Six1/4) and 
Pax9 in the initial organ formation and patterning. Hoxa3 and Six1/4 deficient mice are 
athymic and lack the parathyroid20,21.            
At E11 the outgrowth of the rudiment and patterning begins. At this stage the expression of 
the transcription factor glial cells missing homologue 2 (Gcm2) is initiated22. Shortly after, 
Foxn1 expression initiates the patterning in two distinct organs. The dorsal part of the 
primordium expresses Gcm2 and gives rise to the parathyroid23, whereas the ventral part 
expresses Foxn1 and gives rise to the thymus24. So far it remains elusive what specifies the 
initial organ fate, Gcm2 and Foxn1 seem to be required only for organ-specific 
differentiation. In the absence of Foxn1 or Gcm2 the 3rd pharyngeal pouches and later also 
prospective thymus and parathyroid specific poles are formed but further development is 
hindered and consequently the organs remain in an early progenitor stage. In the absence of 
Foxn1 a thymus primordium is formed, but TEC fail to differentiate into cortical and 
medullary subsets, remain in an early progenitor stage and fail to attract lymphoid 
precursors25–27. As a consequence the three dimensional organisation of the thymus is absent 
and the thymus degrades into cysts5,28. Thus, early thymus development is Foxn1 independent 
but after organ initiation Foxn1 is required for organ maturation.  
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Figure 1.1: Thymus organogenesis. (A) Positioning of the pharyngeal pouches starts at E9.5 and requires 
expression of Pax1, Pax9 and Fgf8. Expression of Hoxa3 defines the axial identity of the for 3rd pharyngeal 
pouch. (B) Initiation and rudiment outgrowth begins at E11 and is dependant on the Hox-Pax-Eya-Six cascade. 
The pouch is surrounded by neural crest cells (NCC), which support development. (C) Between E11.5 and E12.5 
the rudiment outgrowth and patterning into parathyroid domain (dependant on Gcm2) and thymus domain 
(Foxn1 dependant) occurs. (D) At E12 the shared primordium separates from the pharynx and contains two 
distinct areas. The separation from the pharynx is mediated by apoptotic cell death and requires Pax9. The 
migration of the shared primordium is controlled by neural crest cells, and is dependant on Hox3 genes. The 
NCC support TEC differentiation and proliferation by secretion of Fgf7 and Fgf10. (E) At E13.5 the shared 
primordium is separated in two distinct organs. NCC cells separate the thymus from the parathyroid as they form 
a wedge between the organs. (F) From E13.5 until birth the thymus and parathyroid migrate to its final position 
above the heart and beside the thyroid, mediated by NCC. Adapted from Blackburn and Manley 200429 and 
Gordon and Manley 201112. 
 
After patterning into two different domains the common primordium detaches from the 
pharynx by apoptotic cell death13. The precise mechanisms controlling this apoptosis 
mediated detachment are still elusive, however mouse models with absent separation from the 
pharynx revealed a possible role for neural crest cells (NCC) in this process30,31. In Splotch 
(Pax3) deficient mice the thymus remains attached to the pharynx, these mice display a severe 
loss of NCC, indicating that the absence of NCC hinders the separation of the thymus from 
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the pharynx31. Between E12.0 and E12.5 the parathyroid and the thymus separate thus 
forming two distinct organs. This separation process is so far not fully understood. 
Histological analyses showed that neural crest-derived mesenchymal cells move between the 
border of the two poles of the shared primordium and help to push them apart32. A similar 
mechanism was described to take place during somitogenesis33. A possible role for the 
mesenchyme in this process is further supported by the finding that mutant mice with NCC 
specific deficiencies show a disturbed segregation into thymus and parathyroid. Ephrin B2 is 
required for normal migration of NCC derived mesenchyme and consequently, mice with 
NCC deficient for ephrin B2 show a delayed segregation of thymus and parathyroid34. Pax 3 
deficiency lead to a disturbed boundary between thymus and parathyroid domain, identifying 
a role for NCC cells in the separation of the two organs31.  
With ongoing development the two-dimensional epithelial bilayer converts to a clustered 
organisation (E12) and finally TEC form a three dimensional meshwork by E13.526. After the 
separation into parathyroid and thymus at E12.5 the thymus migrates to its final anatomical 
position above the heart. The mechanisms controlling thymus migration are not fully 
understood. However there is evidence that migration of the thymus is supported by neural 
crest-derived mesenchyme. NCC are a migratory population, therefore it is feasible that they 
pull the thymic lobes to their final position. The separation of the rudiment from the pharynx 
occurs normally in mice with a NCC specific deletion of ephrin B2, however the thymus does 
not migrate and is ectopically located in the cervical region. The deletion of ephrin B2 
specific in NCC resulted in a reduced motility of NCC, indicating a NCC specific role of 
ephrin B2 signalling in thymus migration34. However, it is still elusive how thymus migration 
is controlled and which directional clues it follows. It was shown that thyroid migration is 
dependant on the pharyngeal blood vessels35. In hedgehog deficient mice the blood vessels 
are ectopically positioned, and the thyroid tissue is always located next to this ectopic 
pharyngeal blood vessel. Furthermore in zebra fish it was shown that ectopic vascular cells 
are able to redirect thyroid migration35. Due to the close proximity of the carotid arteries 
during migration of the thymus it is feasible that thymus migration is linked to the presence of 
carotid blood vessels.  
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1.1.1. Mesenchymal contribution to thymus organogenesis 
In addition to the epithelial cells of the third pharyngeal pouch neural crest and mesodermal 
derived mesenchyme contribute to the formation of a regular thymus. Epithelial-mesenchymal 
interactions are crucial for the formation of many different organs. The thymus primordium is 
surrounded by a mesenchymal capsule derived from neural crest cells. Interactions of neural-
crest derived mesenchyme and thymic epithelial cells are important for thymus formation, as 
removal of the mesenchymal capsule showed that the epithelial primordium did not develop 
into an organ on its own36. This is further supported by the absence of a thymus or a reduced 
thymus size after experimental removal of the pharyngeal NCC in chick embryos37. In 
contrast to these findings, transplantation of pharyngeal endoderm under the kidney capsule 
of nude mice results in a functional thymus consisting of cTEC and mTEC, thus indicating 
that the initial organ formation is independent of NCC, since the endoderm was removed 
before NCC migration takes place13. However it cannot be excluded that mesenchymal cells 
at the transplantation site contribute to organ formation. Further evidence for an NCC 
independent initial organ pattern is obtained from Pax3 deficient mice. Despite a severe NCC 
deficiency in these mice, a thymus is present, however the boundary between thymus and 
parathyroid is disrupted and the organ fails to migrate to its anatomical position, indicating 
that NCC are dispensable for initial organ patterning, but not for organ migration31.  
The mesenchyme supports TEC proliferation and differentiation via secretion of fibroblast 
growth factors 7 and 10 (Fgf7, Fgf10), which signal to the Fgfr2IIIb receptor on TEC38–40. 
Evidence for the importance of this signalling pathway came from Fgfr2IIIb deficient mice, in 
which the outgrowth of the thymic rudiment is arrested after E12.5. A specific role for 
PDGFR-α+ mesenchymal cells in regulating TEC development via production of insulin-like 
growth factor 1 and 2 was demonstrated by grafting fetal thymus devoid of PDGFR-α+ 
mesenchyme, the thymus did differentiate however it was reduced in size41. NCC derived 
mesenchyme was shown to contribute to the thymus vascularisation. When Foxn1+ ES cells 
devoid of vascular endothelial growth factor (VEGF) expression were injected into 
blastocysts derived from nude mice, the mesenchyme partly restored thymus vasculature, 
although the branching pattern was altered42. By linage tracing experiments these VEGF 
producing mesenchymal cells were identified as NCC derived43. The contribution of neural-
crest cell derived mesenchyme to the thymus was believed to decrease once the vasculature is 
established and epithelial cells support T-cell development44,45. However newer studies, in 
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which NCC were genetically labelled, showed that NCC cells are still contributing to the 
adult thymus. NCC derived cells were shown to differentiate into pericytes and smooth 
muscle cells both involved in forming a supportive network for thymic blood vessels46. 
Recently retinoic acid (RA) generated by the thymic mesenchyme was identified as a negative 
regulator of TEC expansion. Upon adding of a RA antagonist to fetal thymic organ cultures 
(FTOC) an increase in TEC numbers in particular in cTEC was observed. RA generating 
mesenchymal cells were also identified in the adult thymus, indicating a role for RA in 
postnatal TEC homeostasis47.  
 
1.1.2. Immigration of lymphoid progenitors 
The earliest lymphoid progenitor cells arrive at the thymus primordium as early as E11.548. 
The attraction of the lymphoid progenitor cells is controlled by the expression of the 
chemokines CCL21 and CCL2549. At this early stage of development the thymus does not 
have a vascularisation46,49 therefore the progenitors enter the thymus through the capsule26. 
The seeding of the thymus anlage is not a continuous event, rather lymphoid progenitor cells 
enter the thymus in waves at distinct developmental stages of organogenesis11,50. During 
migration of the thymus no additional progenitors enter the thymus. After the thymus has 
reached its final anatomical position, the second wave of T-cell precursors arrive51,52. 
The initial patterning of the thymic epithelial compartment, as defined by a differential keratin 
expression in TEC is independent of the homing of lymphoid cells to the anlage53. TEC 
differentiation in recombination-activating gene 2/common cytokine receptor-chain deficient 
(RAG2/γc) and Ikaros-deficient mice was normal until E13.5 despite a block in early 
lymphocyte differentiation. After this stage interactions with developing T-cells (designated 
thymocytes) are, however crucial for TEC differentiation and the formation of a cortex and 
medulla6,54,55. The regular organisation of the cortex requires crosstalk with thymocytes that 
have committed to the T-cell lineage5,6. Progression in thymocyte development from 
CD44+CD25- to CD44-CD25+ thymocytes has an impact on the development of the thymic 
cortex including the three dimensional organisation. CD3ε transgenic mice have a block in 
early T-cell development (do not develop further than CD44+CD25-) and as a consequence 
the thymus displayed large cysts, the normal cortical organisation was missing and a distinct 
boarder between cortex and medulla was absent. Furthermore the epithelial cells were 
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organised in a two dimensional fashion and local accumulations of B-cells were observed56. 
However reconstitution of thymopoiesis with bone marrow of WT mice lead only to a rescue 
of the cortical organisation in fetal mice, but not in adult mice. This result indicates that the 
induction of a normal cortical organisation takes place only within defined periods in 
development. The presence of a regular cortex, however, is required for the development of a 
thymic medulla. In Rag2-/- mice where thymocyte development is blocked at a later CD44-
CD25+ stage the cortex develops, however the medulla formation is absent. Reconstitution of 
CD3ε transgenic mice with Rag2-/- bone marrow resulted in cortex formation, cysts were 
absent and B-cells were also reduced. A second transplantation with wild type bone marrow 
resulted in a complete reconstitution of the thymic microenvironment57. Similar observations 
were also made in TCR-α deficient mice, in which development is blocked at the CD4+/CD8+ 
double positive stage. These mice displayed a normal cortex but a disorganised medulla58. 
Thus the formation of the medulla is dependent on the presence of single positive 
thymocytes59,60.  
 T-cell development in the thymus 1.2.
Thymopoiesis is a temporally and spatially controlled process, which is reflected by separate 
anatomical compartments each responsible for driving different stages of T-cell development. 
These are the subcapsular, cortical, cortico-medullary junctional and medullary areas.  
The thymus is thought to lack self-renewing hematopoietic precursors securing a continuous 
generation of T-cells. Consequently a continuous supply of blood-borne lymphoid precursor 
cells need to access the thymic microenvironment61,62. However this concept is challenged by 
recent reports suggesting that T-cell development can take place even in the absence of such a 
steady import of progenitor cells, as shown in thymus transplantations into IL-7 receptor 
deficient hosts63 or Rag2-/-γc-/-kitW/Wv mutants64. Grafting of wild type thymus into Rag1-/- 
hosts leads to a first wave of emerging T-cells, however grafting into Rag2-/-γc-/-kitW/Wv 
mutants, completely devoid of T-cell progenitors, resulted in T-cell development that 
continued for several months. From this experiments the conclusion was made that the 
thymocyte turnover is dependent on the competition with hematopoietic precursors. 
Precursors enter the thymus at the cortico-medullary junction (CMJ), where a dense network 
of endothelial cells with high endothelial venules (HEV)65 enable both the entry of precursors 
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and the exit of differentiated thymocytes. Whether after the establishment of the blood 
circulation the same chemokines are of importance as in early embryogenesis is still unclear. 
However a study showed a possible role for CCR9 (the receptor for CCL25) in attracting 
precursors after the establishment of the vasculature66. Transplantation of CCR9 deficient 
bone marrow into lethally irradiated Rag1-/- hosts resulted in a reduced repopulation of the 
thymus compared to wild type bone marrow, indicating a role for CCR9 in the process of 
precursor attraction. Hematopoietic precursors do not continuously enter the thymus, it was 
shown that entrance of precursors is rather a gated and cyclic event67. To show this cyclic 
entrance of precursors mice were intrathymically injected with bone marrow cells to first 
synchronise the gating event, followed by intrathymically or intravenous injection of 
congenic BM cells, the degree of chimerism revealed two distinct phases in the thymus. In a 
first phase an increase in donor thymocytes is observed in the thymus, this phase is followed 
by a decrease in donor thymocytes, indicating that the influx of new precursors is still 
prevented, leading to a cyclic entrance of precursors. T cell development can be easily staged 
by the expression of the co-receptors CD4 and CD8 (Figure 1.2). The earliest thymic 
progenitors express neither CD4 nor CD8 and are therefore termed double negative (DN). The 
DN subset can be further divided in the mouse into four consecutive developmental stages 
according to their expression of CD25, CD44 and ckit (CD117). Since CD44 is also 
expressed on many nonlymphoid cells, ckit is included to define the developmental steps 
expressing CD44.  
The earliest progenitors DN1 are lineage negative and characterised by the expression of ckit 
and CD44 in the absence of CD25. These early progenitors still bear the potential to develop 
into myeloid, natural killer (NK) and dendritic (DC) cells68–70. With ongoing development the 
precursor loose this potential and fully commit to the T-cell lineage. DN1 are located at the 
cortical-medullary junction where they remain for approximately 10 days71. At this early 
stage Notch signalling mediated by one of its ligands, Delta-like 4, which is expressed on 
cortical TEC serves the commitment to the T-cell lineage68–70. Indeed, deletion of this Notch 
ligand exclusively on TEC leads to a complete lack in T lineage commitment and hence in a 
block in T-cell development72. Instead the uncommitted T-cell precursors adopt a B-cell fate 
and regular B-cell development can be observed in the thymus of these mice. DN1 cells 
eventually migrate into the cortex towards the subcapsular zone and acquire the expression of 
CD2573. Now designated DN2, these cells initiate the rearrangement of TCR-β locus.  
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Once accessing the area of the subcapsular zone, the T-cell lineage committed thymocytes 
down regulate the expression of ckit and CD44 and thus acquire the phenotype designated 
DN3. At this stage, these thymocytes have completed the TCR-β rearrangement. In the event 
that this rearrangement has successfully resulted in the generation of a productive β-chain a 
pre-TCR is expressed composed of that rearranged β-chain and an invariant surrogate α-
chain, known as the pre-TCR α-chain. Transition from DN3 to DN4 stage defined by 
concomitant absence of CD44 and CD25 requires the provision of survival signals mediated 
via the pre-TCR. This process is referred to as the β-selection and constitutes a checkpoint in 
thymocyte development74. Thymocytes that did not successfully rearrange the β-chain fail to 
produce a functional pre-TCR, and hence lack the necessary signals to survive and are 
eventually eliminated by apoptosis.  
DN4 cells and their progeny reverse the direction of travel and migrate now from the 
subcapsular zone towards the medulla. In the outer cortex they upregulate CD4 and CD8 
expression, which classifies them as double positive (DP) thymocytes. At this stage the α-
chain of the TCR rearranges and replaces the pre TCR α-chain, forming a complete and 
functional α/β TCR on the cell surface of DP thymocytes75,76. The survival of DP thymocytes 
is dependant on the TCR-mediated interaction with self-peptide-MHC complexes presented 
by cTEC, a process designated thymocyte positive selection. The rearrangement of the TCR 
result in a great variability in TCR specificities, however not all of the receptors are able to 
interact with MHC or they even can cause harm. To avoid these T-cell clones selection 
mechanisms are included. In contrast to B-cells T-cells recognise their antigen in an MHC-
restricted fashion, therefore they have to express a TCR specific for self-MHC molecules 
presenting foreign antigens. DP thymocytes expressing a TCR with intermediate and higher 
avidity for self-peptide MHC complexes receive sufficient survival signals that allow for the 
rescue of thymocytes against a default mechanism which initiates programmed cell death 3 to 
4 days after the expression of the complete TCR. However, in the instance that this interaction 
is too weak or absent, DP cells will not be rescued and undergo apoptosis77,78. If the 
interaction between the TCR and its cognate MHC/peptide complex is too strong DP 
thymocytes will also undergo apoptosis. The selection of immature thymocytes based on their 
TCR affinity for self/MHC complexes has been named the affinity model. DP cells that have 
received a selection signal can be distinguished from pre-selection and late post-selection 
thymocytes by the presence of the early activation marker CD69 and an intermediate 
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expression of the TCR. Positive selection of DP thymocytes results in a down regulation of 
both co-receptors CD4 and CD8 (CD4lowCD8lowTCRintermediate), this down regulation is 
followed by a re-expression of CD4 and shortly after of CD8 
(CD4highCD8intermediateTCRintermediate)79. After this stage the activation of a lineage specific 
program is induced, resulting in the loss of either CD4 or CD8 expression, dependant on the 
MHC restriction. Thymocytes with a TCR specific for antigens presented by MHC Class I 
molecules stop the expression of CD4 and upregulate the expression of the TCR and become 
CD8 single positive thymocytes defined as CD8highCD4-TCRhigh. However if the TCR 
recognises an antigen in a MHC Class II dependant context the thymocytes will stop the 
expression of CD8, upregulate their TCR expression and develop into CD4 positive 
thymocytes defined as CD4highCD8-TCRhigh.  
Following positive selection the single positive (SP) thymocytes migrate into the medulla, 
where the TCR repertoire is screened for self-reactive specificities, which will be eliminated 
in a process called negative selection. This process is mediated by mTEC and dendritic cells 
(DC)80, which display a diverse set of self-peptides. mTEC are specialised to express sets of 
genes representing essentially all tissues of the body. This promiscuous gene expression is in 
part regulated by the autoimmune regulator AIRE81,82 and ensures central tolerance. SP 
thymocytes that express a TCR with low affinity for self-peptide MHC complexes will 
survive, whereas thymocytes with a TCR with a high affinity for self-peptide MHC 
complexes will be negatively selected and eventually undergo apoptosis. Some CD4 T-cells 
with an intermediate to high affinity TCR and thus auto-reactive T-cells were shown to escape 
negative selection by developing into Foxp3+ regulatory T-cells83,84. The precise mechanism 
how they escape negative selection is still elusive, however it was shown that the presence of 
either TGF-β85 or IL-286 could rescue thymocytes from negative selection87. A recent study 
showed that CD27/CD70 interactions rescues developing regulatory T-cells from apoptosis88. 
Mice deficient for either CD27 or CD70 had reduced numbers of regulatory T-cells in the 
spleen and thymus, whereas all the other subsets were not affected. Adding soluble CD70 to 
fetal thymic organ cultures increased the regulatory T-cell output, whereas blocking of CD70 
lead to a reduction of regulatory T-cells. These findings suggest an important role for CD70, 
expressed on mTEC, for regulatory T-cell development.  
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Figure 1.2: T-cell development in the thymus. The thymus is mainly composed of cortex and medulla, each 
containing distinct thymic epithelial cells. Haematopoietic precursors enter the thymus at the cortico-medullary 
junction and migrate through the cortex and the subcapsular region, where they interact with stromal cells and 
develop into CD4+CD8+ double positive thymocytes. The immature CD4-CD8- double negative (DN) 
thymocytes are divided into four subsets based on the expression of CD25 and CD44. DN1 are CD25-CD44+, by 
upregulation of CD25 they become DN2, DN3 have lost expression of CD44 and DN4 are CD25-CD44-. 
Interaction of DN4 thymocytes with cortical TEC (cTEC) lead to positively selected CD4+CD8+ double positive 
(DP) thymocytes that migrate into the medulla where they finally differentiate into CD4+ or CD8+ single positive 
thymocytes. Medullary thymic epithelial cells (mTEC) and dendritic cells (DC) mediate negative selection and 
delete auto-reactive thymocytes. CD4+ or CD8+ single positive thymocytes that have completed differentiation 
leave the thymus through the cortical medullary junction and migrate into the periphery. Adapted from Germain 
200289. 
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Thymocytes that finished the selection process, undergo post selection maturation including 
the upregulation of the homing receptor CD62L and sphingoisine-1-phosphate receptor 1 
(S1P1) required for the egress to the circulation90. 
 Thymic microenvironment 1.3.
The thymus consists as previously mentioned of a heterogeneous network of specialised 
stromal cells including TEC, fibroblasts, endothelial cells, neural cells, macrophages and 
dendritic cells that provide a structural and inductive microenvironment for T-cell 
development. TECs are characterised by the expression of the epithelial cell adhesion 
molecule (EpCAM) and can be divided into two main distinct subtypes, namely cortical and 
medullary TEC. Using cell surface and intracellular markers91 these subtypes are 
distinguished according to their function and localisation (Figure 1.3).  
Cortical TEC (cTEC) are characterised by the expression of Ly5191, CDR192, ERTR493 and 
the cytokeratins (CK) 8 and CK1894. cTEC mediate early T-cell development and positive 
selection of thymocytes. Different functional subsets can be identified according to the 
expression of Dll472, CD20595, Cathepsin L96 and 5t97. The endocytic receptor CD205 was 
shown to facilitate binding and uptake of apoptotic thymocytes98,99. However CD205 does not 
appear to have any role in thymocyte development or selection as demonstrated in CD205 
deficient mice100. These mice did not show any changes in the thymic microenvironment, all 
compartments were present and normally distributed, T-cell development and positive 
selection were not altered. Positive selection by cTEC requires the presentation of self-
peptides that have undergone degradation by proteasomes or endosomal/lysosomal 
compartments. Cathepsin L plays a role in MHC II mediated positive selection of CD4+ T-
cells96,101 as demonstrated in Cathepsin L deficient mice. The thymus specific proteasome 
catalytic subunit β5t is involved in the generation of peptides from self-antigens that are 
loaded onto MHC Class I molecules, the ligand for developing T-cells with a MHC Class I 
restricted T-cell antigen receptor to cause them to develop into single positive CD8+ T-cells. 
Consequently mice lacking β5t have a reduction in CD8 T-cells97 and mice lacking Cathepsin 
L show a reduction in CD4 thymocytes102. 
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Medullary TEC (mTEC) are characterised by the expression of the lectin binding Ulex 
europaeus Agglutinin 1 (UEA1), the cytokeratins CK5 and CK14, CD80, MTS10, ERTR5, 
Claudin3/4 and Cathepsin S. mTEC are involved in the negative selection of thymocytes, 
contributing to a self-tolerant T-cell repertoire by effecting the elimination of thymocytes 
with an autoreactive T-cell antigen receptor. Therefore tissue-restricted antigens are 
expressed, representing almost all peripheral tissues on mTEC. The promiscuous gene 
expression108 is in part regulated by a special subset of MHC IIhigh mTEC expressing Aire. 
However, not all TRA depend on Aire expression. Indeed a subset of Aire-independent TRA 
was shown to be regulated by lymphotoxin signalling109. Nevertheless, the importance of Aire 
is shown in Aire deficient mice, which suffer from organ-specific autoimmunity110–112. mTEC 
differentiation can be characterised by different maturation steps. Immature mTECs 
(mTEClow) are MHC IIlowCD80lowAire- and develop into mature mTEC (mTEChigh) that are 
characterised by the expression of MHCIIhighCD80highAire+ and finally into terminally 
differentiated mTEC identified as MHC IIlowCD80lowairelowInvolucrin+113–116. 
 Thymic epithelial cell progenitors 1.4.
A bipotent thymic epithelial progenitor cell (TEPC) that can give rise to both cortical and 
medullary TEC has been shown to exist in both the embryonic and the adult thymus117,118. 
The first hint for a bipotent progenitor came from histological studies of nude and wild type 
embryos. In the absence of Foxn1 TEC are arrested in a progenitor stage characterised by the 
expression of MTS20 and MTS24107 and the lack of expression of mature TEC markers 
including MHC classII103. Additional descriptive analysis on histological sections on the 
expression of CK5 and CK8 showed that TEC in the thymus rudiment are positive for both 
cytokeratins. With progression of development, in wild type mice, these cells adopt either a 
CK5+CK8- medullary or a CK8+CK5- cortical TEC phenotype54,94,119. Hence these studies 
suggested that TEC early in development express concomitantly CK5, CK8, MTS20 and 
MTS24 and may thus represent the so far elusive thymic epithelial precursor cell. 
The model of a simple bipotent precursor, giving rise to both cTEC and mTEC is challenged 
by recent findings, showing that early embryonic bipotent TEPC sequentially co-express the 
cTEC marker CD205 and respond to RANK stimulation, the latter a feature of mTEC95. 
RANK was shown to control mTEC development in the embryo113, however so far no 
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antibodies or reporter mice are available to monitor RANK expression, thus upregulation of 
the surrogate marker CD40 and MHC Class II are used. The analysis of embryonic TEC 
identified at E11.5 a small subset of CD205+ TEC, which increases in number and from E13.5 
onwards they additionally express CD40. CD205+CD40- TEC express a genetic profile 
associated with cTEC, whereas CD205-CD40+ TEC are considered as mTEC120. 
Transplantation of reaggregated thymic organ cultures (RTOC) using purified CD205+CD40- 
progenitors gave rise to cortical and medullary thymic areas able to support normal T-cell 
development 95. Further evidence for a bipotent precursor expressing cTEC markers comes 
from lineage tracing experiments, showing that the majority of mTEC are derived from a β5t+ 
progenitor population105.  
In addition to the existence of a bipotent precursor, experimental evidence has been generated 
that suggests the presence of cTEC and mTEC restricted progenitors. The presence of a direct 
mTEC progenitor was demonstrated by cell tracing experiments using MHC mismatched 
chimeras, showing the formation of medullary islets, each of them arising from a single 
progenitor121. Separate progenitors were also described for the cTEC lineage using analysis of 
differentiation, proliferation and gene expression profiles. The emergence of the cTEC 
lineage from a bipotent precursors occurs as early as E12 and is dependent on Foxn1, as 
shown by the absence of CD205 and β5t in Foxn1 deficient mice120. The earliest cTEC 
progenitor was detected on E15 and identified as EpCAM+CD205+CD40-. 
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Figure 1.4: Models of thymic epithelial cell development from a bipotent thymic epithelial precursor cell: 
(A) In the synchronous model a bipotent precursor gives rise to cTEC and mTEC restricted progenitor cells 
giving rise to cTEC and mTEC. In the asymmetric serial progression model the progenitor develops first into a 
cTEC like progenitor cell, which develops by default into cTEC, development into mTEC linage requires 
additional signals. In the symmetric serial progression model TEPC develop into a transient TEPC with cTEC 
and mTEC marks that gives rise to both cTEC and mTEC.  
 
In summary two different models of thymic epithelial cell development currently exist 
(Figure 1.4)122. In the synchronous model an uncommitted bipotent TEPC gives 
simultaneously rise to lineage restricted cTEC and mTEC progenitors. In the progression 
model the development of TEC includes a transitional TEC progenitor stage that expresses 
phenotypic and molecular features associated with cTECs. The latter model is supported by 
the latest findings that Aire+ cells originate from β5t expressing cells and that CD205+ 
precursor give rise to both cTEC and mTEC95,105. The progression model includes two 
different scenarios for the development of TEC. A first one designated as serial progression 
model suggests the commitment to the cTEC linage constitutes a default program and 
development into the mTEC lineage requires additional signals. In contrast in the so called 
symmetric progression TEPC can develop with equal likelihood into either mTEC or cTEC. It 
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can not be excluded that the transitional thymic epithelial progenitor has not only features of 
the cTEC lineage but also of the mTEC lineage but the markers are not identified yet122.  
 The transcription factor FoxN1 1.5.
The Forkhead-box transcription factor N1 (Foxn1 also known as winged helix nude Whn or 
Hfh11), belongs to the family of winged helix/forkhead transcription factors. They are 
characterised by a 100 amino-acid monomeric DNA-binding domain that folds into a variant 
of the helix-turn-helix motif. Because of the characteristic butterfly shape of the motif these 
transcription factors were named winged helix123. Winged helix/forkhead transcription factors 
are key regulators in embryogenesis and in the maintenance of differentiated cells124. The 
Foxn1 gene consists of two alternative first exons, 1a and 1b, and 8 coding exons. Exons 5, 6 
and 7 encode for the DNA binding domain. The transcriptional activation domain is encoded 
by exons 8 and 9. Using mRNA from mouse thymus and skin, the tissue-specificity of 
alternative first exon usage was analysed and identified 1a-2 transcripts in both thymus and 
skin, whereas 1b-2 transcripts were used exclusively in the skin. In addition to the alternative 
first exons a second type of splicing was observed taking place at the splice acceptor junction 
in exon 2125. The Foxn1 gene is located on chromosome 11 in mouse and chromosome 17 in 
human125,126. Both sequence and function of Foxn1 are highly conserved among rodents and 
humans125,127. 
Foxn1 serves as the master regulator of the differentiation events that eventually control 
regular thymus development but also coordinate the normal formation of the hair shafts and 
the physiology of the mammary gland. Hence Foxn1 is mainly detected in the epidermis, hair 
follicles, mammary gland and in the thymic epithelium. Mutations in Foxn1 are characterised 
by defects in the keratinisation of the hair shafts leading to an absence of fur due to the 
physical breaking of hair at the skin surface128. The lack of regular Foxn1 expression also 
leads to underdeveloped mammary glands and females are not able to lactate their 
offspring129. Finally and functionally most restrictive thymus organogenesis is arrested at an 
early stage resulting in a primary T-cell deficiency130,131.  
This array of interesting phenotypes was first observed in mice with a spontaneous loss of 
function mutation of Foxn1. The original description of these mice from 1966 noted a hairless 
skin, hence the notion “nude”132. The precise nature of the complex phenotype was however 
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only identified 28 years later using sequencing analysis24. Despite the complete absence of 
thymopoietic activity in Foxn1 deficient mice a small population of T-cells can be observed 
in older animals which are obviously generated extrathymically133. Due to their failure in hair 
follicle formation and the deficiency in T-cell development nude mice are widely used as 
model for transplantation, immunological, oncological and dermatological studies133,134.  
Foxn1 mRNA is first detected as early as E10.5135, the protein is first detected at E11.5 in 
TEC and is robustly expressed at E12.5.22,136,137. The induction of the outgrowth of the 
thymus anlage is Foxn1 independent, however Foxn1 is cell-autonomously involved in 
patterning and differentiation of immature epithelial cells into functional cortical and 
medullary TEC25,107. This was demonstrated in a chimeric thymus where the presence of wild 
type TEC did not induce nude TEC to differentiate into cTEC or mTEC.  
Foxn1 induction and stabilisation is directed by different genes including Wnt5b and BMP4 
that are expressed in the ventral region of the third pharyngeal pouch prior to Foxn1 
expression34,135. Wnt4 and Wnt5b were shown to induce Foxn1 in cultured TEC lines135,138. 
BMP4 is actively upregulating Foxn1 expression in vivo139,140, and Foxn1 expression 
upregulates FgF receptor 2IIIb140. Sonic Hedgehog (Shh) is expressed on the dorsal region of 
the pouch and regulates Gcm2 expression. In the absence of Shh the pouch expresses only 
BMP4, indicating that Shh negatively regulates Foxn1 expression141. FgF8 is also expressed 
before Foxn1 expression in the prospective thymus region. FgF8 was demonstrated to play a 
role in the development of the pharyngeal pouch where it signals to the surrounding NCC 
derived mesenchyme142. Immunohistological analysis showed that Foxn1 deficient epithelium 
was devoid of the Notch ligands Dll1 and Dll4143. Experiments taking advantage of mice with 
different Foxn1 transcript levels showed that Foxn1 directly regulates Dll4, CCL25144 and 
paired-box 1 (Pax1) expression. Reductions in the expression levels of Dll4, CCL25 and Pax1 
in TEC are proportional to the reduced Foxn1 expression106. A comparative analysis of 
transcriptomes between E12.5 nude and wild type mice identified an additional potential 
down-stream target of Foxn1, programmed death 1 ligand145 (PDl ligand). PD1L deficient 
mice show an enhanced T-cell response and CD4+ T-cells produced more cytokines, when 
compared to wild type CD4+ T-cells. The corresponding receptor to PDL1, PD1 is expressed 
on CD4/CD8 double negative thymocytes146, and is important for self-tolerance as mice 
deficient for PD-1 develop autoimmune pathologies147.  
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The absence of lymphocyte precursors in nude mice is explained by the absence of the 
cytokines CCL25 and CXCL12, which are involved in haematopoietic precursors homing. 
Furthermore stem cell factor (scf or kitligand)148 that is involved in expansion of recent 
thymic immigrants is absent in Foxn1 deficient mice149. The absence of Foxn1 leads also to a 
block in thymus vascularisation150. Endothelial cells fail to accumulate in Foxn1 deficient 
mice, whereas they increase in numbers in wild type thymus rudiment shortly after TEC start 
to express Foxn1. VEGF expressed by TEC and mesenchymal cells is involved in thymus 
vascularisation42, VEGF was absent in nude thymus.  
Deletion of Foxn1 using Cre recombinase under the control of K14 regulatory elements has a 
larger impact on the skin than on the thymus. These mice showed a defect in the hair follicle 
formation similar to nude mice, however a thymus was detectable151. The thymus was smaller 
in size when compared to wild type thymus, displayed a disrupted 3-D architecture but 
nevertheless, T-cell development was present. Deletion of Foxn1 under the control of K14 
regulatory elements is only active in cells that are restricted to the medullary lineage. In 
contrast to the thymus Foxn1 expression in the skin is relatively restricted to the hair cortex 
and the skin, whereas in the thymus both cortex and medulla express Foxn1. This suggests 
that Foxn1 in K14+ cells has a crucial role in the skin, whereas its role in the thymus is less 
important.  
Deletion of exon 3 of the Foxn1 gene identified a thymus specific role for the N-terminus, as 
the skin was not affected. The thymus displayed an aberrant architecture lacking cortical and 
medullary regions. Nevertheless this thymus was able to support T cell development, 
although increased frequencies of CD4/CD8 double negative (DN) and reduced percentage of 
CD4/CD8 double positive (DP) thymocytes were noted152. Interestingly DP thymocytes 
developed without passing through a consecutive DN2 (CD44+CD25+) and DN3 (CD44-
CD25+) developmental stage153. These DP thymocytes were shown to arise from an atypical 
ckit- progenitor154. According to the expression of ckit and CD24 (HSA) the DN1 
compartment can be subdivided into DN1a – DN1e, in which DN1a and DN1b are considered 
as the canonical hematopoietic progenitors155. DN1d and e are devoid of ckit expression, 
nonetheless they develop into T-cells in vitro. Their developmental progression into DP is 
faster than DN1a, and in contrast to DN1a-d, DN1e express Rag1 and contain rearranged 
TCRβ chains155. The presence of DN1e could explain the absence of DN2 and DN3 stages 
observed in these mice.  
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The differentiation into the mTEC linage occurs despite the absence of Foxn1, at least as 
indicated by the detection of Claudin4+ CK5+ cells, likely to be early mTEC106. Importantly 
gene dosage experiments showed that the delay in mTEC differentiation correlated with 
reduced Foxn1 expression106. Foxn1 is therefore needed for the initiation of the differentiation 
into the earliest TEC progenitors and for the subsequent progression into cTEC and mTEC. 
The presence of early mTEC in the absence of Foxn1 suggests that Foxn1 is not required for 
the cell fate decision. Low amounts of Foxn1 expression are sufficient for expression of MHC 
class II but not for inducing T-cell development, suggesting different requirements for Foxn1 
in TEC differentiation and their ability to induce thymocyte development106.  
Most of the knowledge on Foxn1 function was gained from experiments on embryonic 
thymus. Studies on postnatal expression and requirements of Foxn1 started only recently with 
the generation of inducible knock-in and knock-out models and are not yet fully understood. 
In the postnatal thymus Foxn1 is required for TEC maintenance. The analysis of different 
Foxn1 mutants with different Foxn1 expression levels showed that TEC maintenance is 
sensitive to Foxn1 dosage156. The observed phenotypes were closely linked to Foxn1 
expression levels, as small changes in Foxn1 levels had large effects on the thymus 
phenotype. A Foxn1 expression of below 50% of normal Foxn1 mRNA results in a loss of 
specific TEC subsets and reduced T-cell development. Different TEC subsets require different 
amounts of Foxn1 mRNA106,156. 15% of wild type Foxn1 mRNA is sufficient for the 
development of mature mTEC, whereas cTEC require higher amounts of Foxn1 for their 
maturation. Furthermore, different TEC subsets have different amounts of Foxn1 mRNA. 
Mature mTEC (MHC Class II high) express higher levels of Foxn1 protein and mRNA 
compared to the mTEClow population. The mTEChigh subset was also the most sensitive to 
experimentally induced down-regulation of Foxn1 expression156. Reduction in Foxn1 
expression in post natal thymus results in changes in the thymic microenvironment similar to 
thymic involution157.  
The first Foxn1 mutation in humans was described in 1999 in two sisters from southern 
Italy127. Foxn1 deficiency in humans leads to an alopecia universalis, nail dystrophies and 
absence of a thymus resulting in a primary T-cell deficiency158. Untreated Foxn1 deficient 
patients rarely survive beyond early childhood due to the T-cell deficiency. There is no cure 
for Foxn1 deficient patients, however their life can be prolonged by bone marrow159 and 
thymus transplantations160,161 
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 Age-related thymic involution 1.6.
Age-related thymic dangers are characterised by a reduction in thymus size, changes in the 
composition and organisation of the thymic microenvironment and consequently by a reduced 
thymopietic activity. Termed in the physiological context as thymus involution these 
alterations are an evolutionarily conserved phenomenon that can be observed in jawed 
vertebrates162. A main feature of thymic involution is the decrease in thymic epithelial 
cellularity, a decline in mTEC resulting in a change in the cTEC:mTEC ratio and a particular 
loss of MHC Class II-high TEC7 which is accompanied by an expansion of the perivascular 
space and an increase in adipose tissue163,164. The segregation of medullary and cortical 
compartments is disrupted163,165 and the complexity of the medullary islets is decreased166 
concomitant with this loss of a regular architecture, areas appear that lack epithelial cells167. 
These changes in the microenvironment lead to a progressive reduction of thymopoiesis, and 
as a consequence to peripheral lymphopenia with an increased memory T-cell pool displaying 
signs of oligoclonal expansion168. The molecular mechanisms that account for thymic aging 
and hence involution are only very poorly defined but clinical observations suggest that age-
related danger in the biology of hematopoietic stem cells and the presence of hormones, 
growth factors and cytokine levels contribute to the changes observed. In addition, and of 
particular relevance for the work presented here, Foxn1 transcripts169 and protein levels137 
decline with age. However it is unclear whether this decrease is the cause or the consequence 
of thymic involution. A direct instructive role of Foxn1 for the structural danger observed is 
suggested by experiments that demonstrate that a reduction of Foxn1 in the postnatal thymus 
accelerates thymic atrophy156,170,171 whereas an over-expression of Foxn1 attenuates age-
related thymic involution172. Independent of the upstream signals operative in changing 
Foxn1 expression, these results suggest that Foxn1 plays a crucial role in thymic involution.  
Aging is also associated with an increased susceptibility for diseases166,173,174. In aged mice 
thymus function is limited, and to compensate the reduced thymic output T-cells proliferate in 
the periphery acquiring a memory/activated phenotype. The frequency of auto-immune 
disease is increasing with age, studies comparing young and aged mice showed that the 
expression of tissue restricted antigens decreases with age166. Consequently T-cells emerging 
from an aged thymus have undergone less stringent selection and include more auto-reactive 
T-cells, leading to auto-immunity with age. 
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Thymic aging is coupled with an increase in fibroblasts175. Thymic epithelial cells can convert 
into fibroblasts by epithelial-mesenchymal transition (EMT)176. EMT in the thymus was 
identified by cell tracing experiments, Foxn1+ cells were permanent genetically labelled using 
LacZ and the phenotype of LacZ positive cells was analysed in 3 month old mice. LacZ+ cells 
colocalise with fibroblast specific protein-1 (FSP1), a marker for EMT177, indicating that 
these cells underwent EMT. In addition these cells are adipogenic. In ghrelin deficient mice 
transcripts associated with EMT are increased, suggesting that ghrelin maintains the thymic 
microenvironment by preventing EMT. Thymic involution is enhanced by the metabolic 
changes in conjunction with obesity, as mice under a high-fat diet accelerate their thymic 
involution178. In contrast mice kept under conditions of caloric restriction display a reduced 
thymic involution and a restored thymic organisation, possibly due to inhibition of EMT179. 
Mice under caloric restriction were also shown to have a reduction in pro-EMT genes, which 
prevents the generation of local fibroblasts.  
Despite the age related changes in the thymic microenvironment thymopoiesis does not stop 
completely180. The reduced thymic output is not caused by a decrease in hematopoietic 
precursor attraction, as shown by experiments where both young and aged mice were sub-
lethally irradiated and reconstituted with either young or old bone marrow. The absolute 
numbers of donor cells recovered in the thymus three days after injection was similar, but the 
numbers increased more rapid in young mice, thus the reduced thymic output is not caused by 
decrease in attraction but is caused by their impaired survival, proliferation and differentiation 
in the thymus181.  
 Homeostatic expansion of T-cells in the periphery 1.7.
A T-cell pool with a broad TCR repertoire of distinct specificities is required for normal 
immune competence. However during aging the thymic output is reduced, and the size of this 
peripheral T-cell pool is maintained against a continuous attrition of T-cells by a mechanism 
of homeostatic T-cell expansion in peripheral lymphoid tissues182. Mature thymocytes leaving 
the thymus receive in the periphery survival signals from self-peptide MHC ligands and 
cytokines especially IL-7183. These interactions provide tonic signals that keep peripheral T-
cells alive. The cells remain in the interphase of the cell cycle and hence hardly 
proliferate184,185. However if naïve T-cells encounter a foreign antigen presented by an antigen 
 29 
presenting cell the TCR signal changes to stimulatory and lead to activation and proliferation, 
T-cell activation requires costimulation via CD28. The homeostasis of the naïve T-cell pool is 
regulated by the competition for survival signals, like IL-7 and self-peptide/MHC ligands that 
are limited under physiological conditions. IL-7 is produced by specialised cells in the 
secondary lymphoid organs. Mice lacking expression of lymph nodes homing molecules like 
CCR7 or CD62L show consequently a reduction in naïve T-cells. The common cytokine 
receptor γ chain is not only used by IL-7 but shared by receptors for the cytokines IL-2, IL-4, 
IL-9, IL-15 and IL-21, which are all important for generation, survival and homeostasis of 
lymphocytes183. IL-4, IL-15 and IL-7 were shown to enhance homeostatic expansion in vitro, 
however in vivo T-cells underwent homeostatic expansion in IL-4 and IL-15 deficient mice, 
but not in IL-7 deficient mice, suggesting an important role for IL-7 in homeostatic 
expansion186. Under conditions of T-cell lymphopenia the consumption of IL-7 decreases, 
which lead to an increase in IL-7 availability and consequently IL-7 now acts as a mitogenic 
stimulus and drives homeostatic expansion. Although IL-2 is able to induce growth, survival 
or death of conventional T-cells, it is dispensable for the homeostatic expansion of T-
cells187,188. Though homeostatic proliferation is a slow process normal T-cell numbers are 
nevertheless restored in the course of weeks given that a sufficient thymic output is still 
maintained or has returned to normal189. Naïve T-cells that undergo homeostatic expansion 
upregulate CD44, down regulate the expression of the homing molecule CD62L and thus 
display a memory like phenotype.  
In mice that are chronically lymphopenic (e.g. Rag2-/-, TCR-/-) rapid homeostatic expansion 
upon adoptive transfer of CD4 T-cells occurs. Beside the normal homeostatic expansion, 
proliferation is also driven by foreign antigens from the commensal microflora189,190. T-cells 
that proliferate in response to foreign antigens require costimulatory signals through CD28 for 
their activation and display a upregulation of acute activation marks180,191. This antigenic 
proliferation was reduced when mice were kept in a germ-free environment192, indicating that 
the response is directed against the commensal microflora. 
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 Extrathymic T-cell development 1.8.
The presence of T-cells in athymic nude mice indicates that T-cell development can also take 
place in the absence of a functional thymus. Designated extrathymic development, this 
phenomenon is observed in nude mice particularly in older animals193. Nude mice have an 
abnormal distribution of T-cells in that they have reduced frequency of CD4 T-cells and 
contain cells that are Thy1pos (a marker for T-cells) but express neither CD4 nor CD8194. 
Extrathymic T-cells were believed to develop in the lymphoid tissues as a function of time. 
However the anatomical sites where extrathymic T-cell generation occurs are still not well 
defined and broadly argued upon. There is evidence for extrathymic T-cell development in the 
gut cryopatches as indicated by the presence of ckithigh precurosrs195, and most importantly 
mice devoid of gut cryopatches did not harbour extrathymic derived T-cells196. In contrast a 
subsequent study using mice that had GFP under the RAG2 promoter, which allows to follow 
cells that express the recombinase activation gene (RAG) and are therefore in the process of 
rearranging their TCR receptor (GFPhigh) or have recently rearranged their receptor (GFPlow), 
did identify mesenteric lymph nodes and to a lesser extent the Peyer’s patches as the site of 
extra thymic T-cell generation197. No GFP expression was detected in the gut cryopatches, 
indicating that this anatomical site did not contribute to extrathymic T-cells generation. A 
recent study addressing extrathymic T-cell development after bone marrow transplantation 
confirmed the mesenteric lymph nodes and Peyer’s patches as sites for extrathymic T-cell 
development. Moreover transplantation of luciferase+ preT-cells (DN2 and DN3) showed 
engraftment in the thoracic and in the abdominal regions. These results are further supported 
by transplantations into hosts lacking lymph nodes and Payer’s patches, which result in a 
reduced generation of extrathymic T-cells, confirming an important role of the mesenteric 
lymph nodes and Peyer’s patches in extrathymic T-cell generation198. In addition, with 
luciferase assays it was shown that nuclear factor of activated T-cells (NFAT) activation was 
detected in the mesenteric lymph nodes of nude mice, indicating that similar signalling 
mechanisms are used in extrathymic and thymic T-cell development198. Closer examination of 
the developmental steps in extrathymic T-cell generation, using mice with GFP under the 
RAG2 promoter revealed that 97% of the GFPhigh cells were double positive for CD4 and 
CD8 showing a similar phenotype as their thymic counterparts, the remaining 3% resemble 
DN2 and DN3 stages197,199. The same study with GFP under the RAG promoter showed that 
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in euthymic mice GFP+ cells were absent in the mesenteric lymph nodes, indicating that the 
extrathymic T-cell generation pathway is supressed under normal conditions and only 
activated in conditions of lymphocytic depletion or in thymic atrophy, as observed in old 
mice197. The absence of extrathymic T-cell development is not linked to the presence of a 
thymus, but rather to the presence of αβ-T-cells. This was concluded from a study showing 
that TCRδ deficient mice did not show extrathymic T-cell development, whereas GFP+ cells 
were detected in the lymph nodes of TCRβ deficient mice.          
A new option to study extrathymic T-cell development provided the use of oncostatin M 
(OM) transgenic mice. The thymus of these mice displays hypoplasia and T-cell development 
is observed only in the lymph nodes and not in the thymus. The OM induced pathway of T-
cell generation was found to be totally thymus independent as demonstrated by lethally 
irradiated nude or thymectomised mice reconstituted with either wild type or oncostatin M 
transgenic bone marrow. These experiments revealed that extrathymic T-cell development 
was only present in mice reconstituted with OM transgenic bone marrow, but not in mice 
reconstituted with wild type bone marrow199. Oncostatin M protein was also shown to induce 
the extrathymic pathway of T-cell generation. Due to the amplification of lymphopoiesis, this 
model enabled further investigations of extrathymic T-cell development that otherwise is 
difficult to study due to limited cell numbers. Studies on OM transgenic mice revealed that 
positive selection in the periphery does not obey the same rules as in the thymus. In the lymph 
nodes CD8 T-cells are selected on MHC I expressed on hematopoietic cells. Thymectomised 
wild type mice transplanted with fetal liver cells from OM transgenic mice that were deficient 
for MHC I did result in a reduction of CD8 T-cells, however CD8 development was not 
completely abolished, indicating that non hematopoietic cells can also support positive 
selection although at reduced frequencies200. Positive selection is mediated by different sets of 
MHC-peptide complexes in thymus and lymph nodes, leading to a different repertoire201. 
Negative selection in the thymus is dependant on Aire expression, Aire expression was also 
detected in lymph nodes although 4 fold reduced compared to expression in TEC201. 
Nevertheless gene chip analysis revealed that genes upregualted by Aire were expressed at 
similar levels in the thymus and in the lymph nodes201. Reporter mice with GFP expression 
controlled by Aire promoter identified extrathymic Aire expressing cells in the lymph nodes 
and spleen. Sorting of these cells revealed that they express a different array of self antigens 
compared to mTEC, nevertheless they were shown to interact and delete autoreactive T-
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cells202. Extrathymic T-cells display a memory like phenotype (CD62Llow, CD44high), have a 
rapid turnover and undergo enhanced homeostatic proliferation203. They differ in their effector 
functions when compared to thymic derived T-cells. Extrathymically derived CD4 T-cells 
expand poorly and fail to provide B-cell help upon viral infections, as demonstrated by the 
absence of antibodies upon infection with lymphocytic choriomeningitis virus (LCMV) or 
vesicular stomatitis virus (VSV)204.  
 The mucosal immune system of the gastrointestinal tract  1.9.
The gastrointestinal tract is the largest mucosal surface. The intestinal epithelium is the 
interface between the intestinal microbiom and the lymphoid tissues, where it forms a 
physical barrier against excessive entry of bacteria and other antigens from the intestinal 
lumen into the circulation. The epithelium also plays a crucial role in shaping the mucosal 
immune response. The crosstalk between the intestinal epithelial cells, the local immune cells 
and the intestinal microbes is important for the intestinal homeostasis.  
The intestinal epithelium consists mainly of intestinal epithelial cells (IEC), which are 
connected by tight junctions and promote digestion and absorption of nutrients but also of 
mucin secreting goblet cells and paneth cells. IEC can produce antimicrobial peptides. Studies 
showed that IEC are able to discriminate between pathogenic and commensal bacteria. IEC 
express a wide range of pattern recognition receptors (PRR), recognising bacterial factors like 
lipopolysaccharide (LPS), lipoproteins or flagellin. Upon triggering of the PRR by microbes, 
IEC produce proinflammatory cytokines, and alert thereby the immune system205. Mice with 
IEC deficient for single-immunoglobulin-domain-containing interleukin-1 receptor-related 
protein (SIGIRR), which is a negative regulator of Toll-like receptor (TLR)206 were more 
susceptible to intestinal inflammation207,208, emphasizing the importance of these receptors. 
Moreover deletion of Toll-like receptor (TLR) 4 or the TLR signalling adaptor protein 
MyD88 resulted in an impaired immune reaction against bacterial infection209,210. Goblet 
cells, located in the epithelial layer of the small and large intestine, provide additional 
protection by secreting a mucus layer and factors that play a role in epithelial repair and 
inflammation211,212. Paneth cells, located in the crypts of the small intestine, but not in the 
colon, contain cytoplasmic secretory granules loaded with antimicrobial proteins like α-
defensins213. 
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The mucosal immune system of the gastrointestinal tract is composed of several lymphoid 
organs collectively referred to as gut associated lymphoid tissue (GALT), which allows a 
rapid and gut restricted immune reaction (Figure 1.5). The GALT consists of secondary 
lymphoid organs like Peyer’s patches (PP) and mesenteric lymph nodes, tertiary organised 
lymphoid tissues (isolated lymphoid follicles), and diffusely distributed lymphocytes, namely 
intraepithelial (IEL) and lamina propria lymphocytes (LPL), and dendritic cells. IEL are 
located above the basement membrane, between the epithelial cells. Underneath the basement 
membrane located in the intestinal villi are the lamina propria lymphocytes. PP and isolated 
lymphoid follicles are located within the mucosa. PP are only present in the small intestine, 
their organisation is comparable to that of lymph nodes, including large B-cell follicles and T-
cell areas214. M-cells are overlying the PP and transport antigens and bacteria to the 
underlying immune cells that activate or inhibit immune responses. The formation of PP is 
dependent on the expression of VCAM1 and the presence of lymphoid inducer cells, but is 
independent of the intestinal flora215. The development of isolated lymphoid follicles is, 
however, dependant on the intestinal flora, as demonstrated by the absence of these structures 
in germfree mice and their increase during chronic inflammation215. In contrast to PP, isolated 
lymphoid follicles are distributed along the whole intestinal tract. The lamina propria 
lymphocytes are composed of conventional T-cells and small populations of unconventional 
T-cells, i.e. invariant NKT cells and mucosal associated invariant T-cells (MAIT)216. Both cell 
types are characterised by the expression of a semi-invariant TCR-rearrangement. Invariant 
NKT cells recognise glycolipid antigens presented by CD1d217, whereas MAIT cells 
recognise the MHC-related molecule 1 (MR1)218. Both invariant NKT cells and MAIT cells 
are thymus derived. Fetal thymic organ cultures cultured in the absence or presence of MR1 
demonstrated the intrathymic origin of MAIT cells219. Furthermore, MAIT cells are absent in 
nude mice, confirming their thymic origin220. The presence of MAIT cells is dependent on the 
colonisation with commensal bacteria, as demonstrated by their absence in germfree mice221. 
IEL are located in the gut mucosa of the small and large intestine and play a crucial role in 
maintaining the integrity of the gut wall. They regulate the immune responses against 
pathogens and commensal microbiota. CD8αα IEL act as regulatory T-cells and prevent 
colitis upon adoptive transfer into T-cell deficient mice222,223. They are further involved in 
immunoregulation at different anatomic sites, as shown in mice which spontaneously develop 
diabetes (NOD mice). These mice display a reduction in CD8αα IEL, reconstitution with 
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CD8αα IEL prevents them from diabetes whereas further reduction of CD8αα IEL accelerates 
the disease224. 
 
 
Figure 1.5: The mucosal immune system: The epithelial layer is covered by a layer of mucus secreted by 
goblet cells, paneth cells secret antimicrobial peptides and protect thereby from bacteria. Intraepithelial 
lymphocytes (IEL) are located within the epithelial layer. M-cells transport microbes to the Peyer’s patches 
where dendritic cells present the antigens to naïve CD4+ T-cells. Upon activation CD4+ T-cells migrate to the 
lamina propria.  
 
IEL can be divided into two groups: (i) conventional IEL and (ii) unconventional CD8αα IEL. 
The first group of IEL are peripheral T-cells that after antigen encounter in Peyer’s patches or 
mesenteric lymph nodes upregulate the expression of α4β7 integrin and CCR9 and home to 
the gut mucosa225,226. These conventional IEL can be either CD4+ or CD8αβ+. The second 
group of IEL is specific to the gut wall. They are CD4-CD8β- but frequently express the 
CD8αα homodimer. These CD8αα IEL are considered to be part of the innate immune 
system. In contrast to the conventional IEL the CD8αα T-IEL are not negatively selected as 
shown by studies using the minor lymphocytes stimulating (Mls) antigen system. In this 
system the presence of a superantigen in the thymus leads to the deletion of conventional T-
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cells expressing a particular Vβ chain. In contrast to conventional T-cells, CD8αα IEL are not 
responsive to this mitogenic TCR-signal227. This tolerance is induced by a mechanism called 
developmental diversion. Upon receiving a strong TCR signal the cells differentiate into 
functionally anergeic and coreceptor negative but TCRαβ+ thymocytes. These coreceptor 
negative thymocytes leave the thymus and migrate into the intestine, where they acquire a 
CD8αα phenotype228. Different selection mechanisms were demonstrated for conventional 
and unconventional IEL using a TCR transgenic system expressing a TCR specific for a male 
antigen. Conventional T-cells were deleted in male mice, whereas CD8αα IEL with a TCR 
specific for this male antigen remained detectable. Strikingly, transgene positive CD8αα IEL 
were absent in female mice, but the conventional T-cell population expressed the transgene229, 
indicating that the presence of self-antigens is required for CD8αα development.  
CD8αα IEL are distinct from thymus derived T-cells and were therefore believed to be 
generated directly in the gut wall. This hypothesis was supported by the finding that in 
primitive vertebrates the adaptive immune system is located in the GI tract. Furthermore, the 
epithelia of the GI tract and the thymus share a common endodermal origin230 and genes 
specific for T-cell development such as Rag, or pTα were detected in lineageneg cells isolated 
from the gut wall231,232. However the finding that CD8αα IEL are 5-10 fold reduced in 
athymic nude mice and, contrary to euthymic mice, almost all of them express the γδTCR 
questioned the sole extrathymic origin of CD8αα IEL233. Experiments showed that CD8αα 
IEL are thymus derived because of their reduction following thymectomy in the neonatal. To 
support this contention, the transplantation of neonatal thymus into thymectomised recipients 
recovered the pool of CD8αα IEL234. While these experiments established that IEL are 
thymus derived, their differentiation within the thymus still remains incompletely defined. 
Two different hypotheses exist about the differentiation state of putative IEL leaving the 
thymus. In the first model, immature precursors leave the thymus before their TCR 
rearrangement and finish their maturation in the gut. In the second model mature thymocytes 
that have already rearranged their TCR acquire the CD8αα phenotype after colonialisation of 
the gut wall235. The first model is supported by a study in which wild type thymus was 
transplanted into Rag/γc deficient hosts. The host thymus was found be to colonised by donor-
derived wild type Lin-CD44+ precursors, that emerged from the wild type thymus. This 
emigration of early precursors from the thymus is further supported by the localisation of 
DN1 cells inside the thymus. The DN1 population resides close to the cortico-medullary 
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junction, where precursors enter the thymus and fully mature T-cells emigrate. In addition, 
approximately 20% of DNI were shown to express S1P1, a molecule required for thymocyte 
egress, and these cells also upregulate α4β7 integrin important for gut homing. Furthermore, 
intravenous injection of CD44+ precursors was shown to reconstitute the CD8αα IEL pool in 
nude mice235,236. The second model is supported by fate mapping experiments, showing that 
all TCRαβ+CD8αα cells were once double positive during their development237,238. Further 
support comes from anergic coreceptornegative TCR-β+ thymocytes, which leave the thymus as 
CD4- and CD8- but TCR-β+ cells and acquire a CD8αα IEL in the gut228. However these two 
models are not mutually exclusive.  
1.9.1. Inflammatory bowel disease 
Shortly after birth the intestinal lumen is colonised by commensal bacteria. These commensal 
bacteria take advantage of an environment that is rich in nutrients derived from ingested food 
and contribute to the digestion of food, provide essential nutrients and prevent propagation of 
pathogenic microorganisms239. The microbiom is species specific and important for proper 
immune reactions in the gut. Germ-free mice that were colonised with human microbiota 
were more susceptible to infections, and the T-cell numbers in the small intestine were 
reduced and comparable to that of germ-free mice. Reconstitution with mouse microbiota, 
however, was able to restore the intestinal immune compartment and protect the mice from 
infections240. The intestinal immune system has to discriminate between commensal and 
pathogenic bacteria and mount an immune response accordingly. A disturbed immune 
response towards components of the normal intestinal flora in the gastrointestinal tract results 
in inflammatory bowel disease (IBD)241. IBD occurs in immunocompetent individuals and is 
characterised by an infiltration of innate and adaptive immune cells into the lamina propria 
resulting in increased numbers and activation of these cells in the intestinal mucosa. This 
leads to locally elevated levels of cytokines and eventually a cytokine driven inflammation of 
the gut. Regeneration and repair of the epithelium is important for the control and clearance of 
the inflammatory response to injury. In the case of IBD the inflammatory response result in a 
constant tissue injury causing erosions, ulcerations and a decrease in the production of 
protective defensins242, leading to a further exposure to bacteria and thereby to an 
amplification of the immune response. Patients with IBD suffer from diarrhoea, rectal 
bleeding, abdominal pain and weight loss. Two common forms of IBD are Crohn’s disease 
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and ulcerative colitis. Crohn’s disease affects both the small intestine and the colon and is 
associated with an increased production of the cytokines IFN-γ and IL-17243, whereas 
ulcerative colitis only affects the colon and is associated with excess of IL-13 production. 
However both diseases are chronic and relapsing. The colon pathology includes edemas, 
infiltrations of large numbers of inflammatory cells, erosions and ulcerations. Several factors 
are identified to contribute to IBD. IBD can be triggered by the immune system itself, by the 
gut microbiota or by genetic factors, however the disease is mostly an interplay of different 
factors244.  
Genetic factors can lead to epithelial dysfunction and favour inflammations. Mice deficient 
for Prostaglandin E receptor 4 (EP4), which is involved in repair and barrier functions, 
showed increased susceptibility to chemically induced colitis245. EP4 was also shown to play 
a role in humans suffering from IBD246. The importance of goblet cells is highlighted in mice 
deficient for the mucin protein MUC2 which developed intestinal inflammation247. In 
humans, MUC 19 was also associated with IBD248. In addition, defects in paneth cells were 
shown to contribute to human IBD249.  
CD4+ T-cells in the intestine can be divided into effector and regulatory T-cells. The effector 
T-cells can mount either a Th1, Th2 or Th17 response, all of them were associated with 
different forms of IBD. In the healthy intestine the regulatory mechanisms are controlling the 
effector T-cells, however if this equilibrium is disturbed inflammation will occur (Figure 1.6). 
There are several regulatory lymphocytes mediating tolerance in the intestine. These 
mechanisms involve not only the reduction of inflammation but also enhancing the integrity 
of the intestinal barrier. These regulatory cells can also interact with IEC and enhance thereby 
their barrier function. The two main key players in providing tolerance in the gut are IL-10 
and TGF-β, both factors can induce regulatory T-cell populations250. IL10 is a potent 
suppressor of macrophage and T-cell function. Mice deficient for IL-10 develop colitis, 
however in specific pathogen-free conditions these mice display only a local inflammation, 
indicating that IL-10 is an immunoregulator in the intestinal tract251. Experiments with IL-10 
deficient mice that were also deficient for B-cells showed that the colitis was induced only by 
CD4+ T-cells252. In animal models injection of recombinant IL-10 rebuilt the intestinal 
homeostasis, furthermore the addition of IL-10 inhibits colitis in adoptive transfer 
model253,254. TGF-β is another regulatory molecule involved in colitis induction. TGF-β 
receptor II deficient mice die because of inflammation triggered by T-cells255,256. The 
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development of NKT cells and CD8+ T-cells as well as maintenance of peripheral Foxp3-
expressing regulatory T-cells depend on TGF-β signalling. TGF-β plays also an important 
role in the homeostasis of the epithelium as demonstrated by TGF-β receptor II specific 
deletion in goblet cells, which results in colitis257. 
 
 
Figure 1.6: Pathways to mucosal inflammation: In the basal status the regulatory mechanism protect from 
colitis. However if this balance is disrupted colitis occur. Reasons for colitis can be an enhanced immune 
reactivity, or the absence of regulatory T-cells. Furthermore the disruption of the epithelial barrier and also a 
reduced immune reactivity can lead to an increase in proinflammatory stimuli and result in colitis. Adapted from 
Izcue et al 2009258 
 
A hyperreactivity to the normal microbiom is observed in various animal models such as IL-2 
or IL-10 deficiency259. However IBD is not observed in germfree mice, indicating that the 
microbiom drives the inflammation of the mucosa. This is further confirmed by crossing of 
IL-10 deficient mice with MyD88 deficient mice, which results in the absence of colitis, 
indicating that microbial components are required for IBD260. Colitis is therefore the result of 
a dysfunctional interaction between the bacterial microflora and the gut mucosal immune 
system. Changes in the microflora, either in numbers or in the composition of the 
microorganisms can cause the loss of tolerance. However a defect in the mucosal immune 
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system can also cause colitis, either by a defective effector T-cell population, which 
overreacts, or by defective or absent regulatory T-cells. 
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2. Aim of the project 
Foxn1 is the key transcription factor for thymus development and TEC differentiation. In the 
absence of functional Foxn1 TEC fail to differentiate and remain in an immature common 
progenitor stage.  
The aim of this project was to establish whether Foxn1 expression is required only at the 
onset of thymus organogenesis, or alternatively whether Foxn1 expression is also critical 
during the postnatal thymus for regular TEC biology. Furthermore it was investigated whether 
reduced Foxn1 expression suffices for TEC development, and weather different TEC subsets 
have different requirements for Foxn1. To assess these questions novel experimental models 
were created that control the expression of Foxn1 in a time sensitive-fashion or the extent of 
transcription, respectively. Specifically I wished to assess whether Foxn1 expression is 
required in the post natal thymus. It was hypothesised that Foxn1 expression at the onset of 
thymus organogenesis would rescue thymus development, as in the adult thymus Foxn1negative 
TEC were detected expressing both Dll4 and CCL25137. This would indicate that Foxn1 is no 
longer required after initial organ formation as TEC develop and maintain the expression of 
Dll4 and CCL25 in the absence of continuous Foxn1 expression, still allowing the attraction 
of precursors and their development into the T-cell lineage. The second aim was to assess 
whether cTEC and mTEC display a differential Foxn1 dependence and weather a reduced 
Foxn1 expression result in thymus development. 
 
The following questions were investigated: 
• The effect of reduced Foxn1 or Foxn1 withdraw for TEC and thymus development 
• T-cell development in the altered microenvironment 
• Functionality of the T-cells and their subsets 
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3. Materials and methods 
 Mice 3.1.
Conditional Foxn1fl/fl mice were designed and generated in our laboratory by Marcel Keller 
and Thomas Boulay.  
In brief a Foxn1 targeting vector was constructed from a PGKneoF2L2DTA backbone (kindly 
provided by Philippe M. Soriano New York USA), the 5’ homology arm contained parts of 
exon 6 and 3’ homology arm parts of exon 9. Exons 7 and 8 encoding for the DNA binding 
domain were inserted at a SmaI restriction site and flanked by loxp sites. The construct 
included a neomycin resistance cassette, for positive selection flanked by FRT sites and 
diphtheria toxin A (DTA) cassette as a negative selection marker. Electroporation of ES cells 
with the targeting vector and mouse generation was done external by inGenious Targeting 
Laboratory Inc. (New York, USA). The received mice were on a 129 x C57Bl/6 mixed 
background and crossed to C57Bl/6 mice in our facility. This mouseline was designated as 
Foxn1loxneo. The mice were crossed to Flp deleter mice (129S4/SvJaeSor-
Gt(ROSA)26Sortm1(FLP)Dym/j)) obtained from The Jackson Laboratory. The resulting line was 
named Foxn1floxed. Foxn1fl/fl mice were crossed to Foxn1-Cre mice [Zuklys at al. 2009] to 
achieve TEC specific deletion of Foxn1. C57Bl/6 nu/nu and C57Bl/6-Ly5.1 [B6.SJL-
Ptprca/BoyJiTac] mice were purchased from Taconic. B6 Rag 2-/- mice were obtained from 
the Jackson Laboratory.  
For developmental staging, the day of vaginal plug was considered as embryonic day (E) 0.5. 
Mice were housed at the center for biomedicine animal facility in accordance with 
institutional guidelines and cantonal review board.  
 Cell suspension and cell counting 3.2.
Cell suspensions of lymph nodes and spleen were obtained by placing the organs between two 
wet meshes, 70-100 µm pore size and rub gently with a plunger or forceps until most cells are 
squeezed out. The resulting cell suspensions were washed in PBS+2% FCS (fetal calf serum) 
and centrifuged 5 minutes at 4°C, 1500 rpm, or alternatively in 1minute at 4600rpm (1.5ml 
Eppendorf tube). Red blood cells of the spleen were lysed in ACT (Ammonium Chloride –
Tris buffer; 1 ml per 30x106 cells), after two minutes the reaction was stopped by adding 
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IMDM (Iscove’s Modified Dulbecco’s Medium) plus 2% FCS, centrifuged and resuspended 
in PBS plus 2% FCS (FACS buffer). Staining and cell counting was performed in PBS plus 
2% FCS.  
Cells were counted using a Z1 Coulter particle counter from Beckman Coulter. 20µl of cell 
suspension and three drops of zap-oglobin II lytic reagent from Beckman Coulter, Inc. 
(Beckman Coulter, Inc. , Fullerton, CA, USA) were added to 10 ml Isoton II.  
3.2.1. TEC isolation 
For thymic epithelial cell isolation, thymi were pooled and digested at 37°C using 1mg/ml 
Collagenase D + 50µg/ml DNase I in FACS buffer. After 10 minutes of incubation on a 
thermomixer (Eppendorf) at 700 rpm the thymi were pipetted up and down around 20 times. 
If still clumps were visible the thymi were incubated another five minutes before pipetting 
again, until all clumps were dissolved resulting in a single cell suspension. The cells were 
washed and resuspended in PBS plus 2% FCS.  
3.2.2. Tissue lymphocyte analysis 
The entire intestine of wild type, Foxn1neo/neo, Foxn1lox/lox::Foxn1-cre and C57Bl/6 nu/nu mice 
were isolated and faeces were removed. The Peyer’s patches were removed from the small 
intestine. A small piece of the colon and small intestine was frozen for histological analysis. 
The colon and small intestine were first cut longitudinally and then into small pieces of 0.5-1 
cm length. The pieces were incubated twice 10 minutes at room temperature in 10 ml IMDM 
+ 10 % FCS + 1mM DTT on a shaking platform (200 rpm) to remove debris. The fragments 
were washed and resuspended in 10 ml IMDM+10%FCS. Intraepithelial lymphocytes (IEL) 
were isolated by vortex (2x 4 minutes, in 10ml each). For lamina propria lymphocytes (LPL) 
isolation the fragments were incubated 45 minutes at 37°C in 5ml IMDM + 10% FCS + 
1mg/ml Collagenase IV. After isolation IEL and LPL were washed, resuspended in FACS 
buffer, counted and stained.  
3.2.3. Bone marrow isolation 
The femur was isolated, cut above the knee and placed open end down in a 5 ml Falcon tube 
which was equipped with a cut-off tube and 300µl media. The tubes were centrifuged at 2000 
rpm 5 minutes, the tip containing the bone was removed and the samples were proceed to 
staining.  
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 Antibodies, flow cytometric analysis and sorting 3.3.
Staining was performed in PBS+2%FCS on ice, antibodies were added at optimized dilutions 
and incubated for 30 minutes. Depending on the amount of cells, either 5 ml or 10 ml Falcon 
(BD, Franklin Lakes, NJ, USA) or 1.5 ml Eppendorf (Hamburg, Germany) tubes were used. 
In case of biotin-conjugated antibodies, a second staining step with fluorochrome labelled 
streptavidin was performed. Prior to analysis DAPI was added to a final concentration of 0.1 
ng/µl. Before acquisition the cells were filtered through a 40µm mesh. Acquisition and 
sorting of TEC, CD4 T-cells and regulatory T-cells were performed using FACS ARIA (BD 
Bioscience), controlled by FACS Diva software, and analysis was carried out using FlowJo 
9.4 (Tree Star). 
Antibodies used:  
FITC labelled: CD24 (clone: M1/69; BioLegend), CD25 (clone: PC61; BioLegend), CD62L 
(clone: Mel-14; BioLegend), TCR Vβ2 (clone: B20.6; BioLegend), TCR Vβ6 (clone: RR4-7; 
BD), TCR Vβ8 (clone: F23.1; BD), TCR Vβ14 (clone: 14-2; BD), CD44 (clone: IM7; 
BioLegend), TCR-β (clone: H57-597 ; BioLegend), CD8β (clone Ly-3; BioLegend), Sca1 
(clone: D7; ebioscience) 
PE labelled: TCR-β (clone H57-597 ; BioLegend), CD44 (clone: IM7; BioLegend), FoxP3 
(clone: FJK-16; ebioscience), Foxp3 (clone: 150D; BioLegend), TCR-γδ (clone: GL3; 
BioLegend), TNF-α (clone: MP6-XT22; BioLegend), TER 119 (clone TER119; BD), CD19 
(clone ID3; BioLegend) 
APC labelled: CD117 (c-kit) (clone: 2B8; BioLegend), Nrp1 (clone: 761705; R&D Systems) 
Cy5 labelled: CD25 (clone: PC61; self made), CD19 (clone: ID3; self made)           
Alexa 647: CD3 (KT3; selfmade), Helios (clone: 22F6; BioLegend), IL-17 (clone: TC11-
18H10.1; BioLegend), CD8 (clone: 53.67; self made), B220 (clone: RA3-6B2; self made), 
APC-Cy7 labelled: CD4 (clone: GK1.5; BioLegend).               
PerCPCy5.5 labelled: CD25 (clone: PC61; BioLegend), EpCAM (clone: G8.8; BioLegend), 
Il10 (clone: JES5-16E3; BioLegend).           
PE-Texas-Red labelled: CD19 (clone: 6D5; Molecular Probes), CD45 (clone: 30-F11; 
Molecular Probers)                  
PECy7 labelled: CD8 (clone: 53-6.7; BioLegend), CD45 (clone: 30-F11; Biolegend), Ly5.1 
(clone: A20; BioLegend), IFN-γ (clone: XMG12; BioLegend), B220 (clone: RA3-6B2; 
BioLegend), CD44 (clone: IM7; BioLegend), CD62L (clone: Mel-14; BioLegend) 
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A-700 labelled: CD8α (clone: 53-6.7; BioLegend), CD45 (clone: 30-F11; BioLegend), 
CD62L (clone: MEL14; BioLegend), TCR-β (clone: H57-597; BioLegend) 
Biotin: CD3 (clone: KT3; selfmade), CD4 (clone: GK1.5; selfmade), CD8 (clone: 53-6.7; 
BioLegend), CD11b (clone: M1/70; BioLegend),  
CD11c (clone: N418; BioLegend), B220 (clone: Ra3-6B2; BioLegend), CD19 (clone: ID3; 
selfmade), CD45 (clone: M1/9.3.4HL2; selfmade), EpCAM (clone: G8.8; selfmade), TCRγδ 
(clone: GL3; ebioscience), F4/80 (clone: BM4; BioLegend), Pan NK (clone: DX5; 
BioLegend), NK1.1 (clone: PK136; Biolegend) 
Streptavidin: PE (BioLegend); PECy7 (BioLegend), PerCpCy5.5 (BioLegend), PE-Texas-
Red (Molecular Probes).  
3.3.1. Intracellular staining 
3.3.1.1. Foxp3 staining 
For Foxp3 staining the cells were fixed and permeabilized using Foxp3 staining kit from 
eBioscience, according to the manufacturers protocol. Unspecific staining was blocked using 
10% normal mouse serum and 15% 2.4G2 supernatant (self-made). For Foxp3 staining in 
combination with Helios the Foxp3 staining kit and antibody from BioLegend was used, 
according to the manufacturers protocol.  
3.3.1.2. Cytokine staining 
For cytokine staining the cells were stimulated using 1µg/ml Brefeldin A (Sigma), 0.5µg/ml 
Ionomycin (Sigma) and 0.05µg/ml PMA (Sigma) 4 hours at 37°C. The cells were fixed and 
permeabilized using cytofix/cytoperm kit from BD, according to the manufacturers protocol.  
3.3.2. Cell depletion 
Prior to sorting of regulatory T cells and CD4 T cells cell suspensions were enriched for 
CD4pos cells. The isolated cells were labelled with biotinylated CD4 antibodies and incubated 
for 20 minutes on ice, followed by a washing step and resuspended at 100*106 cells/ml. 50µl 
of anti-biotin microbeads (Miltenyi Biotec) were added. The cells were incubated 15 minutes 
in the fridge, washed and filtered. The cells were then applied to an AutoMACS separator 
(Miltenyi Biotec), where labelled cells were enriched. The CD4 enriched cells were further 
stained and analysed or sorted. Alternatively for some T-cell analysis B220pos cells were 
depleted using dynabeads. In brief cells were labelled using RA3-6B2 antibody 30 minutes, 
 45 
washed and incubated with dynabeads (life technologies) 15-20 minutes, B220 positive cells 
were removed by magnetic separation.  
 Histology 3.4.
3.4.1. Tissue embedding 
Pieces of colon, small intestine, thymus lobes and whole embryos (E11.5, E12.5, E13.5) were 
embedded in OCT compound (Medite) in Cryomolds (Tissue-Tek; Biosystems). Tissues were 
frozen using 2-Methylbutane (Sigma) in combination with dry ice and then stored at -80°C 
until cutting.  
3.4.2. Cutting 
Sections of 6-8µm thickness were cut using a cryostat (Roche). Sections of embryos were cut, 
stained with toluidine blue and inspected under the microscope. As soon as the thymus was 
reached the sections were collected. The sections were mounted on superfrost plus slides 
(Menzel-Gläser, Thermo Scientific) and air dried over night. The following day the sections 
were either stained directly or wrapped in aluminium foil and stored at -80°C until usage.  
3.4.3. H&E 
Sections were fixed 45’’ in Delaunay fixation (100ml ethanol, 100ml acetone and 0,2 ml 1M 
TCA), rehydrated in gradient ethanol solutions (100%, 96%, 70% and 50% ethanol) 45’’ each 
and then H2O. Afterwards stained 2 minutes with Hematoxyline, washed 3 times 1 minute in 
warm H2O, counterstained in 1% aqueous Erythrosine B solution and washed 3 times 1 
minute in H2O. The tissue was dehydrated in gradient ethanol solutions (50%, 70%, 96% and 
100% ethanol), finally the coverslips were mounted using Pertex. Imaging was done using a 
Nikon Eclipse E600 microscope (10x/0.3 NA Plan-Flour objective. The pictures were taken 
using a Nikon DXM 1200F camera controlled by Nikon ACT-1 software (Nikon instruments, 
Europe).  
3.4.4. Histological analysis and colitis score 
Colon slices were frozen in OCT, and sections of 7 µm were cut and stained with 
Haematoxylin and Erythrosine B. The tissues were graded from 0 to 4, according the 
following features: grade 0, no changes observed; grade 1, mild cell infiltrations and slight 
epithelial cell hyperplasia; grade 2, pronounced epithelial cell hyperplasia, significant cell 
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infiltrations in mucosa as well as submucosa and mild depletion of goblet cells; grade 3, 
marked epithelial cell hyperplasia, extensive cell infiltrations in mucosa, submucosa as well 
as tunica muscularis and significant depletion of goblet cells; grade 4, marked epithelial cell 
hyperplasia, extensive cell infiltrations and substantial depletion of goblet cells (>50%). Each 
section was rated twice at different days, the grade indicated was the mean of both ratings.  
3.4.5. Immunohistochemistry 
6-8µm thick tissue sections were fixed in cold Acetone (-20°C) 10 minutes at RT. The tissue 
sections were encircled with Pap pen (Biosystems) and dried 2 minutes, rehydrated twice 10 
minutes in PBS and incubated 20 minutes with 5% goat serum in PBS to block nonspecific 
binding. Staining with primary antibodies, diluted in goat serum was preformed. After 1 hour 
of incubation the slides were washed twice 5 minutes in PBS and the secondary antibodies 
were added. After 45 minutes incubation time the slides were washed twice 5 minutes in PBS. 
Prior to mounting DAPI was added for 5 minutes, the slides were washed again and the 
coverslips were mounted using Hydromount (National Diagnostics). Images were acquired 
using Zeiss LSM 510 confocal microscope and Zeiss LSM 510 acquisition software, version 
3.2 (Carl Zeiss) or a Leica DMI 4000 microscope using AF 6000 software. All pictures were 
processed and assembled using Image J (http://rsbweb.nih.gov/ij/).  
3.4.5.1. Antibodies used: 
Rabbit anti-CK5 (Covance), mouse anti-CK8 (Progen), mouse anti-CK18 (Progen), rat anti-
ERTR7 (provided by W. van Ewijk, Utrecht, Netherlands), Aire (clone: 5H12; provided by S. 
Hamish, Adelaide, Australia), CD31-FITC (clone 390; ebioscience), rabbit anti-β5t (MBL, 
Japan), Rabbit anti-Foxn1 (provided by T. Amagai, Japan), CD4 (clone H129; self made), 
CK14 (Covance) 
As secondary antibodies Alexa Fluor-conjugated anti-IgG antibodies (life technologies) and 
SA-Cy3 (BioLegend) were used.  
As negative controls only the secondary antibodies were applied.  
3.4.5.2. Antigen retrieval 
For Foxn1 protein detection an antigen retrieval was performed. Thymus or embryos were 
collected and fixed in 4%PFA in PBS for 4 hours (thymus) or over night (embryos) at 4°C. 
The tissue was placed in 20% sucrose in PBS prior to cryopreservation in OCT compound. 
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For antigen retrieval the slides were boiled in 10mM NaCitrate (pH 6), then left on the bench 
20 minutes and boiled again. The slides were cooled down and the staining protocol was 
proceeded starting with the blocking step.   
 In vitro T-cell activation and proliferation assays 3.5.
Freshly sorted CD4 T cells were washed in PBS and labelled with 2.5µM CFSE for 7 minutes 
at room temperature and washed twice with media. Sorted CD4 T cells were activated using 
1µg/ml anti-CD3ε (self made) in the presence of irradiated B6 Rag2-/- splenic accessory cells 
(AC) in a 1:1 ratio. The cells were co-cultured for 72 hours in 96 well plates round bottom 
(Falcon). The proliferation index was calculated using flow jo software. Suppression assays 
were set up using CFSE labelled effector T-cells and Tregs in a 1:1 ratio in the presence of 
anti-CD3ε and accessory cells in a 1:1 ratio.  
 Adoptive transfer of T cells 3.6.
CD4 and regulatory T cells were sorted, washed and re-suspended in HBSS and finally 
injected intravenously into the tail vein of B6 Rag2-/- mice. Injection was preformed with 
100’000 CD4 cells isolated from either wild type, Foxn1neo/neo, Foxn1fl/fl::Foxn1-Cre or nude 
mice. The mice were controlled and weighed every second day. If the weight loss constituted 
more than 20% of the maximal bodyweight the mice were analysed.  
 RNA isolation and quantitative reverse-transcribed polymerase chain 3.7.
reaction analysis 
3.7.1. RNA isolation 
RNA of sorted cells was isolated using the micro RNeasy kit from Qiagen (Qiagen, CA, 
USA). RNA isolation was performed according to the manufacturers protocol. TECs were 
sorted directly into RLT lysis buffer (provided by the kit) and stored at -80°C until they were 
further processed. Thymus isolated on embryonic day 12.5 were collected and cultured on a 
filter until genotyping was performed. Then they were digested as described previously. The 
pellet was resuspended in lysis buffer and stored at -80°C until they were further processed.  
In short the samples were mixed with an equal volume of 70% ethanol and applied to a 
RNeasy micro column and centrifuged (15 seconds, 10000rpm). Then 350µl of RW1 buffer 
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was added and centrifuged (15 seconds, 10000rpm) to bind total DNA. To digest DNA the 
samples were incubated 15 minutes with 80µl DNase1 incubation mix afterwards 350µl of 
RW1 buffer was added and centrifuged (15 seconds, 10000rpm). To wash 500µl RPE buffer 
was added and centrifuged (15 seconds, 10000rpm). In a next step 500µl 80% ethanol was 
added and centrifuged (2 minutes at 10000rpm). Then the samples were dried by 
centrifugation at maximal speed for 5 minutes. By adding 12 µl of RNase free water the RNA 
was eluted 1 minute at maximum speed. The samples were stored at -80°C until further 
processing to cDNA.  
3.7.2. cDNA synthesis 
For cDNA synthesis 12µl of total RNA were transferred into 0.6 ml tubes (genuine Axygen 
Quality, CA, USA) and mixed with 1µl dNTP (10mM), 1µl random hexamere (500ng/µl, 
Sigma, St. Louis, Mo, USA) and 1µl dT20 (1µM/µl, Mycrosynth, Balgach, Switzerland). The 
samples were denatured 5 minutes at 65°C followed by 1 minute on ice. Then 4.5 µl 5x first 
strand buffer, 1µl DTT (10mM, Invitrogen, Carlsbad, CA, USA), 1µl RNase Out (20u/µl, 
Ambion, Foster City, CA USA) and 1µl Superscript III (RT 200U7µl, Invitrogen) were 
added. The samples were incubated at 25°C for 5 minutes, followed by 50°C for 60 minutes. 
The reaction was finally inactivated at 70°C for 15 minutes and cDNA was stored at -20°C. 
dNTPs: Are a mixture of dATP, dGTP, dCTP and dTTP 10 mM each at neutral pH. 
5x first strand buffer: Consists of 250mM Tris-HCl (pH 8.3 at room temperature), 375 mM 
KCL and 15 mM MgCl2 (Invitrogen).  
3.7.3. qPCR- Quantitative PCR 
qPCR was performed using the SensiMix dT Kit (Quantace Ltd, London, UK). 
The reaction mix contained: 6.25µl Sensimix 2x+50x (Quantance), 0.375 µl forward primer 
(10mM), 0.375µl reverse primer (10mM) and 2.75µl H2O. Finally 2.75 µl of cDNA was 
added into 0.1 ml strip tubes from Corbett Research (Corbet Research, Sydney, Australia).  
qPCR was performed in duplicates using a Rotor-gene RG-3000A (Corbet research) and the 
following program: 
95°C for 10 minutes, followed by 50 cycles of 95°C 10 seconds (denaturing), 60°C for 15 
seconds (annealing) and 72°C 20 seconds (elongation) and melting from 72°C to 95°C. Data 
analysis was performed using Rotor gene 6 software. PCR specificity was controlled by 
analysing the melting curves. The data was exported as Microsoft Excel file. Expression 
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levels of specific mRNA were normalised to GAPDH expression by calculating 2-ΔCT whereas 
ΔCT is defined as the CT of the gene of interest- the CT of housekeeping gene. Mean values 
were compared between wild type and mutant mice using a Mann-Whitney U test (two-
tailed). 
Primers used: 
Foxn1: 
(forward primer): TCT ACA ATT TCA TGA CGG AGC ACT 
(reverse primer): TCC ACC TTC TCA AAG CAC TTG TT 
CCL21: 
(forward primer): AGC TAT GTG CAA ACC CTG AGG A 
(reverse primer): TTC CAG ACT TAG AGG TTC CCC G 
CCL25: 
(forward primer): GTT ACC AGC ACA GGA TCA AAT 
(reverse primer): GGA AGT AGA ATC TCA GAG CA 
CCL19: 
(forward primer): CCT GGG TGG ATC GCA TCA TCC G 
(reverse primer): AGA GCA TCA GGA GGC CTG GTC CT 
CXCL12: 
(forward primer): AAA TCC TCA ACA CTC CAA AC 
(reverse primer): GCT TTC TCC AGG TAC TCT TG 
GAPDH: 
(forward primer): GGT GAA GGT CGG TGT GAA CG 
(reverse primer): ACC ATG TAG TTG AGG TCA ATG AAG G 
EpCAM: 
(forward primer): TGA GGA CCT ACT GGA TCA TC 
(reverse primer): TAT CGA GAT GTG AAC GCC TC  
3.7.4. Genotyping of mice  
The mice were numbered and genotyped by toe clipping. A small piece of toe was digested in 
500µl lysis buffer containing Proteinase K at 56°C in a Thermomixer shaking at 750 rpm 
(Eppendorf). PCR was performed either directly from the lysate or if necessary further 
purification was done. To purify undigested tissue was pelleted 10 minutes at maximum 
speed and the supernatant was poured into an equal amount of isopropanol. The tubes were 
inverted and DNA precipitate was formed, after 5 minutes the precipitates were centrifuged 
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10 minutes at maximum speed and washed in 70% ethanol. The supernatant was discarded 
and the DNA pellet was air dried approximately 30 minutes and resuspended in 200µl TE 
buffer. The tube were incubated at 56°C on a thermomixer shaking at 750µm for 2 hours until 
the pellet was resuspended. The DNA was stored at +4°C until PCR analysis.  
PCR reaction mix 
2.5µl 10x buffer 
0.5µl dNTP’s (2.5mM) 
1.0µl forward primer 
1.0µl reverse primer 
19.4µl H2O 
0.1 µl Taq polymerase 
0.5 µl DNA template 
Total Volume 25 µl 
 
PCR conditions 
94°C 4 minutes initial denaturation 
followed by 33 cycles 30 seconds at 94°C (denaturation), 30 seconds at 58°C (annealing) and 
40 seconds at 72°C (elongation).  
And final elongation 10 minutes at 72°C.  
 
For genotyping the following primers were used:  
forward primer: CCCTGTCTCGAAAAACCAAA  
reverse primer: GGCTCTAGGTCTGGGGATTC. 
For verification of Foxn1 deletion the following primer pair and PCR conditions were used: 
Forward primer: 5’ CCC TGT CTC GAA AAA CCA AAC 3’ 
Reverse primer: 5’ CTT TTC CCA GCT TTG TCA GAT3’  
94°C 4 minutes initial denaturation 
followed by 33 cycles 30 seconds at 94°C (denaturation), 30 seconds at 58°C (annealing) and 
60 seconds at 72°C (elongation).  
And final elongation 5 minutes at 72°C.  
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3.7.5. Agarose gel electrophoresis 
1.3 g agarose (Invitrogen) were dissolved in 100ml 1xTAE buffer in a microwave-oven under 
heating. The gel was cooled down and poured into an electrophoresis chamber. 2µl of 6x 
loading dye including gel red (Biotium, Hayward, CA) were added to 10µl of the PCR 
products and to the marker. Per sample 10µl were loaded on the gel. The gel was run for at 
least 45 minutes at 75V. 10µl of a 1 Kb plus DNA ladder (Invitrogen) was used as a standard 
to determine the size of the PCR products. The gels were finally analysed using a Gel Doc 
XR system controlled by Quality One 4.6.2 software from Bio-Rad.  
 Enzyme-linked immunosorbent assay (ELISA) 3.8.
3.8.1. IL-2 ELISA 
IL-2 concentrations were determined in the supernatant of activated T-cells on day 3 of the 
proliferation assay performing an ELISA (IL-2 ELISA kit, ebioscience) according to the 
manufactures protocol.  
3.8.2. Detection of anti-ssDNA autoantibodies in serum 
Blood was extracted from the mouse heart and transferred into Microtainer SST tubes (BD). 
After at least 30 minutes incubation at room temperature the coagulated blood was spun down 
at maximal speed 1 minute. The serum was collected and transferred into a fresh tube and 
stored at 4°C until further analysis. To detected anti-single-stranded DNA autoantibodies a 
flat bottom 96 ELISA well plate (Corning) was coated with 100µl/well PBS containing 2.5 
µg/ml of heat-denatured calf thymus-ssDNA (pH7.2; Sigma) and incubated over night at 4°C. 
The next day the plate was washed 3 times with ELISA washing buffer and 150µl/well 
blocking buffer was added. After 2 hours of incubation at RT the plate was washed 3 times 
before 100µl of sample was added. The serum samples were diluted 1:100 in ELISA blocking 
buffer. After 2 hours of incubation the plate was washed 3 times in ELISA washing buffer 
and 100µl of the secondary antibody IgG2 alkaline phosphate labelled (BD Pharmingen) was 
added. After 1 hour of incubation the plate was washed 6 times in ELISA washing buffer and 
developed with 50µl of the alkaline phosphatase substrate DNPP (Sigma) dissolved in 
substrate buffer. After 15 minutes the reaction was stopped by adding 50µl 1M NAOH and 
the absorption was measured at a wave length of 405 nm.   
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 Anti-nuclear antibodies analysis 3.9.
The serum of mice was diluted in FACS buffer in a starting dilution of 1:100. The serum was 
incubated 30 minutes on a kidney section isolated from a Rag2-/- female mouse. Afterwards 
the sections were washed twice 10 minutes in PBS before staining with anti-mouse IgG-Alexa 
488 (life technologies) for 30 minutes at room temperature in the dark. Then the slides were 
washed again twice 10 minutes in PBS followed by 5 minutes of DAPI staining and washed 
in PBS for another 10 minutes. Finally the coverslips were mounted using hydromount. The 
samples were analysed using a Leica DMI 4000 microscope. Pictures were taken with a Leica 
DFC345 FX camera, the system was running by Leica AF 6000 software. ANA positive sera 
were further titrated 1:500, 1:1000 and 1:2000. 
 Solutions 3.10.
IMDM medium:    500 ml (Gibco-BRL, Gaithersburg, USA)  
   + 10% FCS (Hyclone, Perbio, Erembodegem, Belgium) 
   + 5 ml Kanamycin sulfate (Gibco-BRL) 
   +0.5 ml 2-mercapto-Ethanol (50MM, Gibco-BRL) 
 
1x PBS (sterile):   Dulbeco’s phosphate buffered saline (Sigma)  
    without CaCl2 and MgCl2 
   Mili-Q water 
Filter sterilised (0.22µm cellulose acetate, bottle top filtered, 
Coroning, NY, USA) 
 
HBBS:    500 ml (Gibco-BRL) 
     without CaCl2 and MgCl2 
 
FACS-buffer:    2% FCS in PBS 
 
AutoMACS running buffer:  FACS-buffer + 2.5mM EDTA (Gibco) 
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ACT:   0.16 M NH4Cl (Sigma) 
   2.06g Trizma®base (Sigma)  
   in 90ml dH2O  
   pH 7.65 fill to 100ml  
 
6x Loading buffer:   0.25% Bromophenol blue (Fluka, Buchs, Switzerland) 
   0.25% Xylene cynol FF (Fluka) 
   15% Ficoll (Type 400; Sigma) 
   Add to 50 ml ddH2O 
DNA ladder:   Ready-load 1Kb Plus DNA ladder (Invitrogen) 
 
50x TAE:   242g Trizma®base (Sigma) 
   57.1ml Glacial Acetic Acid (Fluka) 
   100ml EDTA (0.5M, pH 8.0; Sigma) 
 
Collagenase D:    Roche diagnostics  
Dnase:    Roche diagnostics 
Collagenase IV:    Worthington  
DAPI:   Invitrogen  
 
Toluidine blue:    0.25 g per 50ml miliQ H2O (Sigma) 
PFA:    4%; dissolved at 55°C for 2 hours. (Merck) 
Sucrose:   20% (Fluka) 
Acetone:   Sigma 
 
Blocking:   5% normal goat serum in PBS (Gibco-BRL) 
 
Tail lysis buffer:   100mM Tris pH8.5 (Sigma) 
   5mM NA-EDTA (Sigma) 
   0.2% SDS (Fluka) 
   200mM NaCl (Fluka) 
   Fill up to 1L with H2O 
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Proteinase K was freshly added to a final concentration of 100µg/ml () 
 
Cell counting:   Isoton II solution (Beckman Coulter, USA) 
   Zap-oglobinTM II lytic reagent (Beckman Coulter, USA) 
 
ELISA wash buffer:  0.1% Tween20 in PBS (Fluka) 
ELISA blocking buffer:   2% BSA in PBS (Fluka) 
Dinitrophenylphosphate:  100mg/ml in dH2O (Sigma) 
 
ELISA Substrate buffer:   0.1mg/ml MgCl2 x 6H2O (Fluka) 
   2% 1M NaN3 (Fluka) 
   10% Diethanolamine (pH 9.8) (Merck) 
   Fill up with H2O 
 Statistical analysis 3.11.
P values were calculated using Mann-Whitney U test (two-tailed), each experimental group 
was compared independently to wild type mice and to congenital nude mice in an independent 
analysis. Analysis was performed using GraphPad Prism 6 software (GraphPad Software Inc., 
La Jolla, CA, USA). P values of <0.05 were considered as significant.  
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4. Results 
 Mouse models for TEC targeted loss of Foxn1 function 4.1.
Two mouse models that differ in the degree of a decrease of Foxn1 expression and its timing 
were used to investigate the role of Foxn1 in thymus organogenesis and maintenance. The 
two mouse strains specifically differ in the amount and timing of Foxn1 expression. Mouse 
model 1, designated Foxn1neo/neo has been generated to study the effect of reduced Foxn1 
expression during and after ontogeny on thymus development and function. The second 
mouse model designated Foxn1fl/fl::Foxn1-Cre allows a tissue-specific and time-controlled 
deletion of Foxn1 expression. This strain was used to investigate whether Foxn1 expression is 
continuously needed throughout life, or alternatively whether a functional thymus can be 
formed under the conditions that Foxn1 is only expressed during the start of thymic ontogeny 
but not later. The basic principle of the experimental models to be investigated are displayed 
in Figure 4.1.  
All TEC express Foxn1 during embryogenesis, however in the postnatal thymus both Foxn1+ 
and Foxn1- TEC were detected, expressing both Dll-4 and CCL25137. Foxn1 was shown to 
regulate the expression of Dll-4 and CCL25143,144, their expression is absent in Foxn1 
deficient mice, however in postnatal thymus their expression seems to be Foxn1 independent. 
Lineage tracing experiments showed, that the Foxn1- TEC are descendants from Foxn1+ 
TEC261. Therefore the question was addressed whether Foxn1 expression is required in the 
adult thymus. TEC are a heterogeneous population consisting of cTEC and mTEC, with each 
different Foxn1 expression levels. Foxn1 is higher expressed in cTEC than in mTEC106, and 
in mTEChigh Foxn1 expression is higher when compared to mTEClow157. In the aged thymus 
Foxn1 expression decreases169. Therefore the influence of reduced Foxn1 expression on 
thymus organogenesis and on the different subsets was studied.  
Foxn1 expression in wild type mice starts at embryonic day E11.25, and is strongly detected 
at E12.5136. In Foxn1neo/neo mice the expression of Foxn1 is decreased when compared to wild 
type expression, but stably expressed. However in Foxn1fl/fl::Foxn1-Cre mice, Foxn1 
expression will start normally, but will be switched off once Cre recombinase is present (Fig. 
4.1). Since the cre recombinase is under the Foxn1 promoter, Foxn1 will be deleted 
immediately after it was activated.  
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Figure 4.1: Mouse models displaying differences in Foxn1 expression. Schematic representation of expected 
Foxn1 protein expression in wild type (WT), Foxn1neo/neo, Foxn1fl/fl::Foxn1-Cre and nude mice. 
 
Both mouse models were compared to wild type mice and congenital nude mice, using 
histology the thymic microenvironments of all four mouse strains was assessed and 
compared. Thymocyte development and peripheral T-cells were analysed using flow 
cytometry.  
 
4.1.1. Generation of Foxn1neo/neo mice 
To achieve conditionally deficient mice that allows for tissue and time restricted loss of 
regular gene expression, we targeted the Foxn1 locus such, that a loxP site was introduced 
each 5’ of exon 7 and 9. The Foxn1 gene targeting vector was constructed using the 
PGKneoF2L2DTA backbone (kindly provided by Philippe M. Soriano, Mount Sinai Hospital, 
New York, USA). The homology arms of the targeting sequence contained 5’ parts of exon 6 
and 3’ parts of exon 9 . Exons 7 and 8 encoding in part for the DNA binding domain were 
inserted at a SmaI restriction site flanked by loxP sites (Fig. 4.2). The targeting construct 
included a neomycin resistance cassette used for positive selection, flanked by FRT sites. A 
diphtheria toxin A (DTA) cassette was included for negative selection. Electroporation of ES 
cells with the targeting vector was done external by inGenious Targeting Laboratory Inc. 
Targeted ES clones were screened by PCR for homologous recombination and injected into 
blastocysts.  
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Figure 4.2: Generation of Foxn1neo/neo mice (A) Wild type Foxn1 genomic locus, targeting vector and structure 
of targeted Foxn1 allele (designated as Foxn1neo/neo). Exons are numbered. a and b indicate primers used for 
genotyping. The restriction site Nde1 was used to verify correct homologous recombination. (B) PCR of wild 
type, Foxn1+/neo and Foxn1neo/neo locus using primers detailed in panel A. 
 
The neomycin cassette in its intronic position impaired the transcription of Foxn1, which 
resulted in a decrease in Foxn1 expression. The relative amounts of Foxn1 transcripts were 
five-fold reduced in Foxn1neo/neo mice when compared to wild type mice (Fig. 4.3). The 
phenomenon that the PGKneo cassette can interact with locus control regions is well known 
and explained by a cryptic splice acceptor site between the PGK and the neomycin262,263. The 
persistent presence of the PGK-neomycin cassette between exons 8 and 9 generated a 
hypomorphic Foxn1 allele, allowing to study the impact of a reduced Foxn1 expression on 
thymus organogenesis and function. Heterozygous Foxn1neo/+ mice did not show any defects 
in thymus and thymocytes development (Appendix I), suggesting that the presence of only 
one wild type Foxn1 allele result in thymus development and TEC differentiation. This is 
expected as mice heterozygous for the spontaneous Foxn1 mutation display a normal thymus 
and are able to support T-cell development at frequencies comparable to wild type thymus. 
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Figure 4.3: Reduced Foxn1 expression in Foxn1neo/neo mice. Quantification of Foxn1 transcripts in sorted wild 
type (WT) and Foxn1neo/neo TEC at different ages normalised to GAPDH. The data shows mean values ± 
Standard derivation, from three independent experiments. Statistical significance was calculated using Mann-
Whitney test *p < 0.5, ** < 0.01, *** < 0.001. 
 
4.1.2. Foxn1 deletion in Foxn1fl/fl::Foxn1-Cre mice 
To study the consequences of Foxn1 deletion early in organogenesis, conditional knock-out 
mice were generated (Fig. 4.4 A). The Foxn1neo/neo mice described in the previous section 
were crossed with mice expressing the recombinase flippase under the transcriptional control 
of the Gt(ROSA)26Sor promoter264 to excise the neomycin cassette. The resulting line was 
breed to homozygosity and designated Foxn1fl/fl. In contrast to Foxn1neo/neo mice with reduced 
Foxn1 transcripts, Foxn1 transcripts were normal in homozygous Foxn1fl/fl mice and thymus 
organogenesis proceeded normally (Appendix II). Homozygous Foxn1fl/fl mice were crossed 
with Foxn1-Cre mice136. Foxn1-Cre mice express the Cre recombinase under the control of 
the Foxn1 promoter, leading to a TEC and skin specific deletion of Foxn1. Cre specific 
recombination in Foxn1-Cre mice can be detected as early as E11.5 as shown by crossing 
Foxn1-Cre mice with Rosa26loxPlacZ reporter mice136. However at this early time point β-
galactosidase expression is limited to only a few epithelial cells when compared to Foxn1 
protein expression, whereas at E12.5 both Foxn1 and β-galactosidase were broadly expressed, 
suggesting that β-galactosidase expression is approximately one day behind Foxn1 
expression. This delay can be explained by the fact that Cre mediated loxP excision requires 
time, Cre transcription starts at E11.25, initiated by the Foxn1 promoter, this lead to 
formation of mRNA and finally to the protein and consequently loxP excision. Therefore 
there is a gap between the onset of Cre expression and the effect of Cre mediated exicision263, 
which leads to a short one day window of Foxn1 expression before exon 7 and 8 are excised 
and Foxn1 transcripts cannot be generated anymore. 
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Figure 4.4: Generation of Foxn1fl/fl::Foxn1-Cre mice. (A) In vivo removal of the neomycin cassette by 
crossing Foxn1neo/neo mice to mice expressing the recombinase flippase under the transcriptional control of 
Gt(ROSA)26Sor promoter. Foxn1fl/fl mice were subsequently crossed to Foxn1-Cre mice, to delete exons 7 and 8 
in TEC and skin. (B) Genotyping of Foxn1fl/fl and Foxn1fl/fl::Foxn1-Cre mice, using primer a and b indicated in 
Figure 4.2 A. The Foxn1 transgene result in a wild type Foxn1 band (at 176 bp) present in Foxn1fl/fl::Foxn1-Cre 
mice beside the recombined Foxn1 allele (at 305bp).  
 
To construct mice that express the recombinase under the Foxn1 promoter, designated Foxn1-
Cre, a Foxn1 transgene was integrated into chromosome 15 using a P1 artificial chromosome 
(PAC) targeting vector. The expression of this transgene was shown to parallel the expression 
of the endogenous Foxn1 expression136. This Foxn1 transgene was also detected in 
Foxn1fl/fl::Foxn1-Cre mice, as indicated by the presence of two bands, the wild type band 
(176 bp) resulting from the Foxn1 transgene located in chromosome 15 and the floxed allele 
(305bp) whereas in Foxn1fl/fl mice only the floxed allele was detected (Fig. 4.4 B).  
Foxn1fl/fl females were bred with Foxn1fl/fl::Foxn1-Cre males, as Foxn1fl/fl:Foxn1-Cre females 
are typically unable to lactate due to Foxn1 ablation. The litter size was comparable to that of 
wild type mice. Female nude mice were shown to have a reduced fertility, due to lower serum 
levels of estradiol, progesterone and thyroxine265. In concordance with this report, female 
Foxn1fl/fl::Foxn1-Cre mice showed reduced fertility, as demonstrated by the observation that 
pregnancies could not be achieved despite mating for 12 months. 
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 Efficacy of Foxn1 deletion  4.2.
To determine the efficacy of Foxn1 deletion in embryonic E16.5 Foxn1fl/fl::Foxn1-Cre mice, 
RNA and DNA were isolated from sorted TEC collected at different time points (Fig. 4.5). 
The size of the PCR product demonstrated that TEC from E16.5 Foxn1fl/fl::Foxn1-Cre mice 
had successfully recombined, as a very dominant band of the expected 184 bp size could be 
detected. However the Foxn1 locus remained unaltered in non-epithelial stroma cells of the 
same mice thus confirming the TEC-specific deletion. In TEC from Foxn1fl/fl::Foxn1-Cre 
mice a faint WT band was detected, this does not necessarily mean that the recombination 
was not complete, rather this WT Foxn1 band results from the Foxn1 transgene that was 
shown to parallel endogenous Foxn1 expression. The Foxn1 locus was unaltered in sorted 
wild type TEC (Fig. 4.5 B). 
 
 
Figure 4.5: Conditional deletion of Foxn1 in Foxn1fl/fl::Foxn1-Cre mice. (A) Illustration of primer choices (a-
d) for PCR of Foxn1 sequences in genomic and complementary DNA for the detection of Foxn1 exon 7 to 8 
deletions. (B) Genomic deletion of exons 7 and 8. This was verified on sorted TEC defined as EpCAMpos 
CD45neg isolated from E 16.5 thymic lobes. (C) Quantification of Foxn1 transcripts in sorted TEC from mice of 
indicated ages using primers c and d (see panel A). (D) Size of Foxn1 qPCR product from E18.5 WT and 
Foxn1fl/fl::Foxn1-Cre TEC. The expression was normalised to GAPDH. The data shows mean values ± SD of 
three independent experiments. Statistical significance was calculated using Mann-Whitney test *p < 0.5, ** < 
0.01, *** < 0.001. 
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To further characterize the experimental system and to document the change of Foxn1 
transcripts in Foxn1fl/fl::Foxn1-Cre TEC after Cre mediated excision of exons 7 and 8, TEC 
were isolated from Foxn1fl/fl::Foxn1-Cre mice at various ages and analysed by qPCR for the 
relative Foxn1 transcript copy number (Fig. 4.5). The relative amount of Foxn1 transcripts in 
TEC from Foxn1fl/fl::Foxn1-Cre mice was significantly reduced when compared to age-
matched wild type mice. Though the locus was deleted efficiently as early as E16.5, Foxn1 
transcripts could still be detected as late as 4 weeks after birth. In contrast, Foxn1 protein 
could not be detected as early as E12.5 in Foxn1fl/fl::Foxn1-Cre mice using 
immunohistochemistry. These consistently detected transcripts are Foxn1 transcripts from 
exon 6 and 7 as demonstrated by the size of the amplicon. These Foxn1 transcripts result from 
the Foxn1 transgene inserted into chromosome 15, encoding the Cre recombinase under the 
Foxn1 promoter, these transcripts did not translate into protein, since after the ATG the 
coding sequence for Cre recombinase was inserted. In congenital nude mice Foxn1 protein 
was not detected in E12.5 embryos. To identify the epithelial cells of the thymus cytokeratin 8 
was included. Using immunohistochemistry, the Foxn1 protein could not be detected in 
Foxn1fl/fl::Foxn1-Cre mice even when analysed as early as E12.5. Foxn1neo/neo mice displayed 
at the same embryonic stage in comparison to wild type fewer Foxn1 positive TEC. These 
TEC were not equally dispersed but rather clustered in specific areas. In new born Foxn1neo/neo 
mice, thymic Foxn1 protein could still be detected, although the signal intensity was 
significantly reduced when compared to wild type mice.  
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Figure 4.6: Foxn1 protein is undetected in Foxn1fl/fl::Foxn1-Cre mice as early as E12.5. Sections of 
embryonic day 12.5 (A) and new born (B) thymic tissue were stained for Foxn1 protein (green) and cytokeratin 
8 (red). Representative microphotographs of 8 independent experiments.  
 
The conditional deletion of Foxn1 in Foxn1fl/fl::Foxn1-Cre TEC was complete and TEC 
specific. Targeting the neomycin cassette to intron 8 of the Foxn1 locus resulted in lower 
concentrations of Foxn1 transcripts and consequently reduced Foxn1 protein, whereas Foxn1 
ablation in TEC resulted in the absence of Foxn1 protein as early as E 12.5. Hence two 
separate novel mouse models were generated that differ in the kinetic and in the amount of 
Foxn1 expression. These two mouse models now allowed to probe whether Foxn1 expression 
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is required after early thymus organogenesis, whether Foxn1 expression is required 
throughout TEC differentiation, whether physiological TEC development is still possible 
despite a reduced Foxn1 expression level and finally, weather different TEC subsets require 
different Foxn1 expression levels for their development.  
 Foxn1fl/fl::Foxn1-Cre and Foxn1neo/neo mice show a skin phenotype and 4.3.
reduced weights 
Foxn1 is important for hair follicle formation, since its absence results in impaired 
keratinization of the hair shafts and, consequently, to short and bent hair unable to efficiently 
penetrate the epidermis, thus resulting in alopecia128,132,266. Therefore the coat phenotype of 
Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice was analysed. In concordance with reports on 
spontaneous Foxn1 mutations132, Foxn1fl/fl::Foxn1-Cre mice displayed a generalised alopecia 
identical to that observed in congenital nude mice (Fig. 4.7). In contrast and reflecting 
residual Foxn1 protein expression, Foxn1neo/neo mice had a hair coat that was less dense when 
compared to wild type mice (Fig. 4.7). In addition Foxn1 protein is also expressed in the 
whisker pads128 and its absence resulted in whiskers that were curled and shortened, 
indistinguishable to those of nude mice, whereas the whiskers in Foxn1neo/neo mice were 
unaffected. 
 
Figure 4.7: The nude phenotype is improved in Foxn1neo/neo mice Representative pictures of 6 week old wild 
type (WT), Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice.  
 
Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice appeared macroscopically smaller in size when 
compared to wild type littermates as determined by direct comparison of littermates. To 
further quantify the perceived size difference, the weight of the animals was measured over a 
time period of 40 weeks. The weights of Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice were 
significantly lower independent of gender when compared to wild type litter mates (Fig. 4.8). 
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Figure 4.8: Reduced weight in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice. Weight curves of male and 
female Foxn1neo/neo ( ), Foxn1fl/fl::Foxn1-Cre ( ) and wild type (WT) ( ) mice. For each time point and 
group at least 3 and as many as 13 mice were investigated. The data displayed provides mean values ± SD. Only 
three Foxn1fl/fl::Foxn1-Cre males were analysed, they were all died within 15 weeks. 
 
In summary Cre mediated deletion of exon 7 and 8 of the Foxn1 gene on the onset of thymus 
organogenesis results in the nude phenotype whilst only a reduction of Foxn1 expression 
caused a mild decrease in coat thickness but normal whiskers. Furthermore a reduction or 
complete loss of Foxn1 protein, resulted in mice with reduced weight and size, which might 
be explained by a faster metabolism due to absence of fur. 
 Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice display severe thymus hypoplasia 4.4.
Foxn1 is mainly expressed in skin and thymic epithelial cells. In the latter Foxn1 serves as a 
master transcription factor orchestrating thymus organogenesis with the exception of the 
formation of the thymus primordium25. In the absence of Foxn1 a rudiment develops, 
however after early organ formation the thymus fails to attract lymphoid precursors and 
degrades into cysts. To investigate the consequences of an early loss or reduction of Foxn1 
protein expression during thymus organogenesis I first analysed the thymus cellularity in 
Foxn1neo/neo, Foxn1fl/fl::Foxn1-Cre and wild type mice at embryonic days 16.5 and E18.5, on 
postnatal days 1 and 7 and in 5 week old animals. For the latter two time points, thymic 
tissues from nude mice were used in addition for comparison. E12.5 Foxn1neo/neo and 
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Foxn1fl/fl::Foxn1-Cre thymi were macroscopically indistinguishable from wild type organs 
(data not shown) suggesting that early thymus development is independent of Foxn1 
expression. At E16.5 the difference in macroscopic size of Foxn1neo/neo and Foxn1fl/fl::Foxn1-
Cre thymus was already significant and progressively with time (Fig. 4.9 A). The thymi of the 
mutant mice were hypoplastic and typically displayed multiple cysts of different sizes. The 
thymi from Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre were despite these similarities clearly 
distinguishable in appearance from those of nude thymus. For example, the fatty tissue 
surrounding the thymus was different in colour and appearance. Because the thymus in all 
mutant mouse strains was positioned similarly to wild type animals along the carotid arteries, 
an absence or reduction of Foxn1 did apparently not influence thymus migration. Hence, this 
observation confirms that the migration of the thymus anlage during embryonic organ 
development is Foxn1 independent.  
Parallel to the reduced macroscopic size, thymic cellularity in E16.5 Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre mice was significantly reduced to 26’528 ± 8869 and 20’216 ± 11697 
cells respectively whereas age-matched wild type mice had a thymus with a cellularity of 
1’803’750 ± 649’697 cells. This reduction increased over time (***p<0.05) but was 
comparable to that of nude mice (Fig. 4.9 B). Hence, both an initial normal but subsequently 
absent or only reduced Foxn1 expression resulted in a severely hypoplastic thymus, that was 
indistinguishable in size and cellularity from that of nude mice which never express Foxn1. 
Therefore only a short term or overtime reduced Foxn1 expression do not allow for the 
regular outgrowth of the thymus rudiment and the significant presence of lymphoid 
precursors.  
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Figure 4.9: Both reduction and deletion of Foxn1 cause severe thymic hypoplasia. (A) Representative 
photomicrographs of thymic lobes isolated from (i) wild type (WT), (ii) Foxn1neo/neo, (iii) Foxn1fl/fl::Foxn1-Cre 
and (iv) nu/nu mice at E16.5, 1 week and 5 weeks of age. (B) Thymic cellularity at E16.5, E18.5, 1day, 1 week 
and 5 weeks of age. WT ( ) Foxn1neo/neo ( ), Foxn1fl/fl::Foxn1-Cre ( ) nu/nu ( ) mice. Values were 
indicated as mean plus standard derivation, from at least three independent experiments. Statistical significance 
was calculated using Mann-Whitney test *p < 0.5, ** < 0.01, *** < 0.001. 
 
This result indicates that the skin is less sensitive to Foxn1 reduction compared to the thymus, 
however the fur of Foxn1neo/neo mice is less dense indicating that the rescue is not complete.  
 
4.4.1. The Chemokines required for thymocytes attraction are reduced in 
Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice.  
The colonisation of the early thymus anlage is controlled by the expression of the chemokines 
CCL19, CCL21, CCL25 and CXCL1249,148, with the chemokines CCL25 and CXCL12 
directly dependant for their transcription on Foxn1 expression144. To elucidate whether the 
reduced thymus cellularity resulted from a defect in precursors attraction, secondary to 
changes in the chemokine expression I analysed the transcription of the above mentioned 
chemokines in TEC purified from Foxn1neo/neo, Foxn1fl/fl::Foxn1-Cre mice and wild type mice. 
The expression of all four chemokines was severely reduced in both embryonic E16.5 and 
adult TEC of the mutant mice compared to wild type animals (Fig. 4.10). The cytokine 
expression was similar in Foxn1fl/fl::Foxn1-Cre and Foxn1neo/neo mice, despite the presence of 
reduced Foxn1 transcripts. Hence, reduced Foxn1 expression does not induce the presence of 
cytokines. It might be that Foxn1 expression is too weak to drive cytokine expression. 
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Figure 4.10: Reduced transcription of chemokines that are involved in T-cell precursor homing to thymus. 
Quantification of CCL19, CCL21, CCL25 and CXCL12 transcripts in sorted EpCAM+/CD45- TEC of WT ( ), 
Foxn1neo/neo ( ) and Foxn1fl/fl::Foxn1-Cre ( ) mice at E16.5 and adult age normalised to GAPDH. Pooled data 
from 3 independent experiments, values indicate mean ± SD. p values were determined by Mann-Whitney test, 
*p <0.05, ** < 0.01, *** < 0.001. 
 
This result suggests that reduced Foxn1 expression or short term Foxn1 expression does not 
suffice to maintain regular chemokine expression and that therefore the recruitment of T-cell 
precursors into Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre thymus is reduced or absent. This result 
is in concordance with the reduced thymic cellularity in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre 
mice that is indistinguishable from nude thymus, which lack T-cell precursors. 
 
4.4.2. Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre thymus are vascularised  
After the entry of the first progenitor cells, the thymus vascularisation is established in a 
Foxn1-dependant fashion150. Both TEC and mesenchymal cells can produce vascular 
endothelial growth factor (VEGF), which is essential for blood vessel formation in the 
thymus42. In the absence of Foxn1 PDGFRβ+ mesenchymal cells cannot migrate into the 
thymus and the vasculature is not established. CD31+ endothelial cells are detected in the wild 
type thymus as early as E12.5, interestingly both CD31+ endothelial and PDGFRβ+ 
mesenchymal cell were absent in nude thymus. A lack of thymus vascularisation might 
therefore contribute to the small thymus size observed in Foxn1neo/neo and Foxn1fl/fl::Foxn1-
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Cre mice, as T-cell precursors would fail to enter the thymus, precluding of the crosstalk 
between thymocytes and TEC necessary for the regular development, differentiation and 
architectural organisation of the thymic stromal compartment and thus also eventually 
favouring the formation of cysts. To study to consequences of only short term normal or 
continuously reduced Foxn1 expression on thymus vascularisation sections of thymus tissue 
isolated from one and six week old mutant and wild type mice were analysed for the detection 
of the endothelial cell marker CD31. This marker was absent in the thymus of nude mice, at 
one and six weeks of age. This was a thymus organ autonomous finding as CD31+ cells could 
be detected outside of the thymus rudiment in the surrounding adipose tissue. In contrast, 
intrathymic vessels could be identified in the Foxn1fl/fl::Foxn1-Cre, and Foxn1neo/neo mice. In 
six week old Foxn1fl/fl::Foxn1-Cre mice the vascularisation was different from vascularisation 
of Foxn1neo/neo mice as the thymus was less vascularised and most of the vessel were detected 
in the adipose tissue, similar as observed in nude mice (Fig. 4.11). This result implies that 
short term or reduced Foxn1 expression  suffices for the establishment and maintenance of 
thymic vascularisation, further suggesting that the limited thymus size and reduced precursor 
seeding are not directly coupled to the vascularisation of the thymus. However this analysis 
was only descriptive, the quality of the blood vessel was not assessed.  
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Figure 4.11: Vascularisation in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice was not impaired. 
Photomicrographs of thymic tissue sections analysed in confocal microscopy of 1 week and 6 week old wild 
type (WT), Foxn1neo/neo, Foxn1fl/fl::Foxn1-Cre and nu/nu mice stained for ERTR-7 (red), CD31 (green) and DAPI 
(grey).  
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 Architecture and composition of the thymus 4.5.
TEC in nude mice remain in an early progenitor stage107 underscoring the importance of 
Foxn1 for regular TEC development and their differentiation into medullary and cortical 
subpopulations25. In addition, for the formation of a cortex and medulla interactions with 
developing thymocytes are essential5,54. The cellularity of Foxn1neo/neo and Foxn1fl/fl::Foxn1-
Cre thymus was drastically reduced, and chemokines involved in precursor homing were 
reduced in TEC isolated from Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice, both indicators for 
a reduced or absent precursors homing. Because the absence or reduction of T-cell precursor 
homing and their subsequent expansion and regular differentiation will influence the 
composition and architectural organisation of the cortex and medulla, I analysed and 
compared the stromal epithelial compartment of mutant and wild type mice. Darker (i.e. cell 
dense) cortical and lighter medullary zones are typically observed when tissue sections are 
stained with haematoxylin and eosin (H&E). This segregation is however not observed in 
thymi with only an early but normal Foxn1 protein expression (i.e. Fonx1fl/fl::Foxn1-Cre) or 
with a subnormal expression following regular Foxn1 transcripts (Fig. 4.12). This can be 
explained by the absence or large reduction of T-cells in the thymus. With increasing age the 
only epithelial cells, identified by cytokeratin (CK) 5 and 8 expression, in Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre thymic tissue, were restricted to the lining of the cysts, similar to the 
findings in nude thymus (Fig. 4.12). The epithelial stromal network was interspersed in both 
mutant mice already at 1 week of age with adipocytes. A previous study suggested that cyst 
formation is a default pathway of the TEC development in the absence of thymocytes, as the 
presence and expansion of thymic cysts inversely correlated with the presence of 
thymocytes28. The observation that cyst formation is dependant on the absence of thymocytes 
is in accordance with the cyst formation in the nude thymus, where thymocytes are absent. 
The cysts and the absence of cortex and medulla segregation observed in Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre thymus imply a strong reduction or complete absence of thymocytes in 
Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice, which is further corroborated by their low 
chemokine expression level for T-cell precursors.  
Epithelial cells are polarised cells forming a two dimensional structure, however the TEC are 
special as they form a three dimensional network. In the absence of the thymic crosstalk the 
three dimensional network of the thymus is disrupted and TEC consequently adopt a two 
 71 
dimensional organisation and cysts appear5. The cysts observed in Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre mice would suggest that the three dimensional architecture of the 
thymus is absent resulting in epithelial cells which form mainly a two dimensional 
architecture.  
 
Figure 4.12: Loss of regular thymic architecture in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre thymic tissue. 
Hematoxylin and Eosin staining of thymic tissue sections of new born (middle rows) and 6 week old mice 
(lower row). 
 
Next, immunohistochemistry was performed to further investigate the composition of the 
thymic microenvironment, and to identify whether the epithelial cells remained in an early 
CK5 and CK8 double positive progenitor stage as observed in nude mice53,267 or whether their 
development proceeds. In a first step the cortical marker CK8 (green) and the medullary 
marker CK5 (red) were used to characterize the TEC specific cytokeratin expression pattern. 
Specifically I tested whether TEC were double positive, a phenotype typically observed in 
nude mice or alternatively whether separate cortical and medullary TEC subpopulations had 
formed each expressing either CK5 or CK8. In contrast to the impression gained from H&E 
stainings, distinct cortical and medullary areas were appreciated in Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre mice both at 1 and 6 weeks of age (Fig. 4.13 A). However these distinct 
cortical and medullary areas were restricted to small islets in comparison to wild type thymi. 
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This segregation was not complete as an increase in CK5 and CK8 double positive cells was 
also detected, CK5+CK8+ TEC are typically detected at the cortico-medullary junction and 
under conditions where thymocytes are missing or are grossly reduced as in CD3ε transgenic 
mice where T-cell development is blocked at an early stage94. In aggregate, these results 
likely suggest furthermore that T-cell development must be very comprised in both 
Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre thymi.  
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Figure 4.13: Changes in thymic microenvironment in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice. Confocal 
microscopy of thymic tissue sections of 1 (A) and 6 (B) week old mice stained for the epithelial markers CK5 
(red) and CK8 (green).  
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Because TEC are replaced during thymic involution by fibroblasts, possibly at least in part via 
the process of epithelial-mesenchymal-transition176 I analysed the presence of these cells in 
thymus sections of mutant and wild type mice using the fibroblast marker ERTR-7. In six 
week old Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre thymi, the epithelial cell compartment was 
replaced by fibroblasts and TEC were restricted to small islets, surrounded by fibroblasts. The 
increase in fibroblasts correlates with the age of the mice (data not shown). An increased 
number of fibroblasts compared to wild type thymi was also observed in nude thymi (Fig. 
4.14). The increase of fibroblast would argue that a premature thymic involution causes the 
phenotype observed in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice or alternatively the 
absence of T-cell precursors and therefore a lack of regular TEC development causes the 
phenotype observed.  
 
Figure 4.14 Increase in fibroblasts in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice. Confocal microscopy 
sections of 6 week old wild type (WT), Foxn1neo/neo, Foxn1fl/fl::Foxn1-Cre and nude mice stained for the 
epithelial markers CK8 (red), CK5 (green) and the fibroblast marker ERTR-7 (blue).  
 
In summary these results showed that the thymic architecture is severely disturbed, with the 
formation of cysts and a loss of a three dimensional epithelial network and architecture. Thus 
thymic architecture is not induced with short term or reduced Foxn1 expression. Segregation 
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into cortex and medulla was incomplete and with age the only epithelial cells present were 
lining the cysts, whereas the remaining space was filled by fibroblasts. However TEC can 
develop into distinct cTEC and mTEC, which is not observed in nude TEC, suggesting that T-
cell precursor entry is not completely abrogated. 
 
4.5.1. Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice lack hallmark of cortex and 
medulla 
I next analysed the expression of β5t in the thymus cortical areas of Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre mice, since β5t is only expressed in mature cTEC. β5t expression is 
directly or indirectly dependant on Foxn1 expression, since nude mice fail to express β5t268. 
Specifically, I wished to know whether expression of β5t requires continuous and regular 
Foxn1 expression for cTEC to acquire normal β5t expression. This protein was expressed in 
wild type thymic tissue as early as E12.5 in TEC, but could never be detected in E12.5 
Foxn1fl/fl::Foxn1-Cre mice (Fig. 4.15 A). A short term expression of Foxn1 does therefore not 
suffice to initiate β5t expression. In Foxn1neo/neo mice β5t expression was present in a quarter 
of the E12.5 embryos analysed, indicating a dosage effect (Fig. 4.15 B). Since in Foxn1neo/neo 
mice Foxn1 expression is reduced by a hypomorphic allele, which is the result of the 
neomycin cassette, the expression of Foxn1 varies between different embryos. Embryos with 
more Foxn1+ TEC expressed β5t, whereas in embryos with less Foxn1+ TEC β5t expression 
was absent. In one and six week old Foxn1neo/neo thymus β5t protein was absent, although 
Foxn1 mRNA was still present. However Foxn1 protein was reduced in 1 week old 
Foxn1neo/neo mice. These results showed that β5t is dependent on a stable and adequate Foxn1 
expression.  
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Figure 4.15: β5t expression is absent in Foxn1fl/fl::Foxn1-Cre and 75% of Foxn1neo/neo mice. 
Photomicrographs of thymus tissue sections analysed in confocal microscopy. (A) E12.5 wild type (WT) and 
Foxn1fl/fl::Foxn1-Cre thymus section stained for Foxn1 (green) and Dapi (grey) or β5t (green) and Dapi (grey). 
(B) E13.5 WT and Foxn1neo/neo mice stained for Foxn1 (green) and Dapi (grey) or β5t (green) and DNA (grey), 
and 1 week old mice stained for β5t (green) and Dapi (grey).  
 
To further characterise the thymic medulla of Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice and 
the expression of the autoimmune regulator (Aire) was determined. During embryogenesis the 
maturation of Aire- mTEC into Aire+ mTEC is promoted by the presence of RANKL269. 
RANKL is expressed by lymphoid inducer cells113 and by positively selected SP 
thymoyctes269. Because the thymic cellularity is significantly reduced in Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre mice, I investigated whether the medulla contained Aire+ mature TEC. 
Using immunohistochemistry Aire protein could not be detected in the medulla of Foxn1neo/neo 
and Foxn1fl/fl::Foxn1-Cre and nude mice of both one and six weeks of age (Fig. 4.16). Hence, 
a reduced or a short term expression of Foxn1 only was incompatible with a regular induction 
of Aire expression in mTEC, most likely via an indirect mechanism that involves the absence 
of sufficient cells providing Aire-inducing signals269–273. As a consequence of this absence of 
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mTEC known to be essential for the induction of several immunologic tolerance111,112,273, 
autoimmunity may be the consequence of an incomplete or ineffective thymocyte selection. 
 
Figure 4.16: Aire expression is absent in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre thymi. Photomicrographs of 
thymus tissue sections of 1 week old wild type (WT), Foxn1neo/neo, Foxn1fl/fl::Foxn1-Cre and nude mice  analysed 
in confocal microscopy stained for K14 (green), K18 (red) and Aire (blue). 
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 Severely impaired T cell development in Foxn1neo/neo and Foxn1fl/fl::Foxn1-4.6.
Cre thymus 
A regularly structured thymic stromal environment is essential for the normal differentiation 
of T-cells94,261,274,275. Given the significant structural changes in the thymus of Foxn1neo/neo 
and Foxn1fl/fl::Foxn1-Cre mice I next investigated the T-cell development of these mutant 
animals and compared them to wild type controls at distinct stages of embryonic and 
postnatal development (Fig. 4.17 A). c-kit positive early thymic precursors were detected in 
both Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice. Their development to maturational stages 
beyond DN1 was yet completely blocked as thymocytes with a double positive phenotype 
(i.e. CD4+CD8+ cells) could not be detected at E16.5 when already 15.5% of lymphoid cells 
display this phenotype in age-matched wild type controls (Fig. 4.17 B, left). Two days later in 
embryonic development double positive thymocytes were present in some but not all mice 
albeit at reduced frequency (<10%), when compared to wild type animals (>80%) (Fig. 4.17 
C), though a canonical progression beyond the DN1 stage was still not detected in these 
animals without regular Foxn1 expression. Whether T-cell development follows normal 
differentiation but occurs below the detection limit of FACS or, alternatively whether T-cell 
development follows a non-canonical pathway remains to be determined. The latter 
explanation has been identified in Foxn1Δ/Δ mice152,154 where DP thymocytes develop from 
ckitnegative progenitor cells directly into DP thymocytes without passing through the DN2 and 
DN3 stages of maturation. In one week old and adult Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre 
mice, lymphoid cells beyond the DN stage could not be detected (Fig. 4.17 D, E), providing a 
phenotype appearance comparable to that of nude mice where an absence of effective T-cell 
development is characteristic. These results indicate that the thymus may be functional early 
in embryogenesis, though the T-cell development was clearly severely altered in the absence 
of regular Foxn1 expression. 
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Figure 4.17: Severely impaired T-cell development in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice. 
(A) Gating strategy: Cells were stained for CD4 and CD8 and double negative T-cells were further analysed for 
DN1 to DN4 subsets using CD44, c-kit and CD25 expression. T-cell development in E16.5 (B), E18.5 (C), 1 
week (D) and adult (E) mice. Representative FACS plots from at least three independent experiments. 
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4.6.1. Hematopoietic progenitors in bone marrow are not affected by Foxn1 
expression in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice 
To exclude the possibility that the transgenic construct used influenced the developmental 
potential of T lymphoid cells, the frequency of Lineageneg, Sca-1pos and ckitpos (LSK) was 
investigated. Since the thymus lacks self-renewing hematopoietic precursors it depend on a 
continuous supply of blood-borne lymphoid precursor cells identified in the bone marrow as 
LSK cells276–279. The frequency of LSK cells was compared to wild type and nude controls 
increased in both Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice (Fig. 4.18 A). LSK cells 
expressing L-selectin (CD62L) are considered as a bone marrow homologue of the early T-
lineage progenitor in the thymus 280,281, there was no significant difference in the frequency of 
CD62Lhigh LSK precursors between wild type and mutant mice (Fig. 4.18 B). Thus, the 
genetic approach chosen to alter correct Foxn1 expression did not inadvertently reduce the 
frequencies of T-cell precursors in the bone marrow and thus did not account for the observed 
phenotype. However, a significant increase in the frequency of LSK cells was appreciated, 
which may be caused by the residual expression of Foxn1. Overexpression of Foxn1 was 
shown to increase the LSK pool in the bone marrow of aged mice282. Therefore this increase 
in LSK could be attributed to a short term or reduced Foxn1 expression in combination with a 
reduced precursor attraction, resulting in an increased LSK pool.  
 
 
Figure 4.18: Increased frequencies of hematopoietic progenitors in the bone marrow of Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre mice. (A) Frequency of lineagenegSca1posckithigh (LSK) precursor cells in the bone marrow 
of wild type (WT; ), Foxn1neo/neo ( ) Foxn1fl/fl::Foxn1-Cre ( ) and nude mice ( ). (B) Frequency of 
CD62Lpos cells within LSK pool. Pooled data of 2 independent experiments, values indicate mean +SD, n = 3 
per experimental group. p values were determined by Mann-Whitney test *p < 0.05, ** < 0.01, *** < 0.001. 
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 T-cells are detected in the periphery of Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre 4.7.
mice 
The consequences of a time-controlled loss or reduction of Foxn1 in TEC on the peripheral T-
cell pool was assessed next. Despite the striking absence of an overt thymus in nude mice T-
cells can be detected in the periphery. These T-cells are, however, extrathymically derived 
and their frequency increases with age193. I therefore examined and compared the periphery of 
Foxn1-target mouse mutant to specifically evaluate the consequences of a Foxn1 reduction or 
a TEC specific loss of Foxn1 after a short period of correct expression levels of Foxn1. As 
expected, a significant decrease in absolute T-cell numbers was observed in lymph nodes of 
Foxn1neo/neo, Foxn1fl/fl::Foxn1-Cre and nude mice at one week of age (Fig. 4. 19 A), which 
continued to be reduced in 10 week old mutant mice (96-99%) when compared to age-
matched wild type animals. On closer examination, there was however a significant but in 
absolute cell number very small increase in T-cells in Foxn1neo/neo mice when compared to 
nude controls, which was at 5 weeks 10-fold and at 10 weeks 40-fold higher. Similar, but less 
prominent was the expansion of peripheral T-cells in Foxn1fl/fl::Foxn1-Cre (13-fold) when 
compared to nude mice (Fig. 4.19 A). 
CD8 T-cells are preferentially generated in the peripheral lymphoid compartments of nude 
mice194. To further discriminate T-cells present in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice 
from those of nude mice, T-cells were also investigated for CD4 and CD8 expression. The 
absolute number of CD4 T-cells was significantly reduced in both mutant strains at all ages 
when compared to wild type animals but increased in comparison to nude mice i.e. 870-fold 
in Foxn1neo/neo and 48-fold in Foxn1fl/fl::Foxn1-Cre in one week old animals (Fig. 4.19 B). The 
difference continued to be observed for as long as I followed these mice (10 weeks), though 
the fold differences clearly changed between the different mouse strains compared. A 
different picture emerged for the detection of CD8+ peripheral T-cells. At 1 week of age CD8 
T-cells were 2000-fold reduced in Foxn1 mutant mice in comparison to wild type animals. By 
10 weeks of age, the frequency of CD8 T-cells was comparable for Foxn1fl/fl::Foxn1-Cre and 
nude mice, whereas that in Foxn1neo/neo mice was even increased by 12-fold vis-à-vis nude 
animals (Fig. 4.19 C). The difference between Foxn1fl/fl::Foxn1-Cre and Foxn1neo/neo mice 
might result from the continuous but reduced Foxn1 expression in Foxn1neo/neo mice.  
 
 82 
 
Figure 4.19: T-cells are present in the lymph nodes of Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice. 
Absolute numbers of T-cells (A), CD4 T-cells (B) and CD8 T-cells (C) in lymph nodes isolated from wild type 
(WT; ), Foxn1neo/neo ( ), Foxn1fl/fl::Foxn1-Cre ( ) and nude mice ( ) at the indicated ages. 
Significance is indicated as * for WT cells against all other groups; # for nude cells significantly different from 
that of all other groups analysed and 1 for Foxn1neo/neo cells significantly different from that of Foxn1fl/fl::Foxn1-
Cre and nu/nu mice respectively. Detailed analysis of the T-cell compartment of WT ( ) Foxn1neo/neo ( ), 
Foxn1fl/fl::Foxn1-Cre ( ) nude mice ( ) of five weeks (D) and 10 weeks (E) of age. All panels report pooled 
data from 2-3 independent experiments: values indicate mean +SD, n ≥ 3. p values were determined using 
Mann-Whitney test. *p < 0.05, ** < 0.01, *** < 0.001 
 
The relative frequency of B-cells in the lymph nodes of Foxn1neo/neo, Foxn1fl/fl::Foxn1-Cre and 
nude mice was 4-fold increased compared to wild type mice (Fig. 4.19 Di and Ei), which is 
likely explained by the absence of T-cells, since absolute B-cell number in wild type and 
mutant mice were not altered (data not shown). The frequency of TCR-β+ cells was 100-fold 
reduced in Foxn1neo/neo, Foxn1fl/fl::Foxn1-Cre and nude mice compared to wild type mice (Fig. 
4.19 D ii). However after 10 weeks their frequency was significantly increased in Foxn1neo/neo 
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(2.21% ± 2%) and Foxn1fl/fl::Foxn1-Cre mice (0.93% ± 0.68%) when compared to nude mice 
(0.22% ± 0.1%; Fig. 4.19 E ii). Analysing the ratios of CD4 to CD8 T-cells revealed that in 
Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice more CD4 than CD8 T-cells were present (Fig. 
4.19 D iii and E iii), whereas the ratio was reversed in nude mice. More than 80% of the CD4 
T-cells in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice expressed a memory-like phenotype 
(Fig. 4.19 D iv and E iv ), indicating that these cells had undergone homeostatic expansion or 
had undergone specific antigen-driven activation.  
In aggregates these analyses suggest that the peripheral T-cell pool in Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre mice has a composition different from that of nude mice: Foxn1neo/neo 
and Foxn1fl/fl::Foxn1-Cre mice had an increased frequency of CD4 T-cells particularly those 
with a memory like phenotype compatible with limited thymic output. 
 
4.7.1. Composition of the TCR Vβ repertoire among T-cells of Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre mice 
Given a dramatically altered thymic microenvironment, T-cell selection may be affected in 
Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice, thus altering the TCR-Vβ repertoire of peripheral 
T-cells. Because Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice are severely lymphopenic, only 
the four most common Vβ (Vβ2, 6, 8 and 14) were analysed by immunostaining and flow 
cytometric analysis. This collection of Vβ allowed to investigate around 50% of the Vβ 
repertoire. Foxn1neo/neo mice showed changes in the repertoire when compared to wild type 
lymph nodes (Fig. 4.20), Vβ2 (3.61% ± 1.85% and 6.09% ± 0.75%, respectively) and Vβ6 
(9.48% ± 0.41% and 9.98% ± 13.94%, respectively) were significantly reduced when 
compared to wild type mice. The relative frequency of Vβ 8 was increased in Foxn1neo/neo 
mice 35.06% ± 35.6% when compared to wild type mice 20.84% ± 0.57% and Vβ14 was 
reduced in Foxn1neo/neo mice compared to wild type mice (4.87% ± 5.53 and 7.36% ± 0.53%, 
respectively). Although the values were not statistical significant the repertoire composition 
varied between the different mice analysed, as some Vβ clones were preferentially used. The 
variety in the different mice analysed was apparent indicating that the repertoire was not 
polyclonal. 
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Figure 4.20: Vβ repertoire frequency in Foxn1fl/fl::Foxn1-Cre, Foxn1neo/neo and wild type mice. Frequency 
of Vβ2, Vβ6, Vβ8 and Vβ14 was tested in lymph nodes isolated from wild type (WT; ) Foxn1neo/neo ( ) and 
Foxn1fl/fl::Foxn1-Cre ( ) mice. Values indicate mean +SD. Pooled data of 3 independent experiments with 3 
mice per group. Vβ frequencies from mice with less than 10 corresponding cells were excluded from the study. p 
values were determined using Mann-Whitney test. *p < 0.05, ** < 0.01, ***<0.001.  
 
The collection of the Vβ repertoire analysed in Foxn1fl/fl::Foxn1-Cre mice was comparable to 
the repertoire in wild type mice (Fig. 4.20). However if Foxn1 expression is reduced the T-
cell repertoire showed minor changes. The variability in the T-cell receptor chain usage was 
expected as only few T-cells are exported into the lymphopenic environment where they 
undergo extensive homeostatic expansion, a phenomenon known to influence the composition 
of the TCR repertoire. In contrast the Vβ repertoire of nude mice was reported to be 
oligoclonal, and develop from only a few functional T-cells clones283,284 further identifying a 
difference between the new Foxn1 mutant and the nude mice. However, the competence of 
TEC of Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice to support thymopoiesis is (at least for 
some mice) significantly different because of their initial short expression of physiological 
Foxn1 levels.  
 
4.7.2. Regulatory T-cells are present in the periphery of Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre mice 
Nude mice lack regulatory T-cells (Treg)285. In striking contrast to this finding, regulatory T-
cells were detected at regular frequencies in adult Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice 
(Fig. 4.21 A and B). Treg are characteristically either generated in the thymus or, 
alternatively, develop in the periphery via conversion from conventional effector T-cells. 
Thus, the Treg detected in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice could have been 
generated either in the thymus or in the periphery. Cell surface markers have been used to 
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distinguish between these two origins of Treg: Thymus-derived Treg express Helios286 and 
higher surface concentrations of Neuropilin-1287,288 (Nrp1). Using these phenotypic markers, I 
found that the majority of the Tregs detected in the periphery of Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-cre mice expressed Helios (Fig. 4.21 C). However recent reports questioned 
the use of the Helios cell marker as a way to distinguish between the origin of Tregs as Helios 
could be detected on both sets of T-regs289 and, in addition on activated T-cells290, rendering 
as an unreliable marker for the purpose to distinguish thymic from peripheral Tregs. In 
contrast, Nrp1 is exclusively expressed on thymic Tregs287,288. The extent of Nrp1 expression 
on Tregs isolated from Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre was approximately 4-fold 
reduced when compared to wild type mice (Fig. 4.21 D), though a uniform staining pattern 
was observed. Taken together these data show that in the periphery of Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre mice regulatory T-cells were detected, that were absent in nude mice. 
These results emphasise the difference in the CD4 compartment of mice without and with 
pathological Foxn1 expression and implies that Tregs in the latter mice are generated in the 
periphery. This conclusion is further supported by our finding that Aire protein was not 
detected in the thymic medulla of these mice because Treg are dependant on its expression83. 
The reason why CD4 T-cells from congenital nude mice are not able to convert into 
regulatory T-cells and why CD4 T-cells of Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice do so 
remain unclear, but could be linked to impaired CD4 T-cell function in nude mice204,291. 
Hence, the normal frequency of Helios+ cells in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice 
could result from their activation status independent of a regulatory T-cell function.  
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Figure 4.21: Regulatory T-cells are present in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice but lack in nude 
mice. Lymph nodes from wild type (WT; ), Foxn1neo/neo ( ), Foxn1fl/fl::Foxn1-Cre ( ) and nude ( ) mice 
were analysed for the presence of Foxp3pos CD25pos regulatory T-cells. Representative FACS plots and 
frequency of regulatory T-cells among CD4 T-cells in mice 6 (A) and 10 weeks of age (B). (C) Expression of 
Helios in regulatory T-cells. (D) Expression of Neuropilin1 (Nrp1) among regulatory T-cells. ΔMean 
fluorescence intensity (MFI) of Nrp1 expression was defined as the MFI of Nrp1 expression in regulatory T-
cells subtracted from the MFI of Nrp1 of CD4 T-cells. Values indicate mean +SD of three independent 
experiments with n ≥ 3 for each group analysed. p values were determined using Mann-Whitney test. *p < 0.05, 
** < 0.01, *** < 0.005. 
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4.7.3. T-cell effector function in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice 
Next, I assayed CD4 T-cell function in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice. For this 
purpose purified CD4 T-cells were stimulated using mitogenic concentrations of anti-CD3 
antibodies and the cells proliferative response was measured using the dilution of CFSE label 
(details see Material and Methods section). T-cell proliferation (as revealed by the 
proliferation index) was significantly higher for cells isolated from Foxn1neo/neo (2.67 ± 1.02) 
and Foxn1fl/fl::Foxn1-Cre (2.37 ± 0.75) mice when compared to T-cells from nude mice (1.18 
+ 0.01, Fig. 4.22 A), but remained significantly smaller when compared to wild type T-cells 
(Fig. 4.22 A). This reduced response may reflect their partial exhaustion due to homeostatic 
expansion. Consistent with their activation the population of CD4+ T-cells from Foxn1neo/neo 
and Foxn1fl/fl::Foxn1-Cre mice had subsequent to mitogenic stimulation an increased cell size 
(Fig. 4.22 B)292. The failure of CD4 T-cells from nude mice to proliferate in response to 
mitogenic stimulation has been linked to their reduced capacity to produce IL-2291. To extent 
this finding to CD4+ T-cells from Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice the supernatants 
of T-cell proliferation cultures were analysed on day 3 for the presence of IL-2. As expected, 
CD4 T-cells isolated from nude mice produced far less IL-2 when compared to CD4 T-cells 
isolated from Foxn1neo/neo or Foxn1fl/fl::Foxn1-Cre mice which in turn expressed decreased 
concentrations of this cytokine in comparison to wild type controls (Fig. 4.22 C). Thus CD4 
T-cells in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice demonstrate an intermediate 
functionality to TCR-mediated stimulation, which may reflect their exposure to extensive 
homeostatic expansion. 
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Figure 4.22: T-cells of Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice proliferate in vitro in response to a 
mitogenic stimulus. Proliferation of CFSE labelled CD4 T cells isolated from wild type (WT; ) Foxn1neo/neo   
( ), Foxn1fl/fl::Foxn1-Cre ( ) and nude ( ) mice (experimental details are given in section 3.5). (A) 
Proliferation index of CD4 T-cells and representative CFSE profiles. Values indicate mean +SD: data was 
pooled from at least 3 independent experiments. (B) Cell size of CD4 cells as measured by forward scatter 
(FSC). (C) IL-2 concentration in the supernatant determined by ELISA (experimental details are given in section 
3.8. Values indicates mean +SD from one representative experiment with n = 4. p values were determined using 
Mann-Whitney test. *p< 0.05, ** < 0.01, *** < 0.001.  
 
4.7.4. Suppressive potential of regulatory T-cells 
Treg function in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice was analysed using a standard in 
vitro suppression assay. For this purpose wild type CD4pos T-effector cells were sorted, 
labelled with CFSE and cultured for 3 days in the presence or absence of purified 
CD4posCD25pos regulatory T-cells used at a 1:1 ratio (the precise experimental details are 
given in section 3.5). T-cells with a CD4+CD25+phenotype isolated from nude mice were not 
able to suppress at all (Fig. 4.23 iv), whereas those isolated from Foxn1fl/fl::Foxn1-Cre or 
from Foxn1neo/neo mice supressed the proliferation of wild type CD4 effector T-cells by 15 ± 
8.4% and 25 ± 17.5% respectively (Fig. 4.23 ii and iii), which was still significantly smaller 
when compared to Treg from wild type mice (52.7% ± 16.1%, Fig. 4.23 i).  
Though Tregs were identified and purified according to the expression of CD4+CD25+ I 
cannot exclude that activated effector T-cells were included in the assay contributing to the 
reduced Treg suppression observed. This result together with an overall lower frequency of 
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Treg in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre should indeed result in a severely impaired 
Treg capacity in these mice. Consequently, these mice may be more susceptible to develop 
autoimmunity.  
 
 
Figure 4.23: Regulatory T-cells from Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice are less potent compared 
to those form wild type mice. Regulatory T-cells of wild type (WT; ), Foxn1neo/neo ( ) Foxn1fl/fl::Foxn1-Cre 
( ) and nude mice ( ) were sorted according to their CD4 and CD25 expression and co-cultured with 
activated and CFSE labelled responder T-cells (in a 1:1 ratio), cell proliferation was measured at day 3 of 
culture. Values indicate mean +SD from at least 3 independent experiments. p values were determined using 
Mann-Whitney test. *p < 0.05, ** < 0.01, *** < 0.001. 
 
 Wasting disease induction by adoptive transfer of CD4+ T-cells 4.8.
One way to test the function of T-cells and their subpopulations in vivo is their adoptive 
transfer to T-cell deficient recipients. In the case of CD4 T-cells their adaptive transfer into 
Rag-deficient mice lacking all lymphocytes usually results in a severe wasting disease as 
these cells mount an immune reaction against the gut flora293,294. Hence, sorted CD4+ T-cells 
from either wild type, Foxn1neo/neo, Foxn1fl/fl::Foxn1-Cre or nude mice were adoptively 
transferred into RAG2-/- mice and the occurrence of wasting disease was monitored by weight 
loss of 20 and more percent body weight.  
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Figure 4.24: CD4 T-cells of Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice induce wasting disease upon 
adoptive transfer to Rag2-/- mice. (A) Survival curves of Rag2-/- mice injected with 100’000 CD4 T-cells 
isolated from 6-10 week old wild type (WT; ), Foxn1neo/neo ( ), Foxn1fl/fl::Foxn1-Cre ( ) and nude ( ) 
mice. Mice were scarified and analysed when they had lost 20 and more percent of their bodyweight at the time 
of T-cell transfer. (B) Frequency of donor CD4pos/TCR-βpos cells in mesenteric lymph nodes of adoptively 
transferred recipient Rag2-/- mice, and representative FACS blots. (C) Absolute numbers of recovered CD4 T-
cells in mLN and spleen of Rag2-/- mice reconstituted with WT ( ), Foxn1neo/neo ( ), Foxn1fl/fl::Foxn1-Cre       
( ) and nude ( ) CD4 T-cells. p values were determined using Mann-Whitney test. *p < 0.05, ** < 0.01, *** 
< 0.001. 
 
The adoptive transfer of CD4 T-cells from wild type, Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre 
mice caused wasting disease with comparable kinetics (Fig. 4.24 A). Adoptive transfer of 
CD4 T-cells isolated from nude mice did not result in wasting disease, the CD4 T-cells did 
not mount an immune reaction against the gut flora (Fig. 4.24 A and B). Lymph nodes and 
spleen from the reconstituted RAG2-deficeint mice were next analysed for the presence of the 
transferred CD4+/TCR-β+ cells. The highest frequency of these cells was recovered in 
recipients of CD4 T-cells from wild type mice (lymph nodes: 53.8% ± 6.6% and spleen: 
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6.36% ± 2.9%), followed by Foxn1neo/neo (lymph nodes: 12.5% ±5.9% and spleen: 0.08% ± 
0.09%) and Foxn1fl/fl::Foxn1-Cre animals (lymph nodes: 17.4% ± 9.9% and spleen: 1.379% ± 
1%). Transferred CD4 T-cells from nude mice did accumulate only minimally (lymph nodes: 
1.3% ± 0.4%, and spleen: 0.036% ± 0.035%, Fig. 24 B and C, and data not shown). Thus 
CD4 T-cells from Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice could mount an immune 
response similar to that of wild type CD4 T-cells resulting in a wasting syndrome with 
comparable disease kinetics. Moreover these data underline the difference in functional 
competence between peripheral T-cell from nude and other mutant mice investigated here. 
There is a obvious possibility that T-cells in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice 
mount an immune response against the gut flora, since I showed that these cells are functional 
and both mutant mouse strains are lymphopenic, furthermore I demonstrated that the function 
of Tregs in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice is impaired in vitro, all factors that 
could promote wasting disease.  
 Reduced survival of Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice 4.9.
Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice displayed a significantly higher risk for 
spontaneously developing wasting disease when compared to wild type and nude mice. 
When followed up over 50 weeks, the mice had to be sacrificed for animal welfare reasons, 
when the lost more than 20% of their maximum weight, or they appeared passive, showed 
lack of grooming or developed a prolapse. 
 
 
Figure 4.25: Reduced life expectancy of Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice. Mice were monitored 
over a period of 50 weeks for weight loss and indicators of well being. Mice were euthanized when they lost 
more than 20% of their maximum bodyweight or when they appeared passive, showed lack of grooming or 
developed a prolapse. Monitored were 22 wild type (WT; ), 25 Foxn1neo/neo ( ), 15 Foxn1fl/fl::Foxn1-Cre       
( ) and 10 nude ( ) mice. p values were determined using Mann-Whitney test. *p < 0.05, ** < 0.01, *** < 
0.001. 
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Fifty percent of Foxn1neo/neo mice had to be sacrificed within 27 weeks, whereas the same 
percentage of Foxn1fl/fl::Foxn1-Cre mice needed to be euthanized by 17 weeks after birth. In 
contrast all nude and all but one of the wild type mice were healthy and did not need to be put 
down during the first 50 weeks of their life under specific-pathogen free (SPF) conditions 
(Fig. 4.25). The precipitous weight loss observed in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre 
mice was sometimes accompanied by diarrhoea and approximately half of the 
Foxn1fl/fl::Foxn1-Cre mice suffered from rectal prolapse, which was not observed in the other 
mice followed over time. Weight loss can be associated with gastrointestinal problems, 
therefore the colon of these mice were analysed.  
 Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice develop colitis 4.10.
To investigate the aetiology of the observed weight loss Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre 
mice were analysed for the presence of intestinal inflammation, in particular colitis. 
Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice demonstrated a thickened and shortened colon 
(Fig. 4.26 A) macro anatomical features compatible with colitis. On histological examination, 
colonic sections demonstrated many of the pathological features that are scored when 
assessing the histopathological hallmarks of colitis: epithelial cell hyperplasia, increase in 
leucocytes numbers, reduced mucin-secreting goblet cells and crypt abscesses (Fig. 4.26 B). 
These alterations were used to score and rate the colonic histopathological changes295,296. The 
colitis score in both wild type and nude mice was 0, whereas that in Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre was 2.1 ± 1.3 and 2.8 ± 1.2, respectively (Fig. 4.26 C). The extent of 
pathology ranged in the affected mice from mild (score: 0.5) to severe (score: 4). This 
variance is explained by the limited T-cells available, which is different between each mouse, 
explaining the different extent of colitis and different age of disease onset.  
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Figure 4.26: Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice develop colitis. (A) Colon length of healthy wild 
type (WT, ) and nude ( ) mice and colitic Foxn1neo/neo ( ) and Foxn1fl/fl::Foxn1-Cre ( ) mice. (B) Histological 
analysis of colons isolated from WT, Foxn1neo/neo, Foxn1fl/fl::Foxn1-Cre and nude mice. (C) Colitis score of 
healthy WT ( ) and nude ( ) control mice and Foxn1neo/neo ( ) and  Foxn1fl/fl::Foxn1-Cre ( ) mice. p values 
were determined using Mann-Whitney test. *p < 0.05, ** < 0.01, *** < 0.001. Analysed were 6 WT and nude 
mice, 20 Foxn1neo/neo and 13 Foxn1fl/fl::Foxn1-Cre mice. The mice were analysed when they showed sign of 
colitis. 
 
In summary the clinical signs of spontaneous wasting in mutant mice, with aberrant Foxn1 
expression correlated with the macro anatomical and pathological changes of colitis. However 
these investigations did not reveal the mechanism how this is caused.  
 
4.10.1. Colitis is induced by CD4 T-cells 
The inflammatory infiltrations of the colon in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice was 
next investigated both at the level of the lamina propria and intraepithelial lymphocytes. In 
wild type and nude mice the majority of the TCR-β+ intraepithelial and lamina propria 
lymphocytes (IEL and LPL, respectively) were CD8 T-cells (Fig. 4. 27 A). CD4 T-cells could 
be predominantly detected in IEL and LPL of Foxn1neo/neo (78% ± 12.3% and 72.8% ± 15.9%, 
respectively) and Foxn1fl/fl::Foxn1-Cre mice (77.8% ± 12.5% and 79% ± 14.7%). In contrast, 
these cells were less abundant in wild type (33.8% ± 17.7% and 36.1% ± 7.6%) and nude 
animals (10.4% ± 6.96 and 15% ± 19.5%, Fig. 4.27 B). Immunohistochemistry confirmed that 
the infiltrating leucocytes were CD4 T-cells (Fig. 4.27 C), and not B-cells. B220 allowed to 
further distinguish between isolated lymphoid follicles and infiltrating CD4 T-cells (data not 
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shown) in histology, as not all aggregates of CD4 T-cells are infiltrations. The absolute 
number of CD4 T-cells isolated from colon IEL and LPL of wild type, Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre mice varied between individual mice somewhat their order of 
magnitude was similar and 200-fold more abundant than that observed in nude mice (Fig. 
4.27 D). The increase in CD4 T-cells might be linked to their functionality to respond to 
antigens, whereas CD4 T-cells from nude mice do not respond and remain therefore low in 
numbers. In contrast colonic intraepithelial CD8 T-cells were reduced by five to ten fold in 
Foxn1neo/neo, Foxn1fl/fl::Foxn1-Cre and nude mice compared to wild type mice. The absolute 
number of lamina propria CD8 T-cells was four-fold lower in Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre mice compared to wild type mice but still 20-fold more abundant when 
compared to nude mice. The mucosal CD8 T-cells in nude mice were generated solely in the 
periphery, whereas in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre the thymus rudiment also 
contributes to the T-cell pool. Thus Foxn1 withdrawal or reduced Foxn1 expression resulted 
in an infiltration of CD4 T-cells in the intraepithelial and lamina propria compartments. 
Despite a reduced thymic T-cell production in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice, the 
absolute of CD4 T-cells cellularity of the colon was comparable between wild type and these 
mutant strains of mice which strongly suggests that the few T-cells in the mutant mice had 
undergone massive antigen induced homeostatic expansion most likely in the colon. 
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Figure 4.27: Colitis correlates with the presence of CD4 T-cells in colon IEL and LPL. Frequencies of 
colonic CD8 T-cells (A) and colonic CD4 T-cells (B) in healthy wild type (WT; ) and nude ( ) mice and 
colitic Foxn1neo/neo ( ) and Foxn1fl/fl::Foxn1-Cre ( ) mice. (C) Confocal microscopy of colon tissue sections 
stained for CD4 (green) and DNA (grey). (D) Absolute CD4 and CD8 T-cells numbers in colon of healthy WT    
( ) and nude ( ) mice and colitic Foxn1neo/neo ( ) and Foxn1fl/fl::Foxn1-Cre ( ) mice. n ≥ 6, the mice analysed 
were between 10 and 30 weeks old. p values were determined using Mann-Whitney test. *p < 0.05, ** < 0.01, 
*** < 0.001. 
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4.10.2. The CD4 IEL and LPL infiltrating in the colon have of a Th1 effector 
phenotype 
Colitis can be induced by either Th1, Th2 or Th17 cells, though the most common effector 
subtype bear the Th1 type 259,297. I therefore phenotyped the mucosal CD4+ T-cells of affected 
mice for their cytokine secretion profile; IFN-γ for Th1, IL-10 for Th2 and IL-17 for Th17.  
 
 
Figure 4.28: Colitis correlates with infiltrating CD4 T-cells with Th1 polarisation. Frequency and cytokine 
expression of CD4 T-cells isolated from colon IEL (A) and LPL (B) of healthy wild type (WT; ) and sick 
Foxn1neo/neo ( ) and Foxn1fl/fl::Foxn1-Cre ( ) mice. The CD4 T-cells were analysed for production of TNF-α 
(i), IL-17 (ii), IFN-γ (iii), and IL-10 (iv). p values were determined using Mann-Whitney test. *p < 0.05, ** < 
0.01, *** < 0.001.  
 
CD4 T-cells producing IFN-γ cytokine were characteristic among colonic IEL and LPL of 
colitic Foxn1neo/neo (38.9% ± 20.5% and 38.4% ± 14.2% respectively) and Foxn1fl/fl::Foxn1-
Cre (27% ± 20.9% and 43.7% ± 15.7%) mice. In contrast the frequency of Th1 polarized CD4 
IEL and LPL in the colon of wild type mice was significantly lower (Fig. 4.28) 10.8% ± 6.8% 
and 19% ± 6.8%, respectively. The production of IL-10, IL-17 and TNF-α however was 
unchanged between the different mouse strains analysed (Fig. 4.28 A and B). This suggests 
that the observed colitis is associated with Th1 polarized CD4+ T-cells.  
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4.10.3. The draining mesenteric Lymph nodes were also affected by increase of 
CD4 T-cells 
Mesenteric lymph nodes are affected in the context of the immunopathology causing colitis, 
associated with an immune activation in the gut associated lymphatic tissue (GALT). I 
therefore analysed the mesenteric and other lymph nodes of Foxn1neo/neo and Foxn1fl/fl::Foxn1-
Cre mice separately for the frequency of CD4 and CD8 T-cells and the cytokine secretion 
profile of the former cells. αβ TCR-positive lymphocytes were decreased in mesenteric lymph 
nodes of affected Foxn1neo/neo (6.8% ± 8.5%) and Foxn1fl/fl::Foxn1-Cre mice (6.9% ± 4.9%) 
by up to 10-fold when compared to wild type mice but still significantly increased when 
compared to nude mice (1.5% ± 0.7%, Fig. 4.29 A). However the frequency of CD4+ T-cells 
in peripheral lymph nodes was comparable for colitic Foxn1neo/neo (55.2% ± 21.7%) and 
diseased Foxn1fl/fl::Foxn1-Cre (45.3% ± 24.6%) compared to healthy wild type mice (57.0% 
± 5.5%, Fig. 4.29 B). Hence, there was no generalized impact of colitis on other lymphoid 
tissues but the tributary ones. An elevated frequency of CD4 T-cells was detected in the 
mesenteric lymph nodes of Foxn1neo/neo (71.5% ± 12.7%) and Foxn1fl/fl::Foxn1-Cre mice 
(66.7% ± 20.3%) with colitis when compared to healthy wild type mice (58.3% ± 5.2%, Fig. 
4.29 B).  
Colitis is the result of an imbalance of the gut homeostasis, which can be caused by an 
overreactivity of the immune system against the gut microbiota, which is helped by an 
absence of Treg. Indeed the adaptive transfer of Treg is known to prevent colitis258. I 
therefore tested whether a reduction in Treg cellularity in the Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre mice may contribute or even account for the colitis observed. Treg were 
present at normal frequencies in mesenteric and peripheral lymph nodes of colitic Foxn1neo/neo 
and Foxn1fl/fl::Foxn1-Cre mice (Fig. 4.29 C) but I had previously shown that these cells were 
functionally impaired in vitro (Fig. 4.23). 
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Figure 4.29: Increased frequency of CD4 T-cells in mesenteric lymph nodes of Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre mice suffering from colitis. (A) Frequency of αβ-TCR+ cells in peripheral and 
mesenteric lymph nodes of healthy wild type (WT; ) and nude ( ) mice and of colitic Foxn1neo/neo ( ) and 
Foxn1fl/fl::Foxn1-Cre ( ) mice. (B) Frequency of CD4 T-cells in αβ-TCR+ cells in peripheral and mesenteric 
lymph nodes of healthy WT and nude mice and colitic Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice. (C) 
Frequency of regulatory T-cells among CD4 T-cells in the peripheral and mesenteric lymph nodes of healthy 
WT and nude mice and colitic Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice. (D) Absolute number of CD4 and 
CD8 T-cells in mesenteric lymph nodes of healthy WT ( ) and nude ( ) mice and colitic Foxn1neo/neo ( ) and 
Foxn1fl/fl::Foxn1-Cre mice ( ). (E) Cytokine expression in CD4 T-cells isolated from mesenteric lymph nodes of 
healthy WT and colitic Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice: (i) TNF-α, (ii) IL-17, (iii) IFN-γ and (iv) IL-
10. At least 6 mice per experimental group and up to 30 weeks of age were analysed. p values were determined 
using Mann-Whitney test. *p < 0.05, ** < 0.01, *** < 0.001. Statistics were performed for all groups, indicated 
were only significances.  
 
Both CD4 and CD8 T-cells were 2 to 8 fold reduced in the mesenteric lymph nodes of colitic 
Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice compared to wild type mice, however compared 
to nude mice they were over 100 fold increased (Fig. 4.29 D). TNF-α producing CD4 T-cells 
in the mesenteric lymph nodes of Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice were reduced by 
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50% compared to wild type mice (Fig. 4.29 E i). IL-17 and IFN-γ producing CD4 T-cells 
were increased more than ten fold in the mesenteric lymph nodes (Fig. 4.29 E ii, iii), the 
frequency of IL-10 producing CD4 T-cells was not altered (Fig. 4.29 E iv). These results 
showed that the mesenteric lymph nodes were affected by colitis with an increase in CD4 T-
cells and the production of the pro-inflammatory cytokine IFN-γ. Therefore despite the 
presence of Tregs, extensive homeostatic proliferation of CD4 T-cell must have taken place 
leading to disease, indicating that the functionality of Tregs was impaired in vivo.  
 
4.10.4. Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice suffer from enteritis 
I next investigated whether Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice also suffered from 
enteritis. Small bowel tissue from wild type, Foxn1neo/neo, Foxn1fl/fl::Foxn1-Cre and nude mice 
was therefore microscopically investigated for changes in the mucosal integrity and signs of 
inflammation (Fig. 4.30 A). Half of the Foxn1neo/neo and two-third of the Foxn1fl/fl::Foxn1-Cre 
mice displayed histopathological signs that scored as enteritis, though most of the animals 
showed only mild tissue injuries (enteritis score of 0.68 ± 0.8 for Foxn1neo/neo mice and 0.66 ± 
1 for Foxn1fl/fl::Foxn1-Cre mice (Fig. 4.30 B). To characterise the cellular elements of 
enteritis, small intestinal IEL and LPL were isolated and phenotyped. The frequency of CD4 
T-IEL and LPL were significantly increased in Foxn1neo/neo (51.0% ± 27.6% and 60% ± 18%, 
respectively) and Foxn1fl/fl::Foxn1-Cre (57.4% ± 26.1% and 61.8% ± 17.9%) mice compared 
to wild type (24.2% ± 6.9% and 34.1 ± 8.7%) and nude (22.2% ± 11.9% and 48.4% ± 28.3%) 
animals (Fig. 4.30 C). The absolute number of CD4 and CD8 IEL was however reduced in 
these mice (9- respectively 30-fold) with reference to wild type but was comparable to that of 
nude animals. The cellularity of the small intestinal LPL were comparable for wild type, 
Foxn1neo/neo, Foxn1fl/fl::Foxn1-Cre and nude mice (Fig. 4.30 D).  
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Figure 4.30: Small intestine of Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice is not always and less affected. 
(A) Histology of small intestine from wild type (WT), Foxn1neo/neo, Foxn1fl/fl::Foxn1-Cre and nude mice. (B) 
Enteritis score of WT ( ), Foxn1neo/neo ( ), Foxn1fl/fl::Foxn1-Cre ( ) and nude mice ( ). (C) Frequencies of CD4 
T-cells in small intestine IEL and LPL of healthy WT ( ) and nude ( ) mice and sick Foxn1neo/neo ( ) and 
Foxn1fl/fl::Foxn1-Cre ( )mice. (D) Absolute numbers of CD4 and CD8 T-cells isolated from small intestine 
IEL and LPL of healthy WT ( ) and nude ( ) mice and sick Foxn1neo/neo ( ) and Foxn1fl/fl::Foxn1-Cre ( ) mice. n 
≥ 6, the mice were between 10 and 30 weeks old. p values were determined using Mann-Whitney test. *p < 0.05, 
** < 0.01, *** < 0.005.  
 
The prominence of the auto-inflammatory process rather in the colon than in the small 
intestine correlates with the difference in the local bacterial antigen load. This may also 
explain the higher frequency of CD4+ T-cells in the lamina propria of the colon, which serves 
as the first line of defence in mucosal immunity.  
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4.10.5. Auto-antibodies in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice 
Central T-cell tolerance induction critically depends on the correct composition, architectural 
organisation and function of the thymic stroma. Consequently, a lack in regular T-cell 
selection may also impact on the capacity to maintain B-cell tolerance to self-antigens as this 
requires the cooperation between the two lymphoid compartments298,299. To determine 
whether the altered T-cell antigen receptor repertoire of Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre 
mice was permissive to break B-cell self-tolerance, sera from these mice were analysed for 
the presence of T-cell dependant anti-nuclear-antibodies (ANA). The detection of ANA is 
linked to different autoimmune diseases including systemic lupus erythematosus (SLE), 
Sjørgen’s syndrome and mixed connective tissue diseases though they are not disease 
specific. The detection of these auto-antibodies is detailed in section 3.9. As shown in Figure 
4.31 A and B, about half of all Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice at ages above 10 
weeks had ANA, whereas ANA were absent in wild type and nude controls. In contrast 
younger mutants and wild type or nude mice at any age had ANA, revealing again an age-
related correlation with changes in T-cell numbers in Foxn1 mutants.  
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Figure 4.31: Presence of anti-nuclear-antibodies in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice. (A) 
Representative histological pictures of Rag2-/- kidney sections incubated with blood sera of the different mice 
analysed. (C) Titers of anti-nuclear-antibodies in the blood sera of young (4 week) and adult (10-30 week) wild 
type (WT; ), Foxn1neo/neo ( ), Foxn1fl/fl::Foxn1-Cre ( ) and nu/nu ( ) mice. (C) Presence of anti-nuclear 
antibodies against ss-DNA determined by Elisa and indicated as O.D, values below 0.2 were considered as 
negative. 
 
In aggregate, the loss of a regular thymic function in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre 
mice resulted in the generation of a peripheral T-cell compartment unable to maintain 
tolerance to self, including the suppression of anti-self responses (e.g. ANA, ss-DNA) by B-
cells.  
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5. Discussion  
The aim of this study was to elucidate the role of Foxn1 in thymus organogenesis and 
maintenance, in particular the timing of Foxn1 expression and gene dosage requirements. The 
study showed that both a short term full Foxn1 expression, and a continuous but reduced 
Foxn1 expression lead to dramatic changes in thymus development. The regular thymic 
architecture is changed, cortical and medullary areas are reduced to small islets and 
mesenchymal cells are replacing the thymic epithelial cells. Nevertheless a limited thymus 
function is preserved. T-cells emerge from the thymus rudiment and undergo extensive 
homeostatic or activation induced proliferation in the periphery, displaying a memory-like 
phenotype. In contrast to T-cells present in athymic nude mice, T-cells of Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre mice proliferate upon mitogenic stimulation although the proliferation 
was reduced compared to wild type T-cells. Furthermore Foxp3+ regulatory T-cells were 
present in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice, but not in nude mice. However Treg 
function was reduced compared to wild type mice. Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice 
have a reduced life-span, develop colitis and anti-nuclear-antibodies with time. These results 
show how critical Foxn1 expression, both temporal and quantitative, is for thymus formation 
and function, and that modulations of Foxn1 expression can induce the generation of auto-
reactive T-cells, that developed in an aberrant thymic microenvironment.  
 
Thymic microenvironment  
The differentiation into cortical (CK8) and medullary (CK5) areas was more progressed in 
Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice compared to nude mice, where all TEC remain in 
a CK5CK8 double positive progenitor stage. However final maturation of TEC was impaired 
as shown by the absence of mature cTEC and mTEC indicated by the absence of β5t and Aire 
expression. Foxn1 is believed to regulate β5t expression268 since β5t is absent in Foxn1 
deficient mice, furthermore β5t expression was shown to be independent of thymocyte 
crosstalk as demonstrated by β5t expression in Rag2-/- mice268. In E12.5 Foxn1fl/fl::Foxn1-Cre 
thymus Foxn1 protein is absent, and also β5t expression is absent. This result extends on the 
importance of Foxn1 as a regulator for β5t expression, as short-term expression at the onset of 
thymus organogenesis does not trigger β5t expression, demonstrating that stable and 
continuous high level of Foxn1 expression is required for β5t regulation. In new born 
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Foxn1neo/neo mice β5t expression is absent although Foxn1 protein was detected. This result is 
contrary to the literature268, as it would suggest that β5t is not exclusively regulated by Foxn1 
as its presence in Foxn1neo/neo mice did not induce stable β5t expression. Alternatively a 
Foxn1 gene dosage effect is responsible for the absence of β5t. This is supported by the 
finding that β5t expression is detected in only 25% of the embryos but not in post natal 
Foxn1neo/neo thymus. This suggests that the system is tightly regulated by a precise amount of 
Foxn1 and that β5t is strictly dependant on adequate Foxn1 expression. Furthermore it was 
shown that TEC development is sensitive to Foxn1 gene dosage106. Divergence of TEPC into 
the mTEC lineage does not require Foxn1 according to Nowell et al. however for 
development into cTEC lineage low amounts of Foxn1 are required. Already 15% of wild 
type Foxn1 transcripts allow progression into distinct cortical and medullary areas, Aire 
expressing mature mTEC, and T-cell development to occur. However the T-cell development 
displayed an increase in the CD4/CD8 double positive thymocytes and a reduction in single 
positive thymocytes. This is in contrast to Foxn1neo/neo mice, where Foxn1 transcripts were 
found to be reduced to 20% of wild type Foxn1 expression. These thymi did not show 
segregation into cortical and medullary areas, mature TEC were absent and thymocytes 
development was severely impaired. This discrepancy could be explained by the different 
targeting construct used. In Foxn1neo/neo mice exon 7&8 encoding in part for the DNA binding 
domain were targeted, whereas Nowell et al. targeted the intron 1b of the Foxn1 gene using a 
SV40 T antigen106. These results underline the importance of Foxn1 dosage on TEC 
development and function.  
β5t is required for MHC Class I mediated positive selection of CD8 T-cells97 and 
consequently, in the absence of β5t CD8 thymocytes are reduced. This reduction persisted 
also in the periphery. The reduction of CD8 T-cells in the peripheral T-cell pool of 
Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice is probably not linked to the absence of β5t 
expression as T-cell development in general was severely impaired in Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre thymus. However the quality of the CD8 repertoire including a lack of 
negative selection towards certain epitopes might be influenced by the absence of β5t.  
Mature mTEC (MHC Class IIhigh Aire) were absent in Foxn1fl/fl::Foxn1-Cre and Foxn1neo/neo 
thymus. This result is in line with previous reports106 suggesting that Foxn1 regulates MHC 
Class II, thus explaining the absence of mature mTEC. A short term or reduced Foxn1 
expression does not induce progression to mature mTEC expressing Aire, suggesting that T-
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cells emerging from Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre thymus were not properly 
negatively selected. RANKL produced by positively selected thymocytes plays a major role 
in the formation of the medulla and the presence of Aire+ TEC113,269. Mice deficient for 
RANKL displayed a reduction of mTEC numbers and size of the thymic medulla269. However 
thymocyte development in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice was drastically 
reduced explaining the absence of Aire+ TEC and the reduced medulla size. The thymus 
rudiment of Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre had distinct cortical and medullary TEC, 
this is in contrast to nude thymus were mainly CK5 and CK8 double positive TEC precursors 
were detected. However the cortical and medullary TEC form rather small islets than large 
areas, explaining the absence of cortical and medullary areas in Haematoxylin and 
Erythrosine staining. CK5 and CK8 double positive TECs were also quite common in 
Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice. Concomitant expression of CK5 and CK8 was 
observed in CD3ε transgenic mice, where thymocyte development is blocked at an early 
stage, due to an abrogated thymic crosstalk94. Since the thymus cellularity was not increasing 
with age in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice and the chemokines responsible for 
precursor attraction were severely reduced, the concomitant expression of CK5 and CK8 
could represent absent or limited T-cell development. Nevertheless some TEC might interact 
with few thymocytes and develop thereby into distinct cTEC or mTEC. The increase in 
fibroblasts and restriction of cTEC and mTEC to small islets is also observed in thymus 
involution 300. These results lead to the hypothesis that the thymus rudiment of Foxn1neo/neo 
and Foxn1fl/fl::Foxn1-Cre mice is able to develop but thymic involution occurs prematurely, 
as the thymus rudiment resembles an aged thymus. Aging is also known to cause autoimmune 
features as observed in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice166.  
Foxn1 plays an essential role in thymus vascularisation150 as it enables TEC to produce 
VEGF, which plays an essential role in the formation of blood vessel architecture in the 
thymus 42. In nude mice, endothelial cells are detected outside of the thymus rudiment. Timed 
Foxn1 expression only at the onset of thymus organogenesis results in endothelial cells that 
were also detected inside the thymus rudiment, indicating that vascularisation takes place. 
Reduced Foxn1 expression does also allow thymus vascularisation to occur. The supply of 
hematopoietic precursors is low despite the presence of the vascularisation, indicating that the 
quality of the vessel might be changed e.g. the blood vessel are leaky resulting in a reduced 
entry of hematopoietic precursors. This finding is in line with other reports on thymus 
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vascularisation claiming a dosage effect of Foxn1 on thymus vascularisation and the presence 
of leaky vessels301. To analyse the quality of the vascular network angiography could be 
performed. Leaky vessels could thereby be identified and the density of the vessel network 
could be assessed42. The chemokines CCL25 and CCL21 are reduced in TEC of Foxn1neo/neo 
and Foxn1fl/fl::Foxn1-Cre mice. CCL25 and CCL21 are required for the attraction of thymic 
lymphoid precursors, CCL25 was further reported to be regulated by Foxn1 expression144. 
Taken together the small thymus size reflects reduced precursor attraction early in thymus 
ontogenesis and a limited supply with blood-borne hematopoietic precursors as a consequence 
the crosstalk between thymocytes and TEC is abrogated resulting in a thymus devoid of 
mature TEC and TEC with concomitant expression of CK5 and CK8. Su et al.152, however, 
showed that deletion of exon 3 of the Foxn1 gene result in an abrogated cross-talk despite the 
presence of thymocytes. This indicates that the presence of precursors would not rescue the 
phenotype, and that Foxn1 is required after the first initiation of the thymus.  
 
Foxn1 in hair follicle development 
At the time of Foxn1 withdrawal in Foxn1fl/fl::Foxn1-Cre mice hair development is not 
initiated. Thus, Foxn1 is deleted in the hair follicle leading to alopecia similar to nude mice.  
Foxn1neo/neo mice, however had normal whiskers and coat at birth. After the first four weeks 
the fur got dull and scrubby and altogether less dense. This observation is in line with other 
transgenic mouse lines with reduced Foxn1 expression106, where sporadic hair loss is 
observed after 6 weeks. This indicates that different amounts of Foxn1 are required for hair 
follicle development than for TEC development and maintenance. Moreover Foxn1neo/neo 
females were fertile and able to lactate their offspring whereas nude mice have 
underdeveloped mammary glands and are unable to effective lactate their offspring. Nude 
females were reported to have a reduction in the serum levels of estradiol, progesterone and 
thyroxine resulting in a reduced fertility265. In accordance with this report Foxn1fl/fl::Foxn1-
Cre females showed reduced fertility, as they were kept for 1 year in a mating and no 
offspring were born. However female mice with reduced Foxn1 expression were fertile. These 
observations underline the different requirements for Foxn1 in skin and thymus development. 
The N-terminus of Foxn1 gene was reported to be only important for thymus formation but 
not for hair follicle development as deletion of exon 3 affects only the thymus but not the coat 
of the animals152.  
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Impaired T-cell development 
The altered microenvironment had a severe impact on T-cell development. Very low 
frequencies of CD4/CD8 double positive thymocytes were only detected in embryonic day 
18.5, but not beyond. This result showed that the development was delayed and limited to a 
narrow time window or below our detected limit. The delayed development is in accordance 
with other reports152. Mice lacking the N-terminus of Foxn1 protein display also a delayed 
and impaired T-cell development152, characterised by a block in DNI to DNII transition 
similar to Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice. Moreover the DNI precursors develop 
directly to DNIV without passing through DNII and DNIII stages. In contrast to Foxn1neo/neo 
and Foxn1fl/fl::Foxn1-Cre mice these mice had a substantial population of CD4/CD8 double 
positive thymocytes. This does not exclude, however, that the development of CD4/CD8 
double positive thymocytes was completely abolished in Foxn1neo/neo and Foxn1fl/fl::Foxn1-
Cre mice as it might be reduced to an extent below our detection limit. Alternatively T-cell 
development might follow other rules and develop without passing through a CD4/CD8 
double positive stage302. These cells might acquire CD4 or CD8 expression later in the 
periphery upon contact with MHC Class II or MHC Class I, respectively. Furthermore for the 
generation of CD8αα intraepithelial lymphocytes a pathway that consists of a first thymic 
phase followed by an extrathymic maturation was described235. CD4-CD8-CD3-CD44+CD25int 
precursors were shown to be able to leave the thymus and mature in the periphery. 
Foxn1 is also expressed in the bone marrow of wild type mice. Both reduction and 
overexpression of Foxn1 have an influence on the bone marrow as demonstrated in a recent 
report. It was suggested that the role of Foxn1 in the bone marrow niche is to skew the 
multipotent progenitors towards T-cell lineage progenitors282. During aging Foxn1 expression 
in the bone marrow is reduced and as a consequence the multipotent progenitors are reduced. 
Therefore it could be that not only reduced expression of chemokines involved in attraction of 
hematopoietic precursors and impaired vascularisation contribute to the small thymus 
rudiment but also a reduction in precursors due to Foxn1 ablation in the bone marrow. 
However in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice the LSK population was increased 
compared to wild type mice, arguing against an influence on the capacity of the bone marrow 
niches for maintaining LSK.  
 
 
 108 
Peripheral T-cells 
The peripheral T-cell pool of Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice was quantitatively 
and qualitatively different from nude mice. T-cells in nude mice are generated in the 
periphery, mainly in the mesenteric lymph nodes197. Peripheral T-cell generation has some 
special features. T-cells generated in the periphery are mainly CD8 T-cells194, whereas in 
Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice predominantly CD4 T-cells were detected, which 
favours a thymic origin of these T-cells. This thymic origin is also supported by the finding 
that extrathmyic T-cells do not respond to mitogenic stimuli and fail to provide B-cell 
help204,291. Both features however were detected in CD4 T-cells isolated from Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre mice. CD4 T-cells isolated from Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre 
mice were able to respond to mitogenic stimuli as indicated by proliferation, increase of size 
and Il-2 production. Furthermore they were able to induce colitis upon adaptive transfer into 
Rag2-/- mice. In addition CD4 T-cells of Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice provided 
B-cell help, as shown by the presence of anti-nuclear-antibodies. Moreover regulatory T-cells 
were detected in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice but absent in nude mice. Taken 
together all these observations suggest that the CD4 T-cells are quantitatively and 
qualitatively different from extrathymically derived CD4 T-cells of nude mice. CD4 T-cells in 
Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice accumulate with age and are significantly 
increased compared to nude mice after 10 weeks postnatal. As only few T-cells emerge from 
the thymus rudiment, the CD4 T-cells probably underwent homeostatic expansion in the 
periphery, acquiring an activated/memory-like phenotype that is also common in extrathymic 
derived T-cells187,303. The presence of colitis suggest that antigenic activation contributes to 
this phenotype. Similar observations were made with T-cells isolated from Foxn1Δ/Δ mutant 
mice lacking the N-terminus of the Foxn1 gene. The T-cells displayed an atypical memory 
phenotype combined with low homeostatic potential and impaired regulatory T-cell 
function154. These T-cells were of thymic origin, however they developed from a kit negative 
progenitor and developed without passing through DNII and DNIII stages152,153. Nevertheless 
these mice were not reported do develop colitis.  
However it can not be excluded that a cryptic extrathymic T-cell development pathway is 
induced by the short term or reduced Foxn1 expression. To test the hypothesis that the 
autoimmune feature causing T-cells emerged the thymus rudiment and were not generated in 
the periphery, thymus rudiments isolated from Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice at 
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embryonic day 12.5 are placed under the kidney capsule of nude mice. First preliminary data 
showed that transplantation of E12.5 Foxn1neo/neo thymi under the kidney capsule of nude 
mice result in an altered CD4:CD8 ratio. Furthermore by three months after grafting the 
transplanted mouse suffered from colitis. The colon showed epithelial cell hyperplasia and 
leucocytes infiltrations. As observed in Foxn1neo/neo mice the infiltrating cells were CD4 T-
cells. These preliminary results showed that the thymus rudiment transplanted at E12.5 is able 
to support T-cell development and that the emerging T-cells can cause disease. To exclude the 
possibility that Foxn1 ablation has an unexpected influence on the lymphoid precursors in the 
bone marrow, bone marrow chimeras should be analysed. It could be that Foxn1 ablation 
causes changes in the bone marrow and that therefore the T-cells causing colitis do not 
necessarily result from a defective selection in the thymus but are rather a result of altered 
hematopoietic precursors that might develop in the periphery to T-cells causing harm, despite 
all the evidence arguing for thymic T-cell development. 
In addition regulatory T-cells were present in the periphery of Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre mice but absent in nude mice. Although Helios was present on Tregs, it 
can not be concluded that these cells were thymus derived, as recent studies showed, that 
Helios can also be detected on induced Tregs and represent the activation status289. 
Neuropilin-1 was used as a second marker to distinguish thymic and extrathymic derived 
Tregs. Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre Tregs expressed higher amounts of Nrp1 
compared to non Tregs, but the expression is reduced compared to wild type Tregs. Thus 
Tregs display some, but not all, characteristics of thymic origin. Furthermore the absence of 
Aire expression and aberrant selection might also impair Treg development in the 
thymus88,304. Whether the periphery of nude mice does not support conversion of CD4 T-cells 
to Tregs or whether the CD4 T-cells are not able to convert into Tregs is currently not known. 
Conversion into Tregs requires the presence of TGF-β305 and IL-2. Nude CD4 T-cells fail to 
produce IL-2 at substantial amounts291, which might prevent the conversion of CD4 T-cells 
into Tregs. CD4 T-cells isolated from Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice produce IL-
2 and regulatory T-cells are detected in the periphery. However the potential of these 
regulatory T-cells is severely impaired in vitro. This is in contrast to other lymphopenic 
mouse models where Tregs were more potent than wild type Tregs306, one explanation could 
be that these Tregs emerged from conversion of conventional CD4 T-cells. These 
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conventional T-cells might be exhausted from the homeostatic expansion, resulting in a 
reduced function. Thus, reduced Foxn1 expression indirectly influences Treg quality.  
 
Reduced life expectancy 
Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice have a reduced life-span compared to wild type 
and congenital nude mice. These mice have a sudden weight loss accompanied sometimes by 
diarrhoea. Closer examination of the colon revealed the presence of colitis caused by Th1 
polarised CD4 T-cells. In congenital nude mice, colitis was not observed in young or old 
mice. Thus indicate that the CD4 T-cells causing colitis in Foxn1neo/neo and Foxn1fl/fl::Foxn1-
Cre mice emerged from the thymus and were either not properly selected or underwent 
antigen driven homeostatic expansion, since T-cells detected in nude mice did not induce 
disease, which might be linked to the limited response to mitogenic stimuli observed. 
Aberrant thymic selection was shown to cause colitis307, but colitis can also be induced by 
homeostatic expansion308,309. 
Adoptive transfer of naïve CD4 T-cells into nude mice does not result in colitis despite 
lymphopenia. The presence of host intraepithelial CD8 T-cells is protective. However 
transferring activated CD4 T-cells overcomes this protective effect222. In wild type mice the 
IEL are shown to be thymus derived and increased in numbers compared to nude mice233,234. 
The increase in IEL detected in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice compared to nude 
mice is indicating that the IEL are of thymic origin and could therefore be impaired in their 
function due to impaired selection. To test the functionality of CD8 IEL of Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre mice, CD8 IEL could be transferred to a RAG2-/- recipient mouse one 
week prior to reconstitution with wild type CD4 T-cells. The presence of functional CD8 IEL 
should result in a mitigated colitis. Furthermore Tregs play also a crucial role in maintaining 
the mucosal immune homeostasis258, therefore the colitis observed in Foxn1neo/neo and 
Foxn1fl/fl::Foxn1-Cre mice might also be related to the dysfunction of Tregs. To test the 
hypothesis that reduced Treg function leads to colitis in Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre 
mice these mice were reconstituted with wild type Tregs. Preliminary data showed that the 
onset of disease is delayed by reconstitution with wild type Tregs however the mice can not 
be rescued. Alternatively it might also be that the effector CD4 T-cells isolated from 
Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice are more resistant to suppression as observed in 
Gαi2-/- mice310. However in contrast to Gαi2-/- CD4 T-cells, the CD4 T-cells of Foxn1neo/neo 
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and Foxn1fl/fl::Foxn1-Cre mice have less effector function in vitro .To exclude the possibility 
that these CD4 T-cells are more resistant to suppression, experiments with wild type Tregs 
and effector T-cells isolated from Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice will be made.  
There are also reports showing that auto-immunity and aging are closely linked and that not 
properly selected extrathymic T-cells can cause autoimmunity with age311. Moreover there is 
a link between auto-reactive extrathymic T-cells and elimination of abnormal self cells 
generated during aging. The onset of autoimmune disease is often linked with thymic 
involution and activation of the extrathymic pathway for T-cell generation. During thymic 
involution, TECs are reduced and cortical and medullary areas vanish and are replaced by 
mesenchymal cells176. Despite these changes in the thymic architecture the thymus preserves 
a low thymic output. The replacement of TEC with mesenchymal cells was also observed in 
Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre thymus, reminiscent of aged thymus. This finding is in 
line with other reports showing that the deletion of Foxn1 in the postnatal thymus result in a 
premature thymic involution156,157. Furthermore it was suggested that thymic involution is 
initiated by the bone marrow with a decline of the multipotent hematopoietic precursors312. 
Recent studies identified Foxn1 expression in the bone marrow and linked it further to thymic 
involution282. Therefore the absence or reduction of Foxn1 seems to induce thymic involution 
from an early time point in thymus development. In old mice anti-nuclear-antibodies are 
detected without causing harm to the patients311. 50% of all Foxn1neo/neo and Foxn1fl/fl::Foxn1-
Cre mice displayed anti-nuclear-antibodies, whereas they were not detected in aged matched 
controls, indicating that Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice resemble old mice 
concerning the thymus architecture and the presence of anti-nuclear antibodies.  
 
Collectively these data showed that Foxn1 expression is not only critical at the onset of 
thymus organogenesis but also for thymus maintenance. Furthermore these data showed that 
Foxn1 target genes are tightly regulated by Foxn1 expression, as demonstrated by the absence 
of β5t despite reduced Foxn1 expression. Reduced Foxn1 expression does not suffice for 
thymus development. However reduced Foxn1 expression allows initial divergence of cTEC 
and mTEC linages, although they do not fully mature. This partial rescue was also shown be 
Nowell et al., however this study underlines the importance of Foxn1 not only in thymus 
organogenesis but also in thymus maintenance. These experiments demonstrate to our 
knowledge for the first time that mice with insufficient Foxn1 expression develop a T-cell 
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repertoire that is able to cause autoimmune features as shown by the development of colitis 
and anti-nuclear antibodies. This indicates that Foxn1 expression below a certain threshold, 
still allows few T-cells to emerge from the rudiment, although these T-cells were not properly 
selected. Whereas in the complete absence of Foxn1 no T-cells emerge the rudiment and 
above the threshold regular T-cell development occurs and the emerging T-cells were 
properly selected and do not cause autoimmunity. In all Foxn1 targeted mouse models 
described so far no autoimmunity was reported. Furthermore these data suggest that the 
thymus of Foxn1neo/neo and Foxn1fl/fl::Foxn1-Cre mice supports some aspects of T-cell 
development despite the withdrawal or reduction of Foxn1 expression, however this function 
might be limited to a short time window during early thymus organogenesis. A first wave of 
T-cells emerges the thymus, however due to a lack of an organised thymus architecture and 
mature TEC these T-cells are improperly selected, resulting in a T-cell repertoire that reveals 
its auto-reactivity over time.  
However many aspects of Foxn1 function and requirements for thymus organogenesis remain 
still elusive, in particular it’s role in cTEC/mTEC development after thymus organogenesis 
and its role in maintaining the bone marrow niche for T cell progenitors.   
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6. Conclusion 
This study showed, that an adequate and stable Foxn1 expression is required for thymus 
formation and function, as a reduced or short-term expression of Foxn1 at the induction of 
thymus development is not sufficient for thymus formation. Cortical and medullary TECs are 
detected, however they do not fully mature, and TEC that concomitantly express CK5 and 
CK8 are present, indicating severely reduced T-cell development. Nevertheless a reduced 
thymic output is still preserved. The peripheral T-cell pool of Foxn1 targeted mice contains 
CD4 T-cells that are functional and cause autoimmune pathologies over time. Thus adequate 
Foxn1 expression is required not only during organogenesis but also in the adult thymus. 
Therefore inadequate Foxn1 expression result in a T-cell repertoire that reveals its 
autoreactivity over time.  
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9. Appendix 
 Figures 9.1.
 
Appendix I: Foxn1neo/+ mice did not show any thymus phenotype. (A) Relative Foxn1 expression in TEC 
isolated from 4 week old wild type (WT) mice. (B) Foxn1neo/+ and Foxn1 protein expression on E12.5 thymus 
section. (C) Thymus cellularity at six week of age. (D) T-cell development in six week old wild type and 
Foxn1neo/+ thymus. (E) Confocal microscopy on thymic sections stained for the medullary marker CK14 (green), 
the cortical marker CK18 (red) and Aire expression (blue). (F) Confocal microscopy on thymic sections stained 
for β5t (green), Dec205 (red) and CD3 (blue). n=3 p values were determined using Mann-Whitney test. 
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Appendix II: Foxn1fl/fl mice did not show any thymus phenotype. (A) Relative Foxn1 expression in TEC 
isolated from 4 week old wild type (WT) and Foxn1fl/fl mice (B) Foxn1 protein expression on E12.5 thymus 
section. (C) Thymus cellularity at six week of age. (D) T-cell development in six week old wild type and 
Foxn1fl/fl thymus. (E) Confocal microscopy on thymic sections stained for the medullary marker CK14 (green), 
the cortical marker CK18 (red) and Aire expression (blue) n=3 p values were determined using Mann-Whitney 
test. 
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 Posters 9.3.
 
Presented at the EUThyme-Rolduc Meeting 2011, 21-24 May 2011, Noordwijkerhout Netherlands 
Background 
The transcription factor Foxn1 is essential for thymic epithelial cells (TEC) differentiation since its functional loss constitutes the molecular cause of the nude phenotype 
characterised by athymia and alopecia. How thymic Foxn1 expression (as opposed to the skin) controls the maintenance of an established and functional thymic 
microenvironment remains so far unknown, not least because Foxn1 target genes that define the nude phenotype have not yet been identified.  
The aim of the project is to define the requirements of Foxn1 expression for regular organogenesis and TEC maintenance. 
Methods 
Two different mouse models have been generated to test the role of Foxn1 expression for thymus 
organogenesis. (i) Foxn1lox/lox::Foxn1-Cre mice: The DNA binding domain of Foxn1 is deleted once 
the thymus anlage has normally formed (embryonic day 12.5 [E12.5]). (ii) Foxn1neo/neo mice: The 
introduction of  the neo gene into the Foxn1 locus results in a hypomorphic locus.  
Results 
Conclusion 
TEC differentiation and maintenance are dependent on the sustained presence of Foxn1 expression at adequate cellular concentrations as neither the loss of expression 
after embryonic day 12.5 nor a largely reduced expression of Foxn1 allow regular thymus architecture and thymopoietic support to occur. However, continued precursor 
homing to the postnatal thymus and minimal  T cell differentiation can occur independent of the continued presence of Foxn1 once development proceeded normally to 
the E12.5 developmental stage. These results underscore the importance of continuous and sufficient Foxn1 expression for TEC development and maintenance.   
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Lymphoid cells from reaggregated fetal thymus organ cultures were 
tested for the expression of CD4 and CD8. 
T cell precursors able to give rise to single positive thymocytes were 
present  in 6-8 week old Foxn1 mutant mice.  
Severely disturbed stromal architecture with a significantly increased frequency of 
fibroblasts and the formation of cysts. 
In Foxn1 mutant mice, peripheral T cells express 
lower cell surface concentrations of TCR and 
CD4. 
Lymph nodes 
 
CD4 T cells from Foxn1neo/neo and Foxn1lox/
lox::Foxn1-Cre mice proliferate upon mitogenic 
stimulation (?-CD28/?-CD3) and secrete IL-2. 
W
T
C
5
7
B
l/
6
 
n
u
/n
u
%
T
C
R
-
%
 T
C
R
??p
o
s
it
iv
e
c
e
lls
p
o
s
it
iv
e
 c
e
lls
 
F
o
x
nn
1
o
x
/l
o
lo
x
o
x
::
:F
o
x
n
1
-C
re
n
1
-o
x
n
1
F
o
1
 
n
1
 
o
/n
e
n
e
o
o
e
o
C
D
4
CFSE Ce
ll 
c
o
u
n
t 
(A) The thymic cellularity of two week old Foxn1neo/neo and Foxn1lox/lox::Foxn1-Cre mice is 
significantly reduced when compared to wild type mice. 
(B) A five fold reduction in Foxn1 transcripts in sorted TEC (EpCAM+, CD45-) of Foxn1neo/
neo mice (Wild type [WT] value =1) 
(C) Loss of Foxn1 protein expression by E12.5 in Foxn1lox/lox::Foxn1-Cre but not in 
Foxn1neo/neo mice.  
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Presented at the research Day of the Children’s University Hospital Basel 2011, 25 August 2011, Basel, 
Switzerland 
Background 
The transcription factor Foxn1 is essential for thymic epithelial cells (TEC) differentiation since its functional loss constitutes the molecular cause of the nude phenotype 
characterised by athymia and alopecia. How thymic Foxn1 expression (as opposed to the skin) controls the maintenance of an established and functional thymic 
microenvironment remains so far unknown, not least because Foxn1 target genes that define the nude phenotype have not yet been identified.  
The aim of the project is to define the requirements of Foxn1 expression for regular organogenesis and TEC maintenance. 
Methods 
Two different mouse models have been generated to test the role of Foxn1 expression for thymus 
organogenesis. (i) Foxn1lox/lox::Foxn1-Cre mice: The DNA binding domain of Foxn1 is deleted once 
the thymus anlage has normally formed (embryonic day 12.5 [E12.5]). (ii) Foxn1neo/neo mice: The 
introduction of  the neo gene into the Foxn1 locus results in a hypomorphic locus.  
Results 
Conclusion 
TEC differentiation and maintenance are dependent on the sustained presence of Foxn1 expression at adequate cellular concentrations as neither the loss of expression 
after embryonic day 12.5 nor a largely reduced expression of Foxn1 allow regular thymus architecture and thymopoietic support to occur. However, continued precursor 
homing to the postnatal thymus and minimal  T cell differentiation can occur independent of the continued presence of Foxn1 once development proceeded normally to 
the E12.5 developmental stage. These results underscore the importance of continuous and sufficient Foxn1 expression for TEC development and maintenance.   
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B 
Foxp3+ regulatory T cells could be identified in CD4 T cells of lymph nodes of 
Foxn1neo/neo and Foxn1lox/lox::Foxn1-Cre mice (A). The majority of these regulatory T 
cells are thymus derived as they express the transcription factor Helios (B). 
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Lymphoid cells from reaggregated fetal thymus organ cultures were tested for the 
expression of CD4 and CD8. 
T cell precursors able to give rise to single positive thymocytes were present  in 
6-8 week old Foxn1 mutant mice.  
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(A) The thymic cellularity of two week old Foxn1neo/neo and Foxn1lox/lox::Foxn1-Cre mice is 
significantly reduced when compared to wild type mice. 
(B) A five fold reduction in Foxn1 transcripts in sorted TEC (EpCAM+, CD45-) of Foxn1neo/neo 
mice (Wild type [WT] value =1) 
(C) Loss of Foxn1 protein expression by E12.5 in Foxn1lox/lox::Foxn1-Cre but not in Foxn1neo/
neo mice.  
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(A) Distribution of CD4 and CD8 cells in colon derived IEL (intraepitheilial lymphocytes) and LPL (Lamina propria 
lymphocytes)  ??- T cells. 
(B) Infiltrating CD4 T cells are detected in the colons of Foxn1neo/neo and Foxn1lox/lox::Foxn1-Cre mice 
(C) Absolute numbers of T-cells in colon IEL, LPL and mesenteric lymph nodes.  
Background 
The transcription factor Foxn1 is essential for thymic epithelial cells (TEC) differentiation since its functional loss constitutes the molecular cause of the nude phenotype 
characterised by athymia and alopecia. How thymic Foxn1 expression (as opposed to the skin) controls the maintenance of an established and functional thymic 
microenvironment remains so far unknown, not least because Foxn1 target genes that define the nude phenotype have not yet been identified.  
The aim of the project is to define the requirements of Foxn1 expression for regular organogenesis and TEC maintenance. 
Methods 
Two different mouse models have been generated to test the role of Foxn1 expression for thymus 
organogenesis. (i) Foxn1lox/lox::Foxn1-Cre mice: The DNA binding domain of Foxn1 is deleted once 
the thymus anlage has normally formed (embryonic day 12.5 [E12.5]). (ii) Foxn1neo/neo mice: The 
introduction of  the neo gene into the Foxn1 locus results in a hypomorphic locus.  
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Results 
Conclusion 
 
TEC differentiation and maintenance are dependent on the sustained 
presence of Foxn1 expression at adequate cellular concentrations as neither 
the loss of expression after embryonic day 12.5 nor a largely reduced 
expression of Foxn1 allow regular thymus architecture and thymopoietic 
support to occur. Inadequate expression of Foxn1 expression results in a 
genration of a T cell repertoire that reveals its autoreactivity over time by 
causing severe colitis.  
Thymic cellularity and Foxn1 expression Thymic architecture and T cell development in adult Thymus of Foxn1 mutant mouse 
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CK8 
Foxn1 
(A) The thymic cellularity of Foxn1neo/neo and Foxn1lox/lox::Foxn1-Cre mice is significantly reduced when compared 
to wild type mice. 
(B) Quantification of Foxn1 transcripts in sorted TEC (EpCAM+, CD45-) isolated of wild type and Foxn1 mutant 
mice. 
(C) Loss of Foxn1 protein expression by E12.5 in Foxn1lox/lox::Foxn1-Cre but not in Foxn1neo/neo mice.  
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Foxn1 expression during thymus development: 
Comparison of experimental models 
Embryonic day C57Bl/6 nu/nu 
(A) Severely disturbed stromal architecture with a significantly increased frequency of fibroblasts and 
the formation of cysts. 
(B) Thymocyte development in Foxn1 mutant mouse strains compared to wild type. 
Colitis is the prominent cause of death in Foxn1neo/neo and Foxn1lox/lox::Foxn1-Cre mice 
A 
(A) The life-span of Foxn1neo/neo and Foxn1lox/lox::Foxn1-Cre mice is reduced when compared to wild type or 
congenital nude control mice . 
(B) Colons isolated from Foxn1neo/neo and Foxn1lox/lox::Foxn1-Cre mice show hyperplasia and goblet cell 
depletion, which were not observed in aged matched wild type or C57Bl/6 nu/nu control mice. 
(C) Colitis scores in wild type and Foxn1 mutant mice. 
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Colitis correlates with the presence of CD4 T cells in the colon of affected mice 
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(A) Absolute CD4+ T cell numbers in lymph nodes of Foxn1neo/neo and Foxn1lox/lox::Foxn1-Cre compared to wild 
type and C57Bl/6 nu/nu mice at different  time points. 
(B) The CD4/CD8 ratio in Foxn1neo/neo and Foxn1lox/lox::Foxn1-Cre mice is significantly higher than in C57Bl/6 
nu/nu mice. 
(C) Regulatory T cells (Tregs) are detectable in the lymph nodes of Foxn1neo/neo and Foxn1lox/lox::Foxn1-Cre 
mice whereas they are absent in C57Bl/6 nu/nu mice. 
(D) The frequency of regulatory T-cells in Foxn1neo/neo and Foxn1lox/lox::Foxn1-Cre mice is comparable to wild 
type mice. 
(E) Reduced suppressive capacities in Tregs isolated from  Foxn1neo/neo and Foxn1lox/lox::Foxn1-Cre mice 
Both engineered Foxn1 mutant mouse strains display increased peripheral T cell numbers 
compared to congenital C57Bl/6 nu/nu mice 
Infiltrating CD4 T cells display a Th1 effector response 
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(A) Mice suffering from colitis have increased frequencies of IFN-? producing CD4 T cells in the colon IEL 
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The role of Foxn1 in thymus organogenesis and maintenance
Angela Bosch, Thomas Barthlott, Saulius Zuklys and Georg A. Holländer
Pediatric Immunology, Department of Biomedicine, University of Basel and Basel University Children’s Hospital, Basel, Switzerland
Background
The transcription factor Foxn1 is essential for thymic epithelial cell (TEC) differentiation since its functional loss constitutes the 
molecular cause of the nude phenotype characterised by athymia and alopecia. How thymic Foxn1 expression (as opposed to the skin) 
controls the maintenance of an established and functional thymic microenvironement remains so far unkown, not least because Foxn1 
???????????????????????????????????????????????????????????????????????
?????? ???????????????????????????????????????????????????????????????????????????????????????????????????? ???????????
Methods
Two different mouse models have been generated to test the role of Foxn1 expression 
for thymus organogenesis. (i) Foxn1???::Foxn1-Cre mice:The DNA binding domain of 
Foxn1 is deleted once the thymus anlage has normally formed (embryonic day 12.5 
[E12.5]). (ii) Foxn1??????? mice: The introduction of the neomycine cassette into the Foxn1 
locus results in a hypomorphic locus.
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(intraepithelial lymphocytes) 
(B) ?????????????????????????????????????????????????????????
(lamina propria lymphocytes)
(C) Infiltrating CD4 T cells are detected in the colons of Foxn1neo/-
neo and Foxn1fl/fl::Foxn1-Cre mice
(A) Frequencies of IFN-? producing CD4 T cells in the colon IEL and LPL 
and in the mesenteric lymph nodes
(B) Correlation between colitis score and frequency of IFN-? producing 
CD4 cells.
(A) The thymic cellualrity at different time points indicated
???????????????????????????????????????????????????????????+??????-) 
?????????????????????????????????????????????????????????::Foxn1-Cre 
but not in Foxn1????????mice. 
????????????????+ T cell numbers in lymph nodes at different time points
???????????????????????????????????
??????????????????????????????????????????????????
(D) Suppressive capacities of Tregs 
(A) Survival curve of wild type and Foxn1 mutant mice
(B) Colons isolated from wild type and Foxn1 mutant mice
(C) Colitis score in wild type and Foxn1 mutant mice
Colitis is the prominent cause of death in 
Foxn1????????and Foxn1???::Foxn1-Cre mice
T-cell numbers and regulatory T-cells
?????????????????????????????????????????????
response
????????????????????????????????????????????????
A B
C
Foxn1 expression during thymus development: 
Comparision of experimental models
Conclusion
TEC differentiation and maintenance are dependent on the sustained presence of 
??????????????????????????????????????????????????????????????????????????????????
expression after embryonic day 12.5 nor a largely reduced expression of Foxn1 allow 
?????????????????????????????????????????????????????????????????????????????????????
of Foxn1 results in a generation of a T-cell repertoire that reveals its autoreactivity over 
time by causing severe colitis. 
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Thymic archiecture and T-cell development
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(B) Thymocyte development in Foxn1 mutant mouse strains compared 
to wild type mice
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